var title_f6_45_6864="IPAH angio";
var content_f6_45_6864=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Idiopathic pulmonary arterial hypertension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 290px; height: 336px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFQASIDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5as7aW8u4La2TfPM6xxrkDLE4AyeOprsP+FWeMsZ/sfjGf+PqH/4usPwWu7xjoK+t/AP/ACItfXSODO4zhen5UAfK118PfE9q4SfTQrHoPtER/k1RjwJ4jIJGncD/AKbxf/FV7vr0iyXDyLydxrMspnS5MrfcHGPU0AeMP4I8QocNp+D1/wBdH/8AFVBJ4S1uP79lj/tqn/xVe7X6CQBlZVJGR7+1ctq1wqyPEAw9qAPKJNC1GM/Pb4/7aKf61EdLvB1h/wDH1/xrsLuTJKqGUjg+lZs7DrlvTp70Ac82nXSruMXHswP9aj+yTf3MfUitsyK3JLbF9qiEisQeo9DQBkm1mABKcfUUn2eX+7+orYkFuYhtZ0P8XGfyotdPmupCls6SMeRlsfzoAxWidTyppPLbOMGunXRpIXAusjJ7f41p+RDbxIkSgdwccmgDItPAniW8tUubXSZpbdxlZUZSp/HOKm/4V34s3hf7FuNxGQNyc/rW7pXi7xB4e86PRNa1CxSTlkt5SEY+pU8Z61fj+KPxBjGV8U6rj6oQfplaAOdT4VeOJApTw5esD0xtP9ak/wCFSePNu7/hGNQx/ur/AI12uj/E34iXD7n8VX4T0aOMn/0Guuh+IXjZo1c+Iroqw6eXGP8A2WgDx9PhB4+Y4XwxfZ9Pl/xp6/Bz4gt08LX34lB/7NXr7+P/ABeYS3/CQ324HsEH/stNsfiJ4tmk2S+IL0qOuNg/9loA8mT4K/ER/u+Fb0/8Cj/+KqT/AIUf8R8Z/wCEWu8f9dYv/iq9sj8ZeJDGS+vXxJ44kAP8qqN4z8SM23+39QGP+m+KAPGpvgt8QoLWa4n8M3McEKl3ZpYhgDqfvVlQ/DjxXMcR6Vk/9fEQ/wDZq+hodf8AEV7C0Fxrt5NFKpVo3lyGB6ir+kabO0mGQcc5BoA+fLX4OePLv/j30Lf3/wCPyAfzerK/A74iM+1fD2W/6/bf/wCOV9heGLWUOQ8TKnTpjNdPZ6fIk+44C5/GgD4aPwI+JAbafDnP/X9bf/HKP+FEfEj/AKFz/wAnrb/45X3e1rulYs4GKb5EY4MvT3oA+E/+FDfEn/oW/wDyetv/AI5R/wAKF+JP/Qt/+T1t/wDHK+71hh/vk/jUyxx5AVj+dAHwV/wob4k4z/wjf/k9bf8Axym/8KJ+I/8A0Ln/AJPW3/xyvvuSFGXHtUJtkx940AfBJ+BXxGHXw7/5PW3/AMcpP+FGfEX/AKF3/wAnrb/45X3jJaHqrD8aga3kHUA/Q0AfCn/CjfiLn/kXf/J23/8Ajlc14y8DeIvBn2P/AISXTvsX2vf5H7+OTfs27vuMcY3L19a/QplI6qR9a+Zv2zM58IZ/6fP/AGhQB800UUUAbfgc48a+Hz6ahb/+jFr6xPyWk0jfwqea+TPBf/I46F/1/wAH/oxa+tNSYLok7YzuwOD70AcFe7pmKLnLdPfmq1yPLATPC9SK04Yh80rAlRwDWbcFLeKSZ8EKcKD3PagBk10Psfkuw85RkE9h71y+pgl9xII7jHWo3u3N6WeTIbgnPepJlMibQeM8EH+lAGReQJMgeOQBu4ArDvVkQtuJAJrduLZ8/KvXv68VmSE4Pysz9NuOTQBkSAlSTwQcEYpkULy8ouTnGT0rdl0xVtxLOQHfogqvJHviKLlR6L0/GgCkkUSLl/nb0X+H61PEzsw8oKQABgdQPcU+OyTr5m7nn0pUWKF+ZSrY+7/FQBZt9QlR/LGcA455x61rC5SZS0pQHBA3cbawWm8+RQEPB+8Ov6Ul4Hji4XzAcZI60AW7t4kdiyvIuf4enNVIbzL7AiD0Pt6VWjlfZlCeehBzxU1nbSSsXj4I74yO9AG5p+oTeaI0jG0DgAcV1un3jTphQI37KRWTo2nLbRCZ2VnYduwqd3dSCgwc9qANQNJ5hjlRShP41citkiB2nac5256n1qpZ+bdtGsIaWbsFGTXaad4X3RifVrpLeMDO3PIPuaAOUcSGX5QWPZVGa1dL8L6pf4lCGBGP35eP0rZm8RaPoqNb6ZZCZwOZOg/M8ms4+K726iw7vFC3/PM4/wDr0AdRpWgaZpe06reo7jGVDbR+VdbpfiDR7TEenW245xk8frXk9mpkkMoJcnvnmuk0eAttYAbvTNAHrOn6tc3d4ixoixAZJGTXSWc7vvJbiuP8OOIIjnk4yTXUWx2WDP65NADvv5PUE5pgjUk7xTUJAGDwBThyc45oAmVUXoKmj27sYFVVGTmp4+Dn1oAsMxxg9qjPPSlkPT19KYM5PYUAVriQoeCRj3qsL6Vff6mrNyAe+aoS4B6GgCydUjVtsyjivmj9s+e3uB4Oa2YE/wCmbsf9sK95uwwduSc96+bf2rgVbwwDnrdf+0aAPn+iiigDY8G/8jfof/X9B/6MWvq3VnP/AAj8mcjLCvlHwf8A8jbomP8An+g/9GLX1jfJ5umxxsOC/J9qAOanjZY4LdCdzHc1cl4yuN06wRMNsYweDy3eutmmSBrq9kbOwEJ7eled6lOzJI/cnPNAGLO4jbaA2fU0rXjSQEbirA84OBUU8hlTfyT6DtT7C184MWI2jr9fSgBkDXNzNtViAe56D8K07YQQO0cuXYjBcjPPtUqmIRiNCI1UdM/zqrNdWqLMqpuY8g9P1oAddW4ushWG1OA2f51Umt4YFRWYMT+dUJdW2uREDj17Cq13PtILE7W5znqaALrwhkcxAKAPxrKmRI3OY2DEYBJNSRySTQOqHLZyVJxgU1U82PGcsvY9c0AS6fBI2JBjYTwvSrd+37raVCFucjvRZrsjQhwcfeXPNVbwNJdFQCU6LxkAetAD7Wz85cqSrDJOD1Jrc0nTXzuYMB1GBjP1qtoThZ/KI5bHWu9W2RLc7RuJAbPpQBVNxbwWqxSx4Y9GHb2+lVtOsp9RvkhtsdeWb+Ee9QXdtK92kKDczNtUdea7C7mh8L6SttbBXv5x8zjnHv8ASgC/9s0/wlbmCxC3F+w5bHQ+57fSsPUL26v4GnupmYk52Z4H0FY8ChlZnffI53MT1Jq55yoVQ/OncCgCAShiAckjqKdDKZ3PRecAVWEMhlkKocZ6+lXLe3w2/Kj0Gc0Ab+l7kx82CcHgV32iwAorY3N1NcNp6AlQmQwHJNekeHo/9FQAEM3X1FAG/p25Qq4xnGc12Ei+XZRJ9BWBpluHli+XDZGT1zW/ev8AOqKPurQBGvQ05cA0i8JmlXHB/GgCVeeo7U9O1NU5z1zUqLgUAD4ypPTvUZYng1MVJXFR7egHSgCvJ1qtKgfkceoq1MuCahJ5oAyb2P5Tgc18z/tZjD+F89T9q/8AaNfU80e8dK+ZP2w4fKbwkcct9r/9o0AfOFFFFAGx4O/5G7RM9Pt0H/oxa+uSoOkyv/cBAwO5FfI3g7/kbtD/AOv6D/0YtfXjgx6Icc7z/wDWFAHB+KJEg0qNCDmRs/gK4icwM2G6D+E966zxu2L1YRyscYBHoeprirhFBKnlm4XA70AQR20M8xSHcEXljjgj61LdSCNBHbqMLVto1t7ECMfvBy3v7VjvIFJkkOFHWgCnPIyhncnaSc+9ZU915yFFGEzx6n61YurhZZX8xCExwKzZVUMA3U8HNACeZ8mCmfftimxBpeFBJXnOelWreBZDgnCACtG4Fjb2uyMkTHnd+HSgClaxFRtQ7tw5XoTTJSYZzhCMdfpTY5VRlkV/mzyCP1q0byF0YyDdJ0wBx+JoAdNMk0JZGMZBwSew9qtxy7lXdGGyowehqvYRGaUhEKxtxlj0rWSyW2jX7RIm3qAD3oAXTI2juUlRgyhueOa7KC9RY1BjL7uBisS0jhjYCIDcR0H0rodP+ZVXZ8+7aOO9AHQeGdL89Z9YnTYsSlV3cD3P9KwLywlvrw3E8o3Sc7QOFXsK9E1a1e10G1sE4dwGbB4x1NcXJcW0NyUZjkdfY0AVP7IKDcdhGcfezWdfiUTjaEYDkY6V0sr23lEmTA4IBHP41yGozxy3TJCcn+90FAEtlIyvIJZMZ4rTs7bLYjOQe1ZEMeUQgbmIB967TRbNZolMwIYcgA8mgC/odg7lWIOR2NegaMrQyqOenFY2kRtDGB8h9ATyK63S7faDNIANvIUHPPagDptHCNKrYwAPyqzcMrXDsAWOcUaKoEEjuM560giQklXYHrQBIhXy8leM+tKfL4ABz9ak8rNuu1h0qBYHJ4cY+tAEybBg84qxHtJGD+dVlhkAADZH1q1bxdS+PSgBZeAMHrTAOf1okUq20tnnIpyIe44oAhkHPt6VWkjx0+uKvunPsajaMnnNAGeUYMcjHvXzR+2f/wAyd9Lz/wBoV9QsmCe9fMX7aoA/4Q3Hpef+0KAPmKiiigDZ8Gf8jhoX/X/B/wCjFr7Eu0LWsCKOijNfHvgcZ8aaAPXULf8A9GLX2RcnL5BwFBOPwoA8h8WP5+pXLKcnfj8qwbK2DbpXGSPufX1rU1INNqEi4++5/nTbgAFVThU4GPWgDLnjZCSQQOpOa5PW73MzLEVKr0HTHua6PXLxYVa3jBYkfvCT09q5WSNGIchSy9M0AZ0kstw/zc9xkYH0pnYhgS/r2xU91IVkypGehHHFRmZAQRGDxz7e4oAgeRthx8qkdBTDISxJbk+tK77mycfh/npTI42IG7oeaAF+Z32gEir1qttGwMz7nB6Y4+tQsPLjURE7264HNWra2A+ebkkfd7UAX4YpPOZkciMgYBratrbzTGW+ZScHPTFc7dXCxuuxiCB91T1qW21KYSCNDjbyGPJz60AelWmm2ysHV8NgAHOBXTeGLW1GtW8EpLHfv+XkcV5hptxO14sk0rt1IRjXq3w5heS9u7toyEjT5Senr/hQB0GvaiJNUlEMO6NE2cnpjrXnOqPO87ukkcSk9SmTXcajK6abJCR++mzI5P3uTkD8q4+Wy33Ky3DDy+gTPOaAMKe6uyrCQ+ZgYB24IFUFZ2mI2gHoSRnFbGrXENupKMoYAjgZrnVvC6OwUBV7jvQB0azqkxw5JAxxWtpmqTiddmSM9+4rhLe+bzSRjHQDNdJo96gI8wFeQOTQB61o92JlUlFB4zmu00uXdGACB68+tec6OVdUeAhgBnKiut0cs0o5OdwoA9Lt18nS892psKBhkdadOStrEmPmOKSLPboKAJipChR0xihI6mHTPWkAoAbt2jipYhxnsDSbc8Gpk+UHjg0ANc9F4yaduAxng1C4Jkp4UnBPNAAzr61DLSycE1DK2OMnHegBSSRg818wftrqQPBn/b7/AO0K+lmck+gr5l/bSJP/AAhuSTj7Z/7QoA+ZKKKKAN3wJ/yPHh7/ALCNv/6NWvsd1zFNIeytn8q+OPAn/I8eHv8AsI2//o1a+y50/wCJdckc/ITQB5BLEI3mnLYO4qvGeapXDi1s5J3XLZwue7V1Oq25W5it1AOBk/U81wvia4jbUFtxhoosqPr60Ac1ceYxaQNlidxLdazZCWb52+btj+taF5hVIOeO2ayZG81WUfLg/nQBQugRKQOx7/596gHBCj5yfSryWk07NhNxHOSOMVJFaCMhVXdJ13GgDOjjZJAXAJ6eoqaHl1J6FugrRgt2EwU8+mT/AF9KZcXEMR2om6Xu2cAf40AW1tY4ITLJIE3DIyM8VUdjKVSM7Exntk+n/wCqqtxfPKFC4H6VCk8iESLjcf4j2oAuwafNLIYrePcx5yBzx15qVFigYbWUkZBz+tVbGZpS0PmmOWYFdwY4J9D6UXCmCR4FyZOjOeB+FAHofhtY5ZIf3e4bCUyOScf/AF69w8L2Uth4Tk8xUYuuSzr68Y/KvDvh/JLPqsUY6Io2n6DtX1DoVi72VhbNH5iGPdKevOKAPNr2Ca41Lylg2gYxIx5xWR4isHt4WihYeen32x+lfQv/AAj1lIzXE1unmEBeR0FfLXj24ltPEd8bS4MsTSMQc5yuSAP0oA5DxAssIVJQQdu4NnjOexrBklLQrGMgjriu3kuYr+x8mVMSddrDkf41zuqaPJZuJgjNAy4yB0PSgDMsJdtzGc4Knn0NdXM8ZlDQZA4P41y5heBo3G1g65yjZx9fStqwmyIw2QcZFAHovg29nCJAzYGQfr617J4WtI5Jkc4bkdfWvGvCOS8E2MhTnpXvnhZA5iYAFTgg0Ab91/rI1z0FOiXBFOnQG4OewAqaNCT0PsaAFH3cdqVAakEbbelOEZB5FADR1p54X9acEI7UoXigCJlyQcdqMn6CpSvy81G47UAVXPJ5qu33utTTcc1CemaAI2BzivmP9tDr4P8A+3z/ANoV9OPz9a+Y/wBtD/mTv+3z/wBoUAfM1FFFAG74D/5Hnw7/ANhG3/8ARq19sIiyW0q8Y2kn6V8TeBf+R38Pf9hG3/8ARq19tQfJpl456+XtFAHmuoTiKO6vjj5VKjPrXlWpztK7bj855969J8UusWirFj5pJN2B6CvNb/bnphicgCgDKYbwxkOGHUn9Krx27M5CnCDq3YVcSzknlCoSf7xJ+6PWtE2rLDsjjUKBtHGM+5oAx5CYl2x8DoB3PuapyF1Xe5II6gHtW3e7UKL5WTjAOMA8dxWXeTOI2BUIx4yB0FAGW926vncMA9MVWnmWeYO2dp9Kme3AA8wMM+h5x9KrpGsbgujmPHTPX3oAaiDzWGfwPepvJkcErkj0HPFSyRLLHHLDG6KODnp9amFy0TxlIgY93C8/nQBRjYuwVOPc/pWzf6LeQ3aveRNGrqpG7+KptItlSVZdVt0Fs+WyODIBzgfU4rsLfxo2rCEX1nbSxRYWNHUltvTFAGv8I9MM/iOyil2L8xyM8kbTxX1T4fsXticvlAoAwMV5P8KvDdlcXkGrwxC1G4yeTIuGYldo9wBz+de1RyLF+7Qgv356UATalJstmL5VCMbh1FfK3jLSIrfUGkim8+J2ILxr3BPGK+kNQJk3rI5C9hmvB9SRLbStQUEDfeuIlIySueT9OtAHmUtlNLOrl/IywId/4ea7J7VNT0G4QfM4GwlehwKxr+FkLb1YAjO71rX8Az+QLiEnPGQpOfrQB51bW0lvdBTxglWTpntWtZWTtMiZGAeSevvXX+LNMs0uUkSERuwLOQOTnpWhoWhRZinbcZJUDhT0HbrQBreFbUw26IUPOO3SvZPBsRAXIyqjrXIaJpEoiUbAP8/pXoXhy3MKqp7A9KANMq4lJUdfapFEnfGaXLEn0Bpc4Iwc0APAYYpSX9KezADNIG5NAApbHIpwJ70gPFOoAYzc4pCM05+e3PrQoxQBSmXqKrsnvir8wwc461VYe1AFZhgEkY9PevmH9tHk+Dv+3z/2hX1I2O3618v/ALawUf8ACG4GCftuf/IFAHzDRRRQBueBv+R28P8A/YQt/wD0YtfbQX/iTBf+enP6Yr4k8Ef8jpoH/YQt/wD0Ytfb6rugtYf7oXNAHjvjZgmoLbp/yxQLz6964i6jG7aB8x4Fdh4xVpvEF4w7uSOe3Ssi3tFBa4fjblVz3NAGalqsEOwZBYfOT1JpjI/lFkGQvXI/nWldxFo90h2vjoT1FU5ozdJGIpY/OA+WPOC49qAMK7dopR9rUhyM7V9PSlWxW/hjNkg2R5M2TllA5yfUVpnRbm7tJPtssUTAl1BlDH37/pRpPhm4aSL+z7uN0Z8fdIByeQTQBzeqtGhUQq7Kwyr9j/hWHNdb9ySDAJ5IHT8K7rxDokNtfyW9/qEVvBApaIRruDjqQT9axBp+lZWeOd7uNR8wC7FJGeCaAKOlySCGVkAYRRnG88Nu9u9RQXd2DukJVJPkwEAyB1x6VoS6vp0rpBPaIIl4OzO4dgelehfDfwrpUmotdXD3q6fGCvk3Ayr/AEoA53wv4TutYms57wSpZhd5ck7uTngenvXoAl8NeF2UslvG7cMjgOz+/PT8KzfHfi2a1B0/w4ga0RctdquQADjAHcjH4V5kHS5mVrhjJJI3zuxyx59exoA930XxzHrmtW1lpsEscDnYbgjbgeo717DoEzSXN2MOY45CoYng47Z9a8D8E2S2d1p1nbBf7QuCDgt92Mcmva9C1CGO6ezjZXUDcNv949fxoA3r5HMEkkm2NSMKW/HmvAtXvbK8vLVobvzfs+5WRBy3P3vpXtPjKeQaLcMD8yocY7V8laddSz6hI33MAggd+v6UAdnrV9Yz2ixxvudGJMaN0+p6VV8E3yWPiW3naJZVXLFXPDHHtXGwzm4kSMKQCQSFPb3rf0S3lN/GsakxhuMfSgD0vxXfTeILKOBmtYGhkEriKHGFPG0n1rQ0a6ljaMKkckBUKp29AKwPD7i3112uwWhcKrt2I6V21paxWsix7g0LHKYPQ+lAHV6RcoyKzIyM3ftXXaOQZODxiuHsm3TBQFUYHA6DFdnohzKOO1AGqV+c44NG3JFOY/vCKctADGztGacq/h/WlOOKdmgBPYU6kFLQAhPOKMgU3HPH40Ac0AMmbA+79aqs6Z7j9amuCQT71TbNACsyFsAkH6V8w/ts4/4ozaQf+P3/ANoV9N+hIr5g/bU+94O/7fP/AGhQB8x0UUUAbvgQbvHHh4euo24/8irX2/vUTynjainFfEXw/wD+R88N4/6CVt/6NWvtOUhbC7kYkYWgDyDxQjNqT4J3MT/Oqs2Y4/IbkAYGB1NdHqMKTXAnYEiMbjn16CsiZEWNp3zlfuj3PQUAc3rdz5dv9n8sGQDLFzwK5ia+Z7aURoEwNoaMc4+tafiJpkZpJGJZjuJHIIPXms+3mtSyIdvzYzk/zoAp6eYRMn2mU7FYN5Qz82Dnn/GtSXXLzzZPKmkRX+by0bCxjPQCqmo2bWV05ACB/vBSD1/oazYoj9sQSMI1XOSaANdtekicqscU8IG0xyDcGz1ya7/wvYaVp/2qbxdoKQaY0QKuwALsfulV74BIz615xp+l3NrKs0se5Bl40X5tw9Tjp611l3p11rE1mLua7FpbRpved/8AWHHG0dhigDe0v4c+FtWkj1HSNQlFvG37yBxlt3pk4PSo/iD4xsrBYtF0twdi+XLInBRePlHqTXN6p4oaCCWw0QbERCJJgcfiCO/vXGW0DX0zyNbTySDLnyxyxoAuXOqr5xjihBtQMDcxGwfyz71c0e3FvrUbXSp9miUTnHI24yDn/PSsue0vbhzHaaftbG4Fm4UfyrX0LRDNZiS8vJGuI5Astu/EbR/3ge+OeKAOo8D6xdap4ul1OOJVjifYuR/Ceo/L+dej6Zqstl4iFzIchnKhR+n9BWJ4e8Nw6dal7fzDYld0bHqfU/XrWTb3Xm+OtNs4nIWNi7gHPABxmgD27V7hrjRGLE7n+YnvzXzRPC0HmmMCMFmO9hwMcf5FfQOuXjPpoCAbUHKjv7mvnXX76eWSSMqiwIrPtTvnv+ZoAzpL9pJYotPQRKi7dwGGk/2jXo3w1El5qapLGG2rucgZ7dfrXm+mRIsyMFYfKSvOa9V+HbCw0W/unDCWRfLhU8ZPXcf8KAOj1m3QzRvbAIrD7oXrg9a3NEH26yFtKCZYwGU+tYEXnT2UMsRIAbB5PetvTPNjCvjaRzgcZ9CaAOr0reUKSRgMPXrXYaMhjZXPAPArltIvN4RpVBJ4J/GurtnxtPbigDWkIEme+KUEdaVwp2ljx7U0MnQGgCU9KBSbhSlhQAUtICD0NLQA1uAT3pik5p74xzTB69aAIpzz81VHOOBzVuUZqjMccUANc+p4r5g/bROf+EO/7fP/AGhX0yx44r5j/bOJJ8H5/wCnz/2hQB80UUUUAb3gI7fHPh0+mpWx/wDIq19o3x/4kNwWzg4HFfFfgc48aaAf+ohb/wDoxa+xdQmLaCUJIZmCj86AOWuY/wDQVTBzO2fwFcl4qeZpEtLf5hGAzY7k/wCFdvftGjtISPLtlwOe+K8wvrl7uZ5EYZkboWxQBQgg5YTAjdndggj8B61Ubw8L26j+wMg3fKN7Dn6HtVwxKLdlmaJCe/U/T2ptnfw6TD9q+ziWKM4Bb70j+xHagC54i8J3VikD6k/2eOFAsmDuLAZxjFU4NQsLe3CfZGmEJDZmUbj6deTVaXWd008l1c3Tzy8NzwvPBGfTpU+hW+pX+pbLO3GoxbCxVo+Vx646UAXYPFV/cJN5ESwzyqIo0iXJxnGSPTp+ddL4n02/svDttZ6xcJE053TlD8446L6elYtzqOn+EZBcyxIb4j5IY/4W9Cf8a4fVtcuvEbTXWpTSs6vtAR8BAeg57UAWJptHsW8lDLMvTrw341T1HW51mS3t2EMS5G1Byc9yaq+Y00hhBjKDhyTgqfr9ag1qxNrNHNGweKfBRg2ckdRn1oAfPqupMPLE5VumFA/U966LwLa3t/rebuWcJGhdiiAZ9OfrXJ2sZeUGNV35/i468Yr6e+HXhSew8LokymSa6C7wQDtHt+H60AaEUuPDUciyeX5UY2Ke+e+Pc15N4QnA8cNNPCq3OZC20fXJ9uK6zx3BrJ1+3htAsVjacElsbu3T2p2meELg+MtNuneJIpAyOQ3XjigDvrdRcafJuBAKEEGvm3WhHJeXDlyQkhU7up55r6pl01LUSW4LbggJxXy/q2my3mv38EQICTsMDk9aAHeHrcqrXt0WW1iOEVf4z/hXV2U93O3ygqowEVeAKg1BrPTvDWn2cABniyZXPTceg/AVb8PucoT9wHpng0Aek6RbSPpamNMMcM4J+6a09MtnEq4PmMeo9qk8OMkiyYACugPXr71oWkcf2nCMykHgZzQBcgt9kUbA/Ke/fNdVYncqgc4A5rGsbN2ieORhjIIwe9bNnGIowAc8UAbarutwCecdajRM+tOtSNhUGhFKyN7UAPCe/FG3HakzjGaUZ96AHKowODmnDgU3P1p1AEMhO7FLGvGTTmXdin0AQSxnggiqVzGQf8KvzZyMVVYkHk0AUCvJ618yftojB8HcY/4/P/aFfU0iBlOBg+tfLf7ai7T4O5z/AMfn/tCgD5jooooA2fBZx4x0I+l/B/6MWvrrUpClnGwPEfz4PsK+Q/B5x4t0Q+l9B/6MWvrDWpsaE+Bl3YIo7+tAHLeI9SeLQGyBvnfOP9kda8yk1JVmOxfmI4J6V2XjK5T7StqX4hiCnjOD1rz6RGmuB5OTIT91V6n2oA0BdTRwKo8uIvnJ6/nmr0snnWsCy7JEjTbmNcKeeTj+tUrawmaJn1BTbRsRgueWx7VeaSK1dWsFLPjb8+Du49PSgDGa08+Znb93H1LnuPXnt712mk+LYvBXg66GjxMuoXxaMXLrnCkYAH485rDvbmynkdbp/MktYN6hPuFwPuEjqK5IanPd3ckty4KtGV8tBjYv+yO2KAKd3qc92y/aMSNyTKwy5zz1qG9uI9sCWqFEA3NuOSWP9PQVV2EP8uSCep4OP8afHGNww4JzwOgIoAt2l3xtWFNxwWI43n0zW/b3O+3MMVlHdfNlh5ZYp7YH86xZmtrcj7IVaXb82Tnn1ArovAen6jf3KtZ3DwxzOPM8o/M2Og+mc0AenfCrwH/bGo293e2SQW8eJHikTG8kcEe1et+PPFth4M01Y4yDcMMbgPuD+lYvifxjH4O8HxsF8zVGhWNcn+LoCf514ENZnu55LnUH+13DKfOSc/LID2A7Ec0AbGseONR1X7QkiRJCcCIYIeLnO4nufY10/hK91DxBBAj3z+bFID+74B29f0FeXXkNpLIWsJm3lMvC4xsHs3RuOa9W+BGkSpZ3d9ICkWGKbhjqOtAHrk0hFgys5LbACxPJ/GvnHWZpbfW9RCBEM0xUOD2716L8TPGH9iWNuLWMzyFgCc8D1/GvOvFMUV9axa3E5jzhXQcE7u+KAM+e4gghELv577shQeM+9dHo12d6YxkcE153csz3AWJWALdznnNdt4fDoTkhmByfrQB7X4evo0WVPL2/JncB1rpVt0kZJ4HBB4IPFcH4UmzEwlGf3Z/Ku10iRLy3MQYeYPmA6UAb9hIQ+xhtbHU1tWuX/wB7PNc7amRZAG5xgDPWuisJGO0Ec47UAX4iVkzj61cwCM4qouMfWrMRyuKABlyR9KdR9aKAClpKWgBpIzilppJDEelISM8nNADJ3x061VeXnBGc1NOc9+Kqv15oAfwynace1fLv7a4wfBv/AG+/+0K+mGODkda+ZP21GJ/4Q0Ht9s/9oUAfMdFFFAGt4T/5GrRv+v2H/wBDFfVWplVgsY2PCLvbPXpk/wAq+V/Byl/F2hqOpvoB/wCRFr6Y8Sz403Up1PKr5SfU8fyoA8v1q5e8u5ZCMiRyf1OKyopnsbxlR2888b1GQgpXuJS77ZPYYPAqQ2rRwB541MsvPPXgf/WoAsLb/bRtt5kjcjLpI27aw9D2zWJeTywRyRyBgV+Qjv8ASpHvXsjvSZUJI6LkH61NdWVzqq+eQYVADyO4wCf7w9j/AEoAy7m8l+yvsKqZQAyKvOB2x/P1qC9ghhuC8cxZdodjjByR6due1SahDZ290TJcytu5Vk7jPb2pl3dWUWwGB5yV6sefpQBnyOs8m/J3f3euTU2oQRJbxGykeUAZm+X7jHscfzpYtUWFwYLSFf4gSM4/+vWnps+o3ayzWaRPIi+YyDj5ScEn2zQBX8LeH73WLxEt1dY1YFmVSTjPb3r3rS9MtfCmj+cUEdwVHDH5gfp61z+htc6Xphu76VdzKGLIANx/uiuLvfE9xqfjGxiZm+yxTYYkn5z0yfYUAb3jnUZda8iZpBtgYjydv4AmuJvZWjliDNxuBDY4H1rqPEltNaMkyFlUySMZOxXqOenWvO5biRmlMjo7M5Ygc/5FAG9p9r/auqRQQKwlkk8tQOhBPJFfRWr6la+DPASQx5iQIB1+Zsf4mvHvgnYC41qfVZQVjtRsj9AT1P5U/wCLniQanMmnCY7RIX4PCqDgD8aAJfH96b3RrPCsSzq5GMkcHqabax/aPBciuQUjXkjvg9PrV/VNaS18H/ZTaiSKdkErZwTgcYPas+e5tP8AhE3NsLiMNxslbJyT64oA4uWR4bjfkgg9+xruvC22ZEkzkY55riZpoVjV1QySEbT5mTj3A9a6nwdIi2uA5zuIbngUAeyeHGtVt3ZjhwhAAPUnoa3dCkMU6Skn5e2K43w4TJG4YHIGF+ldrpygFQx4KigDtoCJFyuTu/StayQLjHGf1rC0Lm3bJyWxkelbtsG42jPue1AGhH+HNTpwRUUapgHcSalUqOmPzoAmpKARS0AFFFFAEc33QaiHWpZvu1EOKAGyjgcVSkOc1cmPHBqo+c9TQBCTk9OnpXzF+2gcnwf/ANvn/tCvpt+p5r5j/bOOf+EP/wC3z/2hQB8z0UUUAbPgtgnjHQmPQX8B/wDIi1754uudvhsA9ZZWc+4AwK+fvC3HifSP+vyH/wBDFe1+NLgALArACGNV59ep/nQBw9ttluxvXg/NnGR+IrQuZpgQ0yIUQglgccZptvF9nTczxKG+Y5GfpWd4g1Kxe0+ypFK0mcsyMFAPpigDN1i6tYb51tkMzDgF+gPsPQU20nl+xyG/uPLRztj3csO/A/u1kyqGi8yIsy/xgjlPy/nUHnM6JvZ22DaoPagDX02OGO8i8+6gMIYcyruGPp2qLV7OO1u9sbNJAWYxP2K+ufxrPhG9wjAnPCnrmus0bw7dXln5mrR/ZbCI4NxKdoK9seooAworc6hdw2ljGrsQACq557k+gr1jwx4Wg0WNpr6RZb24AB2j7q+gH4Vg2yWultFF4aha7nueEmxuDH1J9q1NfvzoGh5lmL38gwxzzkjtQBm/ELxBNuSxs1aKMLt9MD+XNck1xDZwqtsoUkDzHU9SOwPYVkXN9NdXj3F27Et1ye3tUUpcBUYHbtz6e9AHSy6hPNos8EpkaFhuUHqrDpj+VYFlp809zbxZETSsBk98n0qa3bdpdw28hlZQvOPqK6z4e6RJfO+pXKlkgzGhPagD0pba28H/AA/ma3O/91vdh2yP514RcXjT6n9rmIcM3T1Fd/8AEfVp/wCyE05JCFcgsM+/ArzWJWdwNoYDgjFAHpvipivg1CwIZXTPHIz0qhYmS78KOEcnbliM8jBzXoOveGP7Z+Gb3+nvaxCzt4nlDsWZiq5PPTNec+BL6EQT2bbfnBYe4PBoAw0k3StyAGHGDwB7V0XhRwkzJuBB5xWFfWv2S+kgA+VW5LcZ9K2vDsbR3CSso2EHJxx2oA9j8OHy1WRTwUxz0zXbaZGTCCvJHHIrhPDEhliARSxzwccCvT9JgEcSq5BOPmYUAaejtsOO3Ga6myGR8p4Nc5bQOsgCjjjBFdFa/uxgdeM0AXxGyg8Z9xSoh5pgcsBkmpY2PQ5oAftOB2pw6UjNggA0gJ4z60APNHakBpaAI5OnNRDLEgc1NIMqaRcIKAK1wNn1qlISTxn860bnnFUpF5NAFd1+XPr3r5i/bO/5k/p/y+f+0K+nZDnqa+Yv2z+vg/8A7fP/AGhQB8z0UUUAavhMZ8U6MPW9h/8AQxXpfiGdrvVJ/nHlmU59QAf8K8x8Nv5fiLSn/u3UTfk4ruYpDNBPKS2Z5di49M80ARXlyLe2lmPrgY7k9vpXKySRyDI8yNj+POe9aGv3QMotoWKxRjawxyWzyax1byyGUYPceooA0dMs3c7hc2ixSHawlbbuqK5sbNZXWO8jbaSM7Tz9Koz3kjHhUVeoVV6VFEHmlRfLLk9NowTQBsJarbrDcASSHf8AIoHytj1Pp/8AqrZnutY16QrqLvFbHCiEcKPoKZZmLTLKH7cm+JQX2xvyrH+H9K2LnU4LSxW7uRIEkAMce0AqaAOn8MvaeHNKcyuDcSAHI4wPT2zXnviTVJb/AMRz+c+62c/IB3X1p1/qF1DZPcXJBe6+WIAcIP8AGsVlH2NWnfy5g+MNycdenagCpcDe7NkNtPXgZ9KSNtykkA7QKkjsrh5AyDzBngoN2fStOXQ9Rgi8xrO4CMNwxGT+eKAKETQyK0cimMEgbkPT/aIPWvafD0cOj6Fb2qrv3LkkHg8ZzXmfh3w3cXU6XLoEtl5w38XtXrGh+TfabfCQDFohiHru254oA8h8X30l9rrLKPlQ8D3P+RWYkahiGypKnoP6Vt6qyG5kuoRELogAxyH7jDrtrCOqXJ/dmYkk5JI6euD9aAPT4dYmvPhzZ6MCI/NDCQqcbsdAa4Dw6k0WrxxopEqE57YA65qz4OvkXUvs027yZv4j1U+pFbOpxmxvJpEiAguBtXb1z359+KAN+7FjNpwnisFvp3QZfOGjwc5TtntzVCxm8+7Vo1aNDjMR5AOeaPBuofZblLdx/os5x1yVPYiusi8NLeXZbT5U8wP86n1/pQB23hLYYV2qN3GVxj8q9M0rDRKzYyuOMVxmgaVbqRGl7AZQOTu7+gFdRZXMkDpCCoxxt29frQB1MBLgdjV+EnjArPgZvlyAPcGta1QPHnPAoAnHYdhUqjBFRoMe9Sj1oAXHJ5pQcfhSEnPP6U3uKAJAaWkGMU6gA6imMpzxyKHbApvm46jNAEcvIPrVVyMYNXmkjP3qikhR+UYYNAGbMuOecV8wftnjH/CH/wDb5/7Qr6qe2bGMA18tftrRNG3g7cMZ+2f+0KAPmKiiigC1phI1K0KnBEqY/wC+hXaPKILaUggi3TC+u81xWmME1G1Y9FlQn8xXQazK0MEUCHlx5shB9elAGaq5Z2nmKyj7pYZzTopreEZnVrjngD5eTWacyHJJPH5UoZ/uqCBnOKANaOSC5huDFFDbGJd53MTu5xtHvVzT0itrQ3M17HESCEjCH5j6/Ssa1gkuJVjRThznpn6k1tTWkuoTQaTZpvjgGDIOzd80AJaWovrtZ57pGhTqqHsOwrW8SASW1ld3EqlVVmWBhjb6ZP8ASoL422h28duTukHJXjrXM6nfTXtzLLMxJZzhQfu/SgC1rF4zTW80LMCFGwg8Lj0rPDtLGwZ/3md2T1P401tywoMbs/Mp7datxwRSWTu7FZFOT3B9PxoAt+HTPbatA0e8BSHdcdR9a9P0jxdrOq6kVsbSCK0hGGEi53j0zXOfDvR7S9imvL+48hIRhc/8tAe3vWydWtreaSGwdIYYQ2WT5TJgdFB70AXfGXiV2je30uGCGfpJJjiMfyzWd4a1lopLi0tZC6GNZ5G6Fj2NcPqOqNexGOJfJjJyybslj6mus+Gtn9tlDKv7uNWSdhyemVoA4HV5JG1O4djmTzG6nryadPaSgpIn7xJFzkDofQ1o+LLA2muXJCsInbKse/tTbS2L6Y/zbQzfKp9upoAj0+2kRZpxlSi4BPueg55Nd1p0ba34YIDgTQFs7e5/+vXD20BadNqMwJ4JJ4r0Lwl9ms7r7OGcm5XeF7Ljt9aAMSzWOJBJIfugbQvX8q7rSrphc2l3HIVnZNrg8bh/+qsCfTHi1q4RkULncAB0BrpYLaPzoWjyFSMKfr9aAOtsIBZ3pWNjtzkNjt1r0LTrxjArsiPKeA5HI964i0X7RbW8zIVkQbWz1I7Gup0wsFGM5HTHYUAdXpTu6EPkq3fuDXUWY2Q43DPfFc1peXQNzkY4xXSwqQoAGaALKEYx3qQVGinJzUgGATn86AGsT/jTUPPHP0pzR55LUqp6EZoAcvv37UP92lA5FB9qAIWJIx37VGOcZqRlOTxUR+9jNAEc/Qc1VLspypOKtTcgVUk7+lADhdSdA2K+Y/21Jnl/4Q3ec4+24/8AIFfSL8YJr5m/bKkL/wDCIZ7fbP8A2hQB81UUUUAT2OPttvu+75i5/OrV1dG5vZZiflZjtHXjsPyrPHBGKlXB+7ywoAdnaQy8YPQUscskbDaSefrmp7eMeasLRyM0nygD1Nb+m6cmlX0g1CBWkUYKlvlTPfjvQAuk2l2wU6chfUZcAQAfd966uW1k8J6KGuo0XU7hd7eUQQB3+h6Vy8+spYM01iz+Z91JDxke3rWOt9KZZZ55neWdWU7jxg9RQBVvL17i6M8mXcnPzDio1InlG9FUsfXC8/yqEqQxAPHr7VpWelXcrhjCyoD1IoAtGwieOWSW4igMQVY4927d/hg1a0nRbq9nVnG6DPVOcitnwv4GbUrvdcgiCPBfjhq766tYYrYW9lGi+WMAev0FAHGeJPNgt4LLSwuzgykHpgfdx71zVrpl5fTGQo4G7fg/5+teg2eis13vZS0m4MGA5GKvXenyLKwTd5hPJ6flQB5eugXU1xtx1PNet/CLQpbHStbYbHBKhxtzjHbPvUtjoZkXPlgyRjOP75r1fwLYwaf4P1R2j2XQBZVU47encUAfPWrWSanq1zb3x8uJ5SID1CHp17VUk0Oa0tHgmGBG/Cj+PtXoOq6RHFL9oKKUkHmIuOmasadp8erwSpcoftKrtjkB6gdFIoA8zstPf7ZGJR+4yGZUxuwP4c9q17KMw30VwoXdG2Qe+30ra/saS1aQSxbG6c5yDU1tp43KQOP6UAbus6Xuisr2KMndw5/UU7SbZ0cYXJdskfjXV6ZbC88KPlCWjAGPTBz/ACqlHarsHkqQx96AL/h8gTyeaA6uuGB9a6S1UwyYkB3Z/P6VzdnCVIOAP71dZaBjHGxAOQGUHsKAOi0YjafXiuhiJCjBNc3phKsCRgn2rpbZMoCWAz0oAl3EDBNSbztqFh7g05SAMdRQA55CMAHn6U0SEUEA96aU568UAShzjg0pY8nJpiKB3qQIGUj2oAg3tnO400E8mpdiDrk1GwCnigCOY5UVTkarkp+Q+lUZMHPagCvIT2NfM/7Y3P8AwiP/AG+f+0K+lpH2nAxXzN+2Icv4Tz/09/8AtGgD5wooooAUdRTwDnnimCpOwO0mgDS0kzw30RhYhwck4B2Ct68uo7zThHDHELKKUPNOXAkmPpjOcdaxYpvK02W33EXEuGdu4Qds1TgV5vljQspwNo7e9ADr2586ZsptjJ+VR/CO2Kt2ej3eoTR+XGwixtD46gVvaL4aSQ7pP3pONrYwK7jRtCeCJVVDycnBBJNAGNp/gyztxA6gTttBZm5Ct6V1ul+FZ7l1JXardWx0rrNL02LT7cSyhXuHHEeegrRtbiV5gp2xRnj5RQBWsbK2tPD19DZgNPCvJA5+v1rmrbTneQsOc9T3Nei6Daww38ttdWqukilGHIzx1zWddaYtvOUiUBQcKevFAHPWOmvuyMZOO1X4NMZ3JZMkHlscj6V0VnYYjLEc1o21usI+RBvwR/n3oAxzo0kcKvGgMpGB22j2roUt3sPDbI215pk2lvr/APqqq8Plqy5JcnDc81t/Zlu9Dt9xwsRGePSgDzVrZ5JnyTsJ43D7v/1qsadZrCrmIiM9TtGOfWuqv9OZCWjEYV/mXb0IqjHa+W6uQMHjGO1AHPT2P2tpGmH7wdWP8WelLYaOJJCfNRY0GSP6fWuklshIrkfLu4696qeQuNqFgF/U0AdJ4XgtbvTJrS3/AHbjqD/ECOtYtvZQQxMhk3TKxAIHQDtWx4PhMd5K5U7QnPvk0mraaY5WuLdt8THJK84NAFS0tPOdOcggc+ldZp9uqQRZA4JrH02E+UC3DDv2NdHZY8tQ31BoAs28Pz5PGOh9a01PQCqKdz3q0jHePegCVu/FR5Oe9SE1Hkk8UAOyeadk8Ypi56HjFPHX2oAenUVYJ2oMd6rrwalLZANADZOSDTBznPSlLZWm7uMUANmH7ontWbJn8603bEJzWTcPtFAEEmGPPNfNP7YYw3hPH/T3/wC0a+kGbBJ7182/tgMGPhPn/n7/APaNAHzlRRRQAo61YhIjcF8nvhar1PbRNLKqIeW447CgC7ptpPezmKIfK5yxPp6V3Oh+H44oUDL844YevNP8K6UsUYfaDjt7121naCKYPjMhAOe1ADdI0Z2dEjiwO1dnZWSWOEVc3OOSR92q+kWxlmU7j8vJHSteP95Mzvksec0ARQ2zu5Mmdx71rQ2kIKMzM2MZwKkhRXTkYNaGn2wdsycInLH1oAnaP7MpkIzPKODj7q1HDal8FwWXPGeoq+cXD5ZMqPlHsKswRDcPl460AVvsW1BkcHoKesKx5IHIHBFX5BgkGofvnHSgCs1mHkDj5gece/0rY02INYyxYxnIx+FMsoQ8gZSQR1PpV4ypG4Ucs2AzCgDnxatjaFOO3PSonswB8xAY1vTQOG+UfKelImnSzLhEz684xQBgyWaeUvGWBzVZLMMx3Lt9TjrXTzabJAv7yLg9xyBVfyMNyPl/lQAzRdPNvbXM4dWLIQAO1QaCsscpR1JibqpHetOyiKQzBMhWqZflQqvAx1oAc9tbsCIk2MOcetNgKxuAw5Azim3Ds8Ssh2leCafCwlQCQjOOCKALKTA+1X7cB1V1PIrKXCkjHPqav2R2pQBZ5B709R81N357UqHAPrQAp4NNLegpX9qYvUd6AJU5HNPDADFRq2KYWOTQA7PzH0qPJAOeKRm9vxqNjhvUGgCdzmNsVl3Iz1q8HyDxVK4xg55oAzpDtJycE+tfNf7XGN/hbBz/AMfX/tGvpC9ycDqR0r5q/axJ3+GM5yPtX/tGgD59ooooAUcnA612fhXSfMxuHzHqSOgrkrJPMvbdCM7pFGPxr2DQrNbcKxGBjJ/woA19PtBFEiqACK6O0t8whgOV5qlpsWcE10VjH8y+h60AT2S+Sq44c8/hW1bqsigFRn1FZ8cPzlMZA/lWpbLtI7YFAFu1ieNwExg+tbcKRvG0aZUZ3EjvVKEDYFAwSOfetGzi8tgBjB6igB0EQHQ8VdgU9ehHSmooByfyqUcDigBrbsjGBTvKDsF27D+YNLGATgmrEKnzGPotACqFhi8rG5m+9USxhc/1pdpyc1Jt+WgB9tkrsJ5PCk9q07l/s8KrGCQmBj1NZSDawPpWqs8cqBZMK3v6UAOs5TOjBwMD5SOorMMOJnQH5QcZ9q0vNhiUCMgsOgHSqhyc5oAFVREyqKpzMVyEHPrV5CA39arOFJJXPXpQBVgVjuDdCOlLGNuMf/qp5yrBgTx2pzEFsjAzzQBLGd23PWtCIYTHas6E/P8A4VoRsQKAJ0U46VIQQMZquZGx1pd5K5AoAmK9OaXAx1quWx+VHmdyMUATkD1ppAzndTA3B5pScigBce4pk3ypgnntUJY7uc00knjmgB5bIzVSZ+2efWp81QuT79KAKl64ByOvtXzf+1sVYeE2CgE/a847/wCpr6HuHDAsfwxXzr+1mwYeFMcAfauP+/NAHz3RRRQBd0QZ1mwH/TxH/wChCvbreIgIuMEfMf6V4noRxrmnE9PtEf8A6EK9z04GRtxHLGgDc0xcICcV0VpHjHv1rK06HAA7jmuhskGMfjQBYjjyA3fpV63UcE8io4UweO9XLaPDdeAPSgC9arg55FaUAHc//WqlGcY44qyjhRnPNAFtCOmanHMYHfOapLIc81cicFOen60ASrgAbgPb3p6v1U4wfSoN2SM09cA0ASgYNOHTmmlju4zilzxmgB30qTBbb7DrUQyTUucLjtQA5SBx0pQwFMz1NIe2KAJCSV9zUeTkD86Tdxz1pcHPvQA2UDnaeaYmDkH8KlIzz3pu35s0AOhGOavJz0qnGCD9auQkUAK+QRmgMR0FMdjjr0pgY880ASkMSSRRtPpTN/uaN9AEsYI6ipVHPaq6txmno200AOdVJ+brUcibR8pzTpGBFRFsA0ANzVK66kVZ3ADPeqVyxOaAMi9I5UcYr52/aq3Y8LlhwftWP/INfSkVkZH3S42jtXz7+2FGsa+EFQYH+mf+0KAPm+iiigC9on/Ia0//AK+I/wD0IV7vpp+VefpXz9BK8E0csTbZI2DqcZwQcit2Lxlr0Q/d3+P+2Mf/AMTQB9G6c2NprobMg7e31r5bj+IXiiP7mp4/7d4v/iasr8T/ABen3dXx/wBu0P8A8RQB9XRLytaMKAD3FfIy/Fjxqv3da/8AJWD/AOIp4+L3jgdNb/8AJSD/AOIoA+v0OMVIGya+Pv8AhcPjr/oOf+SkH/xFKPjF47H/ADHf/JSD/wCIoA+xU61YRue1fGf/AAuTx5/0Hf8AyTt//iKd/wALm8e/9B7/AMk7f/43QB9po3I6YqVT3PSvikfGr4gD/mP/APknb/8AxulHxs+II6eIP/JK3/8AjdAH2vnvT/QV8Tf8Lt+IP/Qwf+SVv/8AG6UfG/4hD/mYP/JK3/8AjdAH22BgUucnrXxJ/wALw+If/Qw/+SVv/wDG6P8AheHxD/6GH/ySt/8A43QB9tk0Zr4k/wCF3/EP/oYf/JK3/wDjdH/C8PiH/wBDD/5JW/8A8boA+3O2KBntXxH/AMLw+In/AEMP/klb/wDxulHxx+Ig/wCZh/8AJK3/APjdAH22B705evPSviL/AIXj8RP+hh/8krf/AON0D45fEQdPEP8A5JW3/wAboA+3j/eqaJuMfjXw3/wvL4if9DD/AOSNt/8AG6UfHP4ig5HiH/yRtv8A43QB9xtz3pMZzXw9/wAL0+I3/Qxf+SNt/wDG6B8dPiMP+Zi/8kbb/wCN0AfcW096CCPpXw9/wvX4j/8AQxf+SNt/8bpP+F6/Eb/oYv8AyRtv/jdAH3HnFLuFfDf/AAvX4jf9DF/5I23/AMbo/wCF6/Eb/oYv/JG2/wDjdAH3IW44qORulfEH/C9fiN/0MX/kjbf/ABukPx0+Ip6+Iv8AyRtv/jdAH22aZsHUgV8Tf8Lz+Iv/AEMI/wDAG2/+N0v/AAvT4i/9DF/5I23/AMboA+2GHNfNv7Y3/Mo/9vn/ALQrzn/henxF/wChhH/gDbf/ABuuZ8Z+OfEXjT7H/wAJLqH237Jv8n9xHFs37d33FGc7V6+lAHM0UUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This angiogram, obtained after injection of contrast material into the proximal right pulmonary artery, demonstrates a large central pulmonary artery with marked attenuation of the peripheral pulmonary arteries with no intraluminal filling defects to suggest the presence of emboli.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Photo courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6864=[""].join("\n");
var outline_f6_45_6864=null;
var title_f6_45_6865="Stool diary sample PI";
var content_f6_45_6865=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F67114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F67114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Stool diary (sample)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 602px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6865=[""].join("\n");
var outline_f6_45_6865=null;
var title_f6_45_6866="RTT motor dysfunction";
var content_f6_45_6866=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52460&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52460&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rett syndrome, motor dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This child with RTT continued to ambulate, though she had an abnormal dyspraxic gait with toe walking.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Glaze DG, Schultz RJ. Rett syndrome: Meeting the challenge of this gender-specific neurodevelopmental disorder. Medscape Women's Health 1997; 2. Copyright &copy; 1997 Medscape.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6866=[""].join("\n");
var outline_f6_45_6866=null;
var title_f6_45_6867="Benzydamine: Drug information";
var content_f6_45_6867=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Benzydamine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?37/4/37955?source=see_link\">",
"    see \"Benzydamine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F140265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Benzydamine&reg;;",
"     </li>",
"     <li>",
"      Dom-Benzydamine;",
"     </li>",
"     <li>",
"      Novo-Benzydamine;",
"     </li>",
"     <li>",
"      PMS-Benzydamine;",
"     </li>",
"     <li>",
"      Tantum&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F140278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Local Anesthetic, Oral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F140269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Acute pharyngitis:",
"     </b>",
"     Oral rinse: Gargle with 15 mL of undiluted solution every 1",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     -3 hours until symptoms resolve. Patient should expel solution from mouth following use; solution should not be swallowed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Mucositis:",
"     </b>",
"     Oral rinse: 15 mL of undiluted solution as a gargle or rinse 3-4 times/day; contact should be maintained for at least 30 seconds, followed by expulsion from the mouth.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2613140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F140270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment required.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F8120605\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral rinse: 0.15% (100 mL, 250 mL)",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11217335\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F11449984\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patient should not swallow the liquid. Begin treatment 1 day prior to initiation of radiation therapy and continue daily during treatment. Continue oral rinse treatments after the completion of radiation therapy until desired result/healing is achieved.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F140253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic treatment of pain associated with acute pharyngitis; treatment of pain associated with radiation-induced oropharyngeal mucositis",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F140276\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Drowsiness, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea and/or vomiting (2%), xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Numbness (10%), burning/stinging sensation (8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cough, pharyngeal irritation",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F140256\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to benzydamine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F140245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Irritation/burning: May cause local irritation and/or burning sensation in patients with altered mucosal integrity; dilution (1:1 in warm water) may attenuate this effect.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F140275\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F140248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F140258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Safety has not been established in pregnant women. Use only when potential benefit outweighs possible risk to the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F140271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16257741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if benzydamine is excreted in breast milk. The manufacturer recommends that caution be exercised when administering benzydamine peroxide to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F140259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Andolex (NO, SE);",
"     </li>",
"     <li>",
"      Bendamina (PE);",
"     </li>",
"     <li>",
"      Benzirin (CO);",
"     </li>",
"     <li>",
"      Bevidam (VE);",
"     </li>",
"     <li>",
"      Bucodrin (PE);",
"     </li>",
"     <li>",
"      Difflam (AU, HK, IE, MY, NZ, PH, SG, TH, TW);",
"     </li>",
"     <li>",
"      Easy Gel (IL);",
"     </li>",
"     <li>",
"      Opalgyne (FR);",
"     </li>",
"     <li>",
"      Tantum (AT, BG, CZ, DE, GR, ID, IN, IT, PK, PL, PT, TR, VE);",
"     </li>",
"     <li>",
"      Tantum Verde (IL, RU);",
"     </li>",
"     <li>",
"      Vantal (CR, DO, GT, HN, NI, PA, SV)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F140244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Local anesthetic and anti-inflammatory, reduces local pain and inflammation. Does not interfere with arachidonic acid metabolism.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F140255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral rinse may be absorbed, at least in part, through the oral mucosa",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (primarily as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Epstein JB, Silverman S Jr, Paggiarino DA, et al, &ldquo;Benzydamine HCl for Prophylaxis of Radiation-Induced Oral Mucositis: Results From a Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 2001, 92(4):875-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/45/6867/abstract-text/11550161/pubmed\" id=\"11550161\" target=\"_blank\">",
"        11550161",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Henschel R, Agathos M, and Breit R, &ldquo;Photocontact Dermatitis After Gargling With a Solution Containing Benzydamine,&rdquo;",
"      <i>",
"       Contact Dermatitis",
"      </i>",
"      , 2002, 47(1):53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/45/6867/abstract-text/12225419/pubmed\" id=\"12225419\" target=\"_blank\">",
"        12225419",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lang DH and Rettie AE, &ldquo;",
"      <i>",
"       In vitro",
"      </i>",
"      Evaluation of Potential",
"      <i>",
"       in vivo",
"      </i>",
"      Probes for Human Flavin-Containing Monooxygenase (FMO): Metabolism of Benzydamine and Caffeine by FMO and P450 Isoforms,&rdquo;",
"      <i>",
"       Br J Clin Pharmacol",
"      </i>",
"      , 2000, 50(4):311-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/45/6867/abstract-text/11012553/pubmed\" id=\"11012553\" target=\"_blank\">",
"        11012553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ribldi E, Frascaroli G, Transidico P, &ldquo;Benzydamine Inhibits Monocyte Migration and MAPK Activation Induced by Chemotactic Agonists,&rdquo;",
"      <i>",
"       Br J Pharmacol",
"      </i>",
"      , 2003, 140(2):377-83.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?6/45/6867/abstract-text/12970098/pubmed\" id=\"12970098\" target=\"_blank\">",
"        12970098",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8682 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-24A2ECD58B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6867=[""].join("\n");
var outline_f6_45_6867=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140265\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140278\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140269\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2613140\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140270\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8120605\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11217335\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11449984\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140253\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140276\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140256\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140245\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140275\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140248\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140258\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140271\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16257741\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140259\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140244\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140255\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8682\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8682|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/4/37955?source=related_link\">",
"      Benzydamine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_45_6868="Time course of loop and thiazide diuretic-induced electrolyte complications";
var content_f6_45_6868=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Time course of loop and thiazide diuretic-induced electrolyte complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6868/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6868/contributors\">",
"     D Craig Brater, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6868/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6868/contributors\">",
"     Richard H Sterns, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6868/contributors\">",
"     Michael Emmett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6868/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6868/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/45/6868/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy with a loop or thiazide-type diuretic may be associated with a variety of fluid and electrolyte complications, including volume depletion, azotemia, hypokalemia, metabolic alkalosis, hyponatremia, hyperuricemia, and hypomagnesemia [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/1\">",
"     1",
"    </a>",
"    ]. (See appropriate topic reviews). In addition, the potassium-sparing diuretics &mdash;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/12/38085?source=see_link\">",
"     amiloride",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/60/43973?source=see_link\">",
"     triamterene",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/22/17767?source=see_link\">",
"     spironolactone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    &mdash; can induce hyperkalemia and metabolic acidosis, while carbonic anhydrase inhibitors such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    can cause hypokalemia and metabolic acidosis.",
"   </p>",
"   <p>",
"    What is underappreciated is the time course with which these complications occur, which has been best studied with loop and thiazide diuretics. Assuming that the diuretic dose and dietary solute (eg, sodium and potassium) and water intake are relatively constant and that the patient is hemodynamically stable, all of the above problems develop during the first two to three weeks of therapy if they are going to occur (",
"    <a class=\"graphic graphic_figure graphicRef74940 \" href=\"UTD.htm?15/33/15901\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The reason for this time limitation is that the initial solute and water loss leads to compensatory changes that limit further losses. Thus, after the initial period of solute and water loss, a new steady state is attained in which solute and water intake and excretion are roughly equal, as they were before diuretic therapy was initiated. This phenomenon has been called",
"    <strong>",
"     diuretic braking",
"    </strong>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=see_link&amp;anchor=H838162389#H838162389\">",
"     \"General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)\", section on 'The steady state'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SODIUM AND WATER LOSSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial sodium and water loss induced by diuretic therapy leads to increases in a variety of sodium-retaining factors, such as angiotensin II, aldosterone, and norepinephrine, and a possible reduction in systemic blood pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/2,4\">",
"     2,4",
"    </a>",
"    ]. These sodium-retaining forces eventually equal the sodium-wasting activity of the diuretic. When this occurs, there is a new steady state in which sodium and water intake and excretion are roughly equal. There will be no further diuresis (unless the diuretic dose or frequency is increased), but the extracellular fluid volume will be reduced by the amount of sodium lost during the first few days of therapy. This persistent volume depletion accounts for the efficacy of the diuretic in the treatment of hypertension or edema.",
"   </p>",
"   <p>",
"    In addition to the acute neurohumoral responses, structural adaptations also contribute to the compensatory sodium retention induced by chronic diuretic therapy. Experimental studies show that the increase in sodium chloride delivery out of the loop of Henle seen with a loop diuretic leads to hypertrophy and increased sodium reabsorptive capacity in the distal and cortical collecting tubules [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]; with a thiazide diuretic, the increase in delivery and the subsequent hypertrophic response are limited to the cortical collecting tubule [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Indirect evidence suggests that the same phenomenon occurs in humans. When compared to controls, subjects who have received a loop diuretic for one month show, after 24 hours off the diuretic, an impaired response to a loop diuretic (compatible with increased sodium reabsorption at some other site in the nephron) and an enhanced response to a thiazide diuretic (suggesting increased sodium reabsorption at a thiazide-sensitive site, presumably the distal tubule) (",
"    <a class=\"graphic graphic_figure graphicRef53198 \" href=\"UTD.htm?27/35/28221\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although these observations have primarily been obtained in nonedematous patients with hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/2,4\">",
"     2,4",
"    </a>",
"    ], the same principles apply to edematous states such as heart failure [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/3\">",
"     3",
"    </a>",
"    ]. However, the time to reattainment of the steady state may be delayed in those patients on the flat part (rather than the ascending limb) of the Frank-Starling curve (",
"    <a class=\"graphic graphic_figure graphicRef58693 \" href=\"UTD.htm?32/56/33677\">",
"     figure 3",
"    </a>",
"    ). In this setting, initial fluid loss will lower intracardiac filling pressures but not the cardiac output. As a result, the counterregulatory hormonal responses will not be activated and the diuresis will continue until forward output begins to fall. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/55/3962?source=see_link\">",
"     \"Use of diuretics in patients with heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=see_link&amp;anchor=H6#H6\">",
"     \"Pathophysiology of heart failure: Left ventricular pressure-volume relationships\", section on 'Pressure-volume relationships in heart failure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The patient is in sodium balance in the new steady state, but the pattern of daily sodium excretion is altered: sodium will be lost during the period that the diuretic is acting, while sodium excretion will be very low for the remainder of the day due to increased activity of the sodium-retaining forces [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, a 24-hour urine collection can be obtained to assess compliance with dietary sodium restriction (since daily sodium excretion will be roughly equal to intake if the patient&rsquo;s weight is stable), but measurement of the urine sodium concentration in a random urine specimen will often be misleading, varying with the time since the diuretic dose. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=see_link\">",
"     \"Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One other characteristic resulting from activation of sodium-retaining forces is that the maximal natriuretic response to an intravenous diuretic is seen with the",
"    <strong>",
"     first dose",
"    </strong>",
"    ; even with continuous intravenous infusion of a loop diuretic, for example, the natriuresis usually begins to diminish within the first 12 hours (",
"    <a class=\"graphic graphic_figure graphicRef75714 \" href=\"UTD.htm?31/33/32285\">",
"     figure 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/9\">",
"     9",
"    </a>",
"    ]. This principle also applies to oral therapy assuming no defect in drug absorption. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=see_link\">",
"     \"Treatment of refractory edema in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The sequence is somewhat different in patients who are markedly volume expanded due to renal sodium retention (eg, in acute glomerulonephritis or acute or chronic kidney disease). In this setting, the renin-angiotensin system is suppressed and will not be activated by initial sodium loss since hypervolemia persists. Thus, the second and subsequent doses may produce as large a natriuresis as the original dose until most of the excess fluid has been removed. Even in this setting, however, the first dose still represents the maximum response that will be seen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     POTASSIUM LOSSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Similar considerations apply to other diuretic-induced losses, including potassium. The development of hypokalemia will limit further potassium losses (",
"    <a class=\"graphic graphic_figure graphicRef74940 \" href=\"UTD.htm?15/33/15901\">",
"     figure 1",
"    </a>",
"    ), an effect that is mediated in the cortical collecting tubule both by decreased potassium secretion in the principal cells and by increased potassium reabsorption in the intercalated cells. However, the kaliuresis may persist for a several days longer than the natriuresis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6868/abstract/10\">",
"     10",
"    </a>",
"    ], since the inhibitory effect of hypokalemia will be counterbalanced by the hypovolemia-mediated rise in aldosterone secretion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/9/9366?source=see_link\">",
"     \"Evaluation of the patient with hypokalemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H185395927\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Therapy with a diuretic may be associated with fluid and electrolyte complications. This primarily involves volume depletion, azotemia and hypokalemia, but metabolic alkalosis, hyponatremia, hyperuricemia, and hypomagnesemia may also occur. Assuming that the diuretic dose and dietary and water intake are relatively constant and that the patient is hemodynamically stable, most of these problems develop during the first two to three weeks of therapy if they are going to occur. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial sodium and water loss induced by diuretic therapy leads to increases in a variety of sodium-retaining factors, which eventually equal the sodium-wasting activity of the diuretic. When this occurs, there is a new steady state. There will be no further diuresis but the extracellular fluid volume will be reduced by the amount of sodium lost during the first few days of therapy. This persistent volume depletion accounts for the efficacy of the diuretic in the treatment of hypertension or edema. The patient is in sodium balance in the new steady state, but the pattern of daily sodium excretion is altered: sodium will be lost during the period that the diuretic is acting, while sodium excretion will be very low for the remainder of the day due to increased activity of the sodium-retaining forces. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sodium and water losses'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Similar considerations apply to other diuretic-induced losses, including potassium. The development of hypokalemia will limit further potassium losses. However, the kaliuresis may persist for several days longer than the natriuresis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Potassium losses'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001, pp. 453-456.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/2\">",
"      Bock HA, Stein JH. Diuretics and the control of extracellular fluid volume: role of counterregulation. Semin Nephrol 1988; 8:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/3\">",
"      Ikram H, Chan W, Espiner EA, Nicholls MG. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) 1980; 59:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/4\">",
"      Wilcox CS, Guzman NJ, Mitch WE, et al. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney Int 1987; 31:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/5\">",
"      Ellison DH, Vel&aacute;zquez H, Wright FS. Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest 1989; 83:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/6\">",
"      Stanton BA, Kaissling B. Adaptation of distal tubule and collecting duct to increased Na delivery. II. Na+ and K+ transport. Am J Physiol 1988; 255:F1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/7\">",
"      Garg LC, Narang N. Effects of hydrochlorothiazide on Na-K-ATPase activity along the rat nephron. Kidney Int 1987; 31:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/8\">",
"      Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/9\">",
"      Rudy DW, Voelker JR, Greene PK, et al. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann Intern Med 1991; 115:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6868/abstract/10\">",
"      Maronde RF, Milgrom M, Vlachakis ND, Chan L. Response of thiazide-induced hypokalemia to amiloride. JAMA 1983; 249:237.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2356 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-655B890CD5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6868=[""].join("\n");
var outline_f6_45_6868=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H185395927\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SODIUM AND WATER LOSSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      POTASSIUM LOSSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H185395927\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/2356\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/2356|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/33/15901\" title=\"figure 1\">",
"      Time course of diuretic action",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/35/28221\" title=\"figure 2\">",
"      Distal response to furosemide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/56/33677\" title=\"figure 3\">",
"      Frank Starling curves in HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/33/32285\" title=\"figure 4\">",
"      First dose diuretic response",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/9/9366?source=related_link\">",
"      Evaluation of the patient with hypokalemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/48/11018?source=related_link\">",
"      General principles of disorders of water balance (hyponatremia and hypernatremia) and sodium balance (hypovolemia and edema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=related_link\">",
"      Pathophysiology of heart failure: Left ventricular pressure-volume relationships",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/41/21151?source=related_link\">",
"      Patient information: Collection of a 24-hour urine specimen (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/40/650?source=related_link\">",
"      Treatment of refractory edema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/55/3962?source=related_link\">",
"      Use of diuretics in patients with heart failure",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_45_6869="Dyshidrotic eczema foot 2";
var content_f6_45_6869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82782&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82782&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dyshidrotic foot eczema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6869=[""].join("\n");
var outline_f6_45_6869=null;
var title_f6_45_6870="Multiple system atrophy: Prognosis and treatment";
var content_f6_45_6870=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Multiple system atrophy: Prognosis and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6870/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6870/contributors\">",
"     Stewart A Factor, DO",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6870/contributors\">",
"     Christine Doss Esper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6870/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6870/contributors\">",
"     Howard I Hurtig, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6870/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6870/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/45/6870/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple system atrophy (MSA) is a unifying term that brings together a group of neurodegenerative disorders &mdash; olivopontocerebellar atrophy, striatonigral degeneration, and Shy-Drager &mdash; characterized by various degrees of autonomic dysfunction, cerebellar abnormalities, parkinsonism, and corticospinal degeneration.",
"   </p>",
"   <p>",
"    This topic will review the prognosis and management of MSA. Other clinical aspects of MSA are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=see_link\">",
"     \"Multiple system atrophy: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disease progression in MSA usually occurs over one to 18 years, and is often faster than that of idiopathic Parkinson disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In mainly retrospective studies, the median times from disease onset to disability milestones in MSA were as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Development of autonomic dysfunction, 2.5 years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/3\">",
"       3",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Need for walking aid, 3 years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/4\">",
"       4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Wheelchair confinement, 3.5 to 5 years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bedridden state, 5 to 8 years [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The median time from MSA onset to death is 6 to 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/1,3-6\">",
"     1,3-6",
"    </a>",
"    ]. However, survival is quite variable, and some patients with MSA live for 15 years or more after symptom onset [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The available data suggest that older age at disease onset and early autonomic failure are risk factors for shorter survival [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/3,6,8,9\">",
"     3,6,8,9",
"    </a>",
"    ]. Female gender and a short time from disease onset to the first clinical milestone of disability (frequent falling, cognitive disability, unintelligible speech, severe dysphagia, wheelchair dependence, urinary catheter use) may also predict shorter survival [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both motor presentations (parkinsonian and cerebellar) of MSA appear to be associated with similar survival rates [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/6\">",
"     6",
"    </a>",
"    ], although patients with MSA-P may have a more rapid functional deterioration than those with MSA-C [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/1,4\">",
"     1,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;No effective disease-modifying or neuroprotective treatment is available for MSA [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/10\">",
"     10",
"    </a>",
"    ]. Management is symptomatic.",
"   </p>",
"   <p>",
"    The main clinical features of MSA are parkinsonism, autonomic failure, cerebellar ataxia, and pyramidal signs in varying combinations. Additional manifestations can include sleep disorders, breathing disorders, and depression. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=see_link&amp;anchor=H4#H4\">",
"     \"Multiple system atrophy: Clinical features and diagnosis\", section on 'Clinical characteristics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The motor symptoms in MSA are highly resistant to pharmacologic treatment. However, the autonomic symptoms may respond to pharmacotherapy. Physical, occupational, and speech therapy are helpful for the supportive care of patients with MSA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Motor symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no effective medications for the ataxia and gait abnormalities that predominate in MSA-C [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/7\">",
"     7",
"    </a>",
"    ]. Furthermore, the parkinsonian manifestations of bradykinesia and rigidity in MSA are resistant to treatment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical therapy is important for fall prevention, reduction in contractures, and maintenance of mobility while possible. Therapists are also helpful in determining requirements for and facilitating walker and wheelchair use when a patient becomes nonambulatory. Occupational therapy may promote longer independence in performing activities of daily living. Additionally, in-home visits for safety evaluation and driving evaluations are beneficial.",
"     </li>",
"     <li>",
"      Botulinum toxin injection is often useful in alleviating symptoms from focal dystonias that occur in MSA, such as cervical dystonia and blepharospasm. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12105?source=see_link&amp;anchor=H8#H8\">",
"       \"Treatment of dystonia\", section on 'Botulinum toxin injections'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For patients with anterocollis, it is important to differentiate dystonia from myopathy as the cause. This should be done before using botulinum toxin, which may worsen symptoms when myopathy is the cause. Electromyography usually clarifies the picture, although biopsy may be necessary when the diagnosis is uncertain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Speech therapy referral early in the course of disease allows objective determination of the progression of dysphagia. The need for percutaneous gastrostomy tube placement should be assessed by videofluoroscopic swallow evaluation and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      swallow studies.",
"     </li>",
"     <li>",
"      Nocturnal positive pressure ventilation with either continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP) should be considered if a patient develops respiratory complications secondary to laryngeal stridor. In a study of seven patients who had MSA with predominantly autonomic dysfunction, stridor during sleep was the most commonly observed respiratory abnormality [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/11\">",
"       11",
"      </a>",
"      ]. Three of these patients experienced sudden death during sleep.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In cases of severe, life-threatening stridor, tracheostomy becomes a necessary intervention. Thus, the option of tracheostomy placement should be discussed with patients in advance. However, it is possible that tracheostomy can aggravate central sleep apnea. This conclusion comes from a study that evaluated seven patients with probable MSA who received tracheostomy for moderate or severe vocal cord abductor paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/12\">",
"     12",
"    </a>",
"    ]. All had frequent central sleep apneas. In addition, the apnea-hypopnea index (the total number of apneas and hypopneas per hour of sleep) increased after tracheostomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Levodopa and dopaminergic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The main role of levodopa in patients with suspected MSA is diagnostic; a poor or unsustained response to levodopa therapy is generally observed in patients with MSA and can help to distinguish MSA-P from idiopathic Parkinson disease. However, some patients with clinically probable MSA do better on levodopa treatment than off it. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=see_link&amp;anchor=H12#H12\">",
"     \"Multiple system atrophy: Clinical features and diagnosis\", section on 'Levodopa responsiveness'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Therefore, we suggest a trial of levodopa for patients with suspected MSA. Levodopa is given with a peripheral decarboxylase inhibitor (eg, levodopa-carbidopa) in escalating doses up to 1000 mg of levodopa daily as necessary and tolerated over a three-month period. The total daily dose must be increased to 900 or 1000 mg before a trial of levodopa can be declared a failure.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"     Amantadine",
"    </a>",
"    has been used in doses up to 300 mg per day to treat MSA, but it is no more effective than levodopa [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role for dopamine agonists is limited, both for the older (pergolide and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/40/8840?source=see_link\">",
"     bromocriptine",
"    </a>",
"    ) and newer agents (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/19/32055?source=see_link\">",
"     pramipexole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18615?source=see_link\">",
"     ropinirole",
"    </a>",
"    ). They rarely lead to motor benefit and frequently exacerbate orthostatic hypotension, gastrointestinal symptoms, and sleep disorders that are prevalent in MSA. Patients who do not respond to levodopa are unlikely to respond to dopamine agonists, so their use should be avoided in this situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Orthostatic hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of orthostatic hypotension is reviewed here briefly and discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"     \"Treatment of orthostatic and postprandial hypotension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The plasma volume expander",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"     fludrocortisone",
"    </a>",
"    acetate is the medication of first choice for chronic orthostatic hypotension due to autonomic dysfunction. This agent has a long duration of action and is well-tolerated by most patients with chronic autonomic failure. Patients treated with fludrocortisone must be monitored for the development of edema and worsening seated or supine hypertension. These side effects may necessitate discontinuation or dosage reduction. Potassium supplementation is usually required, particularly when higher doses are used.",
"   </p>",
"   <p>",
"    Second line agents for orthostatic hypotension include the alpha-1 adrenoreceptor agonists ephedrine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/47/19190?source=see_link\">",
"     pseudoephedrine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/36/39488?source=see_link\">",
"     phenylephrine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/35/2613?source=see_link\">",
"     midodrine",
"    </a>",
"    . Supine hypertension can be a significant side effect with these medications. Raising the head of the bed by 30 to 45 degrees may help ameliorate this problem.",
"   </p>",
"   <p>",
"    Supplementary agents for orthostatic hypotension include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/55/27509?source=see_link\">",
"     pyridostigmine",
"    </a>",
"    , nonsteroidal antiinflammatory drugs, caffeine, and erythropoietin. These agents may be used in combination therapy with first or second line agents in patients with persistent symptoms. However, there are anecdotal reports suggesting that pyridostigmine causes worsening parkinsonism [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nonpharmacologic measures are important components of the therapy of chronic orthostatic hypotension. These include removal of offending medications, patient education and physical maneuvers (eg, arising slowly from supine to sitting, raising the head of the bed 10 to 20 degrees, custom-fitted elastic stockings that extend to the waist), increased salt and water intake, and avoidance of precipitating factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Postprandial hypotension",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of postprandial hypotension is reviewed here briefly and discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link&amp;anchor=H27#H27\">",
"     \"Treatment of orthostatic and postprandial hypotension\", section on 'Treatment of postprandial hypotension'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Optimal therapy of symptomatic postprandial hypotension has not been defined. The following general suggestions may be helpful in selected patients:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Eat small meals",
"     </li>",
"     <li>",
"      Eat low carbohydrate meals",
"     </li>",
"     <li>",
"      Avoid salt restriction",
"     </li>",
"     <li>",
"      Avoid standing up suddenly or standing still after meals",
"     </li>",
"     <li>",
"      Walk between meals; if walking is not tolerated, lie semirecumbent for 90 minutes after meals",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The somatostatin analogue",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    can minimize postprandial hypotension. However, octreotide must be given subcutaneously 30 minutes before each meal. It is expensive, and often leads to side effects such as diarrhea and pain at the injection site. Therefore, it should be reserved for the most severely symptomatic patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Urogenital symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;For detrusor hyperreflexia, the muscarinic acetylcholine receptor antagonists",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/59/10167?source=see_link\">",
"     oxybutynin",
"    </a>",
"    (2.5 to 5 mg two or three times daily) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/19/14646?source=see_link\">",
"     tolterodine",
"    </a>",
"    (2 to 4 mg daily) may prevent overactive bladder. However, these drugs can cause confusion in susceptible patients and can worsen constipation.",
"   </p>",
"   <p>",
"    For bladder atony, intermittent self-catheterization should be used for retention or residual volume &gt;100 mL.",
"   </p>",
"   <p>",
"    The treatment of erectile dysfunction is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=see_link\">",
"     \"Treatment of male sexual dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depression is a common problem in patients with MSA, often requiring psychiatric treatment with counseling for the patient and family, and in some cases antidepressant pharmacotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"     \"Initial treatment of depression in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/37/39514?source=see_link\">",
"     \"Diagnosis and management of late-life depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Sleep disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;REM-sleep behavior disorder can be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    (0.25 mg at bedtime), melatonin (3 mg), or tricyclic antidepressants [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Support groups",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local, regional, and national associations can play an integral role to benefit lives of patients, family members, and caregivers. These groups include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The American Parkinson Disease Association (",
"      <a class=\"external\" href=\"file://www.apdaparkinson.org\">",
"       www.apdaparkinson.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The National Parkinson Foundation (",
"      <a class=\"external\" href=\"file://www.parkinson.org/\">",
"       www.parkinson.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      The",
"      <span class=\"nowrap\">",
"       Shy-Drager/Multiple",
"      </span>",
"      System Atrophy Support Group (",
"      <a class=\"external\" href=\"file://www.shy-drager.org/\">",
"       www.shy-drager.org",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      We Move &ndash; Worldwide Education and Awareness for Movement Disorders (",
"      <a class=\"external\" href=\"file://www.wemove.org/\">",
"       www.wemove.org",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H615066360\">",
"    <span class=\"h1\">",
"     INVESTIGATIONAL THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is currently no effective disease-modifying or neuroprotective treatment for MSA [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/18\">",
"     18",
"    </a>",
"    ]. Strategies under investigation include reducing alpha-synuclein aggregation using rifampicin [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/19\">",
"     19",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/13/24791?source=see_link\">",
"     rasagiline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/20\">",
"     20",
"    </a>",
"    ], and infusing autologous mesenchymal stem cells [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6870/abstract/21\">",
"     21",
"    </a>",
"    ], which theoretically may have a neuroprotective effect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The main clinical features of MSA are parkinsonism, autonomic failure, cerebellar ataxia, and pyramidal signs in varying combinations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=see_link&amp;anchor=H4#H4\">",
"       \"Multiple system atrophy: Clinical features and diagnosis\", section on 'Clinical characteristics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Disease progression in MSA is often faster than in idiopathic Parkinson disease, as illustrated by median times from MSA symptom onset to autonomic dysfunction (2.5 years), wheelchair confinement (3.5 to 5 years), and bedridden state (5 to 8 years). The median time from MSA onset to death is 6 to 10 years. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no effective disease-modifying or neuroprotective treatment for MSA. Management is symptomatic. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Physical therapy is important for fall prevention, reduction in contractures, and maintenance of mobility",
"     </li>",
"     <li>",
"      Occupational therapy may promote longer independence in performing activities of daily living",
"     </li>",
"     <li>",
"      Focal dystonia may be alleviated by botulinum toxin injection",
"     </li>",
"     <li>",
"      Dysphagia should be monitored with respect to the need for feeding tube placement",
"     </li>",
"     <li>",
"      Laryngeal stridor may benefit from nocturnal positive pressure ventilation; severe cases may necessitate tracheostomy",
"     </li>",
"     <li>",
"      There are no effective medications for the cerebellar manifestations of ataxia and gait impairment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although a poor or unsustained response to levodopa therapy is generally observed in patients with MSA, some patients with clinically probable MSA do better with levodopa treatment than without it. The total daily dose of levodopa should be increased to 900 or 1000 mg daily before a trial of levodopa can be declared a failure.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/46/13031?source=see_link\">",
"       Amantadine",
"      </a>",
"      is no more effective than levodopa. Dopamine agonists (pergolide,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/40/8840?source=see_link\">",
"       bromocriptine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/19/32055?source=see_link\">",
"       pramipexole",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/11/18615?source=see_link\">",
"       ropinirole",
"      </a>",
"      ) rarely lead to motor benefit and frequently exacerbate orthostatic hypotension, gastrointestinal symptoms, and sleep disorders that are prevalent in MSA. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Levodopa and dopaminergic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/9/21655?source=see_link\">",
"       Fludrocortisone",
"      </a>",
"      acetate is the medication of first choice for chronic orthostatic hypotension due to autonomic dysfunction. The optimal therapy of symptomatic postprandial hypotension has not been defined. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Orthostatic hypotension'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Postprandial hypotension'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=see_link\">",
"       \"Treatment of orthostatic and postprandial hypotension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Depression is a common problem in MSA. It should be identified early and treated appropriately. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Depression'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=see_link\">",
"       \"Initial treatment of depression in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/37/39514?source=see_link\">",
"       \"Diagnosis and management of late-life depression\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/1\">",
"      Wenning GK, Ben Shlomo Y, Magalh&atilde;es M, et al. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994; 117 ( Pt 4):835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/2\">",
"      May S, Gilman S, Sowell BB, et al. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 2007; 22:2371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/3\">",
"      Tada M, Onodera O, Tada M, et al. Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy. Arch Neurol 2007; 64:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/4\">",
"      Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002; 125:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/5\">",
"      Schrag A, Wenning GK, Quinn N, Ben-Shlomo Y. Survival in multiple system atrophy. Mov Disord 2008; 23:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/6\">",
"      Ben-Shlomo Y, Wenning GK, Tison F, Quinn NP. Survival of patients with pathologically proven multiple system atrophy: a meta-analysis. Neurology 1997; 48:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/7\">",
"      Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol 2004; 3:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/8\">",
"      Petrovic IN, Ling H, Asi Y, et al. Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Mov Disord 2012; 27:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/9\">",
"      O'Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008; 131:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/10\">",
"      Stefanova N, B&uuml;cke P, Duerr S, Wenning GK. Multiple system atrophy: an update. Lancet Neurol 2009; 8:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/11\">",
"      Munschauer FE, Loh L, Bannister R, Newsom-Davis J. Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure. Neurology 1990; 40:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/12\">",
"      Jin K, Okabe S, Chida K, et al. Tracheostomy can fatally exacerbate sleep-disordered breathing in multiple system atrophy. Neurology 2007; 68:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/13\">",
"      Colosimo C, Pezzella FR. The symptomatic treatment of multiple system atrophy. Eur J Neurol 2002; 9:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/14\">",
"      Iwasaki Y, Wakata N, Kinoshita M. Parkinsonism induced by pyridostigmine. Acta Neurol Scand 1988; 78:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/15\">",
"      Kao KP, Kwan SY, Lin KP, Chang YC. Coexistence of Parkinson's disease and myasthenia gravis: a case report. Clin Neurol Neurosurg 1993; 95:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/16\">",
"      Schenck CH, Mahowald MW. Rapid eye movement sleep parasomnias. Neurol Clin 2005; 23:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/17\">",
"      Panossian LA, Avidan AY. Review of sleep disorders. Med Clin North Am 2009; 93:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/18\">",
"      Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. Trends Neurosci 2011; 34:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/19\">",
"      Ubhi K, Rockenstein E, Mante M, et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport 2008; 19:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/20\">",
"      Stefanova N, Poewe W, Wenning GK. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol 2008; 210:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6870/abstract/21\">",
"      Lee PH, Lee JE, Kim HS, et al. A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol 2012; 72:32.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4891 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-89768E4622-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6870=[""].join("\n");
var outline_f6_45_6870=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Motor symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Levodopa and dopaminergic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Orthostatic hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Postprandial hypotension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Urogenital symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Sleep disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Support groups",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H615066360\">",
"      INVESTIGATIONAL THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/37/39514?source=related_link\">",
"      Diagnosis and management of late-life depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/8/40074?source=related_link\">",
"      Initial treatment of depression in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=related_link\">",
"      Multiple system atrophy: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12105?source=related_link\">",
"      Treatment of dystonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/36/30282?source=related_link\">",
"      Treatment of male sexual dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/2/5161?source=related_link\">",
"      Treatment of orthostatic and postprandial hypotension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_45_6871="Pressure ulcer sites PI";
var content_f6_45_6871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F81059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F81059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 590px\">",
"   <div class=\"ttl\">",
"    Pressure ulcer sites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 570px; height: 431px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGvAjoDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKb5iCQIXXeRnbnn8qAHUVka94h03Q40+3T/v5DiK3iBeaU+ioOT/ACqLw74jg1qe5tja3Nje24VntrkLu2Nna4Kkgg4I4PBBBpcyvYrldrm5RRRTJCiiigAooooAKKKKACise58T6Da3HkXOt6ZFN02PdIp/ImtK1ure7iElrPFPGejxuGH5ilcdmTUUUUxBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyWteOLPS9UNp9hvbpVlFu80AQqspTfswWBOF5JAwO54OOsdlRGd2CqoySTgAeteDtDH4nvFtw+XvJrm8GW4hSVvvv7iDYAP+moPGKyqzcVoa0oKV7nQ6Jc2Pi7Wtf1FJLt7cXESQj7Q6bB5Ee4AI2PvZ5GQeoJr0jw8zPoGmM7M7G2iJZjkk7BySeteb+Ap4brUvE09qm22kvI2i4ABTyI9rAehGCPY16P4c/5F7S/+vWL/wBAFaR1imTNWk0aNFFFMgKKKKACiiigAooooAKKKKACiiigDz74la/qSedouhafNdXTQCV5oZdjQEk7COnOVB4PQdOc1pPqmrWVnma9sWjjHzTzwMGAHdsOAT9Ao/lVDSb+DUIr7WVcCC6maQOx6RoNg57D5CfxrS0qwM6Je6h+8lciSKIj5YR/Dx3b1J79MVxSqy5nZnWoRjFXRhXd5qWsLgya3dW+eYrOAWSv/wACcqxH0b86jh8IW9xDJLNpNjYkcq8zGSfPqZVYFPqGNd3WR4ntZrzSjHDEbhfMRpbcMB50YYb05IHIzweD0PBqG29w57aLQ5Hw/HZyGaTRbvRTqjqxUea9xJcY9ZnIYg/Q4680/V3t9UvNOexil/tTe8JMN0beeHClmQkd/lxg8HrnvW+LafVrmzRrL7DpVm6yokigSSOv3Qqj7iKfxOMYx13fs0H2n7R5Mf2jbt83aN2PTPXFK4+dnE2t14l02aL7RcasI48mOOW2S7RkPXzGjO9mGeMEHp97mt/RPFUl1rVnY3D2lzFeRyGG4tgUCvHgsjKWbnBz17EEVu1wGuXCQ65H4gsoGeDTL1RceUuTIvlvHK4A+8VDgHv+7I7VpCo01dkcqmnoeo0VV0+/tNStUudPuYbm3cZWSJwwP5VZdlRWZ2CqoySTgAV2nMLR061x954xF6zW/hWFdQlBw13JlbWP1+ccufZc+5FY9yt5eeZbapcT6zeSDJtYAYLeNT2YA42/75YnHAPSspVox2NY0W9Xob2oeK3kvXs/D9omoPG22e5aXZBCf7u4ZLN/sgcdyKw9aiSdxJ4k1maSJ+EtEk8iFiewRTucnpgls+laukaJFBb+TcSRhl4W3tCYYoR12hVIJ6jJPX0HSsiznSy1C3vo9M021sLidbdSkIE+GO1JC/TliPlxnDdc8VzSqSkbRUY/Ci1p2mu8Xl2OjWljZkY/foELDtiNR0/3iD7VnaloC6e/2tdH2nOGn0WV4Zx7lV2lh7ZY+xq4+oX39tXTCWR/J1OK0WFWwgiZIyxx3PzliT6cYFRXN9NYajqV39pmMNnqKRyq8hK+S8cZbgnACmTdxj7uOlQVeTLuiXmo/Y0l0/XDe2zfdN7AJGX1BK7DkdMNyO9af9oaz/z86d/4CP8A/HaybJVk8UapZ34BZv38U0LGIsgC5VtpGSodPmPXPtUNnqa+SbuCZrzR2PE4U+ZbdDiVeu3BBDY4BGePmq/aSXUSUHujbbU9aX7rac/sYnX/ANmNQTeIPEFuQ39kWN5H3EN4Uf8AAMmP/HhUysrqGRgykZBByCKWj20+5XsodhbTxxozyCHUpm0i7PHkagBFn6Pko34Ma6OC5guEDQTRyq3QowYH8q5eeGOeNo540kjbqrqCD+BrIPhTQPO80aNYLJnO5YFU59eBWixD6ozeHXRnohIAyTgVlXviPRLA4vdY063bpiW5RT+prlW8OaO67ZNOtpF/uum4fkatWmmWFmMWdlawDGMRRKv8hTeI7IFh+7NP/hN/DPH/ABPLHByd3mjHHv0qxa+K/D12QLbXNMkY9lukz+Waz/aoLiztbgEXFtDKD1DoG/nS+sPsH1ddzr43SRQ0bKynoVORTq4KLQdLtXMtlYQ2s3XdajyWP4pis241O+jACQ+KLV+/ltHP/wChM4qliF1RLw76M9PorycavrhB2X/i0kdjY2Y/nHU8d9rrrnyvEs3fdLNaRZ/BSMflT9vEX1eR6jRXmTT+IWXENndIx/il1Yg/orDn2qbSr7xlZTyNIlheWzr8sNzenfG2eodYBkY7HP1pqvEHQkej0Vx7a74jCkjSdJJ9P7QkH/tGlTxLraA+f4fhbH/PC/DZ+m5FqvbQ7k+xn2OvorlU8Zwx/wDIQ0fWLQDqxgEyj/v0zHH4VfsPFmg38oit9VtPOPSKR/Lk/wC+Wwf0qlOL2ZDhJbo26KAQRkHIoqiQooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDlfiDPI2mppsbGOO8Dm5kU/Mtugy+33OVX2DE9q4y9tPsfhu2meDa+pI3mfZyBM5lKlbaLPAG0AM/ZUz7jUjkbxX4nu5JZJBpAWS3gRTjzo4yoc567Xd+oxkRr2Jy34j6fK0VtewXi2y2kEqxRK5V3kcKqBB0yc7cjkBiB1yOKrLmkdUFypIq+CDN/aviUXUUMMy3UKmOE5RMW0WAD3wO/H0FeieHP+Re0v8A69Yv/QBXmfw4tGsLvxLaO7SGG+VA7HJYCGPBPvjFemeHP+Re0v8A69Yv/QBXXD4ImFT42aNFFFUQFFFFABRRRQAUUUUAFFFFABXIfFM3p8K+Xpkzw3kt1Akbo205LjjPv78V19cl8Sp3t9I0+SOFpR/aVqG2n7oMgGcd/THvUz+Fl0/iRk6XpcCTWWi2y/6BZIJpxjhiSdiH2J3Mf90DvXY1z3hnLanr7t2uo4xx2EEbfzY10NcB0Td2FFFFBAUUVDdXEFpA891NHDCgy0kjBVX6k0AUfELSnTxb28hjluXEO8HBVTyxB7HaGx74qGGKOCFIoUVI0G1VUYAFVIJn1O+GoMrx2qoY7aNxgkE/NIR2zhcDqBn+8QL1I3hGyKUulafK7PLYWju3VmhUk/pWeNP0xmkWx003rq+0xLzEjDqPmOxcdwOR6VJrTTywSeW7pEkqwLHG5R5pG24yw5VAGydvzHBxjHL9OV9I1Oxt1uZZoXhlMyNgJGihSHCjgAHC++/JJxQOT7Bb+XNfx2+q3cAIcRrY2m50D4yBI+BnjnbhRjrmrmgask+oTWSWKWsJ8xrcx9JFjfY5YAALyQR1yD7Vk+Ggljb6bDJGIIrW2kvZtwwY85ADe5DOT7qaf4duRp+jXuo3MbF4LYSvH/ErsXlMYz3+dB+VMzku4zwlBEmv70G6VYrtGkbJd1FzgFieTwvU0JGbiHSLSRcia/8ANA6/u43aVW/8dT8xUFjHqGgw3eoRfZLmG0tY7eWKRmR3dQXZkYA8sZMYI5IHNQ6RqOoQagZ7nRLl00u0+zyeRPE2GbazN8zL/Cin1+bpQPa5raZJv8T3sfcag7j3AtkB/VsVTn/0y3uFTk6rqXlqP70asFYj28uJjWFBr8lhPLdS2GoJeC2uJin2ZmxNcSr5Knbn+6Vz3xWpaeINF0tLITS3Cxadasw821kjJYAIOGUckFhQO1tTZtQJ/HsroxIghl3Y6fMIAP1jf/vmszw6GtdQ097dgII9Lc3SgffClRFn/wAiY+hpfBF9aPdaldi8tZ3a1jll8qUNhy80kgGD0G8CjworP4f1S6l4kFnFbk+u2DzDj/gUzD8KCXpdC2N8BqUDTWy6fcyIPPt4zmJ1cjZKDgDcG+QjAJLdwAa6Suf1BfOk1SUDJSWztIx6OJFkJ/8AH0P/AAGpLCfF3dahNO4tpTMBvc7ESEqmQOg58w575HoKRonbQ3KKq6fdPdwl5IGgYEfIxywBVWGfQ4YZHY1aoKCorm4itYGmuHCRr1Y/kB7knjFS1UtUj1LWiroXi04hyT90zMOB9VU5/wCBqe1ApOyuFtp0uqO02orcW9qpxDbrKY2f/bfbgjPZc9OvJwrp9CnhmMmj332ZX+/Fco1xH9VG8FT9Dg+mea6CimYczvc5ktf6cxGq+TNb7d32u3jZFX1DoSxX/eyR1zjjL7LVNPv3ZLG+tbl1GWWGVXIHuAa6OqGoaTZagoF1bqWU7lkUlHQ+quMEH6GkUqncx7mK6vtVhs7e6ltYFhaaaWFVL5yoRfmBAB+c9P4e1OsZZ47q5sL1g1xAQySY2+dEfuvjpnOVOO654BFWyNL8M2ksrylDJyWnmaSSYgcAFiST6KPXgViW+qJ4gvLSSALZ6nEhMau29JUYAvC3QqwwpxjIwCNwzQNTbd+hvUVWsbtLuN8ApLG5jljPWNx1B/Qg9wQehqzQahRRSEgdSBQAtRzQxTpsmjSRfR1BH604soGSRj60K6McK6k+xoAoy6PYsmI4Ps5/vWrtA3/fSEGmxRa3Y4Gm620sY/5ZajF54/BwVf8AMmtKimpNbMTinuQw+J9VgcJqWhNIvQzWFwsi/Xa+1h9Bn8a1H8VaPCm+6u2tU/v3ULwr+bgCqNRzwx3EEkM6LJFIpV0YZDA9QRWqryW5k6EXsb+n6vpupR79P1C0uk9YZlcfoavV543hXw9g50TTAMdfsyDH6VlxaXZuFn0Gz1mK0U/6/TLvyYnHfC+YNw9wvOOCatYjyIdC3U9Xorz3TJNQTE2j6/cXCI22S2v1EoB7qTgSI31Jx3BrYu/Fr6aok1PSrkW+QGmsz9oCe5XAfH0U1pGtFmcqMlsdVRXN2njrwvc8JrljG39yeTyW/wC+Xwa0E8RaI6hk1jTmU9CLpDn9a0ujPlfY1KKz01zSZGxHqdix9BcIf61ZivLaY4iuIXPorg0XCzJ6KKKYgooooAKKKKACsDxpcomjmx88xXGoMLaPYcOQfvlT2wm459q36811SSPxFrlrPOGNrcFrO0hP8UWd00p9nVAo9iO7YGdWXLE0px5mang+3jZbq+hQLbSFYLML90QIMAqPQsWOe42+1OvYkuvEfmyrn7FDsiBHRpDlm/JFAP8AvV0CKqKFRQqqMAAYAFc/FM82t6t5i7fJeOFP9pfLD5/N2H4VwnRB3lc53wPJ52seLZByDqe0H/diQf0r0Xw3z4e0v/r1i/8AQBXn3gRVWfxOqABRrEvAGP8AlnFXoPhv/kXdK/69Yv8A0AV6MPgic1T42aNFFFMgKKKKACiiigAooooAKKKKACue+IFvNceD9T+yjNxAguoh6vEwkUfiUArW1bUbbSrCW8vpPLhjHOBksTwFAHJJPAA6mubY6pqn+k6jJNYWrjEVjC+1tp7yuOd3+ypwPU9aVubQa01KPg2/jvLu7miBWO+gt79A3X5k2Efh5a/nXV157aF9I1OCztbZvOsd32aPcB9ptGxuRCTjch28E/wLyA1d3Z3MN5bR3Fu4eJxkH+h9COhHauCUXF2Z0y195dSeiiikSFVb+xttQt/JvIVljyGGeCrDoykcgjsRyKJL62j1O3095MXk8MlxHHtPzJG0auc9BgyxjBOTu46HHD+IfFZtJmuZdY/s6F5Ggs4BbCczYyDIygbiCQduCBjBOc4osOKb2Omj8OwWriXT57iKXneZZpJlk/3gzdR2IIPbpxUN1Hq9vLtgtbe9QjIcS+Tt9QQd2fYj8cdTzcHii5t0Z01SRrYEEPqWlzR5OACDIAqgd+mcn0q9pnxA0xmkgvry3nnVl2yWSM8ZRiBubk7MMcHcfQ98UWZfvIdb3RvdRtA8U0CrLNctHKu1kdI4o9rf9/W5GQcAg9KWSQ7mLsvnX0Hmztji3tBnC/7zZP8A49/dFbd/BZ6vYfa7KG21BirLGROUSQEgMpZQeDtGRg9MVhJDdW9rPf6zF9kgiUzXPmyruuZAPlQbSQIx0Azk8AjrkBSvuPeH7Rm2u1dbq/VJ7qPP+pt1PyRE+5yD65k7Yqm9wr6UHmytvfStqVw+M4hQqIlA9XCJx3G72pbZpb6xDWlneanHOwe8u4mSMXIA5WMuwJXOAMcbcgGqNprMLvcXOpJMLuDYFspYXiijlzlVJKgbYxg57kswBO3APY2yk8qQWl7tQ7l1C954Q5zHFn22DJ/2B/epPM8jT/sgYefqQe9vJGH+phIAx9doVB/uk9sVRj1DT7hLn7RqltfRxA+bbrPGr3suBnOWACDgbenY8DBvaNY3GpEzXCrCjjfOGlR3uZMcKShIWIZ4UHJHHAzuAuuosMQL27Xi7Ly+kF5JE3/LKKNcIp+jFT/vFqgMf2yFbydhHDfSLMxc4C2sBLJ/30xDH/ZfHatGw0C8lcvrM0EhkXFwIyzNNjOFLcYTknYF79eu4bQL67a4uNSurd5nG2G3CEwQLkYBGRv6Z5wCeo4XALmRga7/AGffabKl1p0csl6xmJeENLHDwibcjIeQjCDg/MT1Uioxpj2sBtrS7ubS3t8T3sKuJYTNkOsCbhnjgHBGRgY5OOki8LyBVe41Sea7MnmSXLRrv4GAEH3UPbOCQCcY7Q3WgXUuLWyJt4o23fbrqQzyFidxaOPO0Nk/fbkHnB60BzI56e81SyumtpFgl/0jzLm6tkZzHO0YBATksscfcdTtzjmrlre6Xq88dlYXcJ0TTIB5ku/JdI9rOD/sk7ASeuHHvWnH4UdHFva3ElnbJkPdJJvurgN8zfMRiMFuTgEsR27zR+CNF+1q0mm2bwRqFjVo9zkgYyzHkgDgL0HPXjALmQlkmtzJJcrY2ii4czBZ7lo3UH7oKiNsEKADz1zWkun37RjzLu3RiPm8uAnafYlv5j8KrW9hp+uWFnfaffailnKnmRmC6liEinpkE5H6VeGj2ccZDSXjIBz5t7Mw/HL0BzvoVD4e8wYudW1OZfQSJF+OY1U/rSeB4Ui8NWrIzu8peSR3bcxcsc5J5OOnPYCoJrDww9hJd/Y7K9gUhCyIJyWJAC9+ckfnWTo+leGZNbkhg0+1xcKZVgmtdjwSKQGAyOjA5A/2WIyDwCu2d5RXK6BDb3ep+IrQRG3j06/S2iFtPLFuQ2sEuWAbBO6VxkY4A75Ju3GmanA5l0vWJcdRbXkYmj+gbhx9SxoasStTdorzrR9X1a402C91e1vZ1nUS+ZYXGVjB52+WNjcdMAOfc1Zm8RWsEZudO1NjNADJJZXLsHlQfeULJ8wbHTHfAPFBp7NnT6eouNUv7mZF86F/s0fHKIAG6/7W4E47BfSotc8OWGsXFvcTiaG6gcMs9vIY5CMEYLDnHJ+lWJ7T7Xsu9PvHt5JFVvMjAZZVxxuUjnr1GD701dJE246lcy3jHopOyNfoi/zOT70EECeFtDTP/Ertmz1Lrv3e5z1NSL4c0dQAunW6gdAq4xWC1zq1zfCy0zUC2mxyES3Rt8OoBP7tZGYhz23BeADli1arWcbptle4kU9Q87sD9RnFItQbJZvD+gRgtcadYYzuJmRT0+tVJbfwfCcyw+H4yDjLLCMe1Iui6WpLLptkGPU+QuT+lWltYEUKsESqOgCDAouV7N9yh/xQ6y4/4poSPzj9xk1KD4NmXr4ekAP/AExNaHakKg9QDQHs/MpR6f4Sn3+TBopyMExCMfyqzF4d0Z8SQQkDGAYbiRRj/gLU2W0t5TmW3hc+rIDVRtC0lmydLsd3r5CZ/PFFw9m+5d/4RnTwylZNRXb0A1G4x+W+kXw3bLn/AEzUyD2N4/H61EthAmPL82PAwAkzqB+RqnrB1KwgF5pN1Kxh5lt5gZ1kTI3EAnduAyQAwBPBoE4S7lm98NTPG4ttWvcFCpguNkkUmRjD/LuwfZgeaz9EbXTFLFp2I1tcQvBqTl9kmMlVZRuK4KkMSchuldfa3EV3bRXFs6yQSoHR16MpGQazrUFfFOpAABGtLZjju2+YE/kFH4UEcztqY8um6zf6pa3k9rYW8sBOZEfa7AggqeG3LyTjI5A6VsS2V+qZimtZHH8LRsgP45OPyrXophztbHMzf2jHkXmkLNGe9rMsuPqHCH8s1Rkl0EyD7Zb2lvK3G28txCx+m8DP4V2lNZQylWAKkYIPQ0ilUZzQ0fSnUMNOsWU8g+Qhz+lV38MaC4w2i6aR/wBeqf4VurommI5eKxt4XJyWhQRkn6rinnSrU/8APf8A8CJP/iqCvao5xfDGlRHNrFPaH/p1upYf/QGFTx6be25BtPEGsRAfwvKkw/8AIisf1rabSbcj5ZLlD7Tsf5k1G+jggBL28j+jKf5qaabWzE5xe6I4bvWYlCm/tpsfxTWvzH/vl1H6Usura5GD5UOm3B9GZ4c/+h1FcaSIl3ya3fQKBySYcf8Aj0dZu+wUbR4snmccERm3dj+Cx9fwq1Un3JtTfQ0R4k11P9b4ftnH/TDUd3f/AGo1px8WaiCQfDF8fdbmD+rissjeR5Go+IJcdlsEUH8WhA/I0+Oy1KXCRx6g3rJfzxRKPoIBuJ9jj60/bT7i5afYmvdR1vWoJrV4E0W0lXYZFmEtyQeoXA2ocZ5y3tjrVjwxpkUMEGoMd08tuiRrjCwRYBEaD06ZPUkDsABDa2GnXN4LfUtMRNRjUukjsZNyg4LRyH5sDIyOCMjjoTp+H5FfSYVUACEvb4H/AEzYp/7LUSk5bg7JWiXLqdLa2mnmOI4kLsfQAZNc/pbT3XmahdIsT3YR1hU58tQvAJ7n17ducZPRyIskbJIoZGBVgRwQe1cmGuNAjFvfQSyaej7IrxCGVEJwiyDO4EZC7gCOMkjnElU7J6mf4GINz4o2nONYl/8ARcVegeG/+Rd0r/r1i/8AQBXnXw9JL+JSep1Zyfr5MOa9F8N/8i7pX/XrF/6AK9GPwROap8bNGiiimQFFFFABRRRQAUUUUAFcrr3iC8XWG0fR4oEu0jWWW4uslI1bptQENIeD3Cj1J4rqq4nxHq+ialdzWUlpqVxd2MuwXNlbMWt5CAflkxjOCMjkdiKBofoOjSQ6i+oaxq9xqt4RhPNVUih/65xjhT79a6OaNZV6ivNrXWNdsdSaKWx1LVNPYkJILJYZk543fOFI9wF+lbi+Jkj4msdXiPvYSv8AqgIq426A0y5q/grStXRBcwMjRtvjeCVoijf3htI5rJuPBuuQEtp+sxSEHKtPCY5j/vSxsN3/AAJG9waux+MrDaDuuwPezmH81p6+OdJO3F0ST0Ajcn8sZqZU4y3HGco7GdBZfEC3GFn0ic9P9JmLD/xyJD+tOWP4juSrL4WjXPDDzyfyrVTxpYucQx30x/6ZWUzfqFxUf/CZTMy+X4f1t4258zyEX9GcN+lZ+wgVzyOMfwvreu+NHsvEOrq8trZRzym0Rol8maRh5IIIPJtycn06HFd5aeFNKs1UW+nWaEDG7ylLH6seT+NczpniIJ4x8RXzabqbs62tmVjty7RiNGkw2Ccf8fGR/nO8PGdoC3mWOsIB1J02fH6JWkYqOxLbZYuvD9o6MBbJEx/5aQZikH0dcEfgawNRgt7BCPEsMl/YL/q9UUhLu0zxhmXDMOmGXnsQetbEnjbRlAE008OehmtZYx+bKBWXqHjKwZWbTLe+1VgOVsLdpQPq33R+dU0pbiV0Y8MirNK+j6jNqCxbJ47yOV9ygH7lzCuDyAV8zYcjrgjJ67+0rXW9InS2KNeG2MggJBddykAj1HYMOD2NYWh6tbtr8es6nbapbSRW7QRW6aZcMcMQWLuE5+6MLjA5OTnjP1tNM+3fatDGr2+GMpgfS7nYjnq0ThMxE9wAVPdetcdSj1ibqd9JHoFje2d0jLZzRN5XysinBjPoy9VPsQKrf21BK8i2EM9/sO1mtgpQHuN5IXI7jPGa85HjBpXEfiHwfeajMnypcHTCCy/RgT/L6CtbQ/HbvHdtJpd19l+0vHaiG0lKxxx/uypKIwJ8yOQ9uGFY8kuw7HYf2lKSfM0e/X3Iib+Tmhm09+ZLF8/7Vkx/9lrn28bOw/c6VfH3FlcnH4eUKq/8JVq622EtbqWQnIl/se4GB6FCwz9cj6Uckuw7HSSyaLEpM9vFbr/eltjEB+JUVXtYtIvXP9k61Iso4P2a/wDNx/wBiyj8q5e78c66yRxweG9XicffmGntIG+il12/marXmp/8JBGsPiLRtV8hBnbFpMqFz7sCxA68Aj60ckuwJeZ332TVoeINUimX/p6tQzfmjIP0pBLrkeN1np0wHVluXQn6KUP864i0fSbSJYrK38VWkafdSOK9Cj8OR+lWU12aIfu7/wAT47CXR2cD8fJBP50uWXYfL5nXnUb9Pv6LdMef9VNCR/4861Q1HWdViWOWHS57SCNWkmkuRE4AGOPkl44ySecY6VzUvi7U7df3Y1W5bP8AFoEv/wAUtZ+t+O76Twtrwu9OvoSlhct5kumSwj5YnOfvOO3cimoO+wmrF3wTYam/hXw9AtqrGPTLSASXIbyYwsQy5QkFnYnoPTlqv3WnavaahbWU8q39tcEyJBFKYIgyYJDK29tvoA20kYK45p+neMrC0tIbATafE9oogZbi88phtAH3Sue309Cay9T8VLeatHeWt27Laxska2MEsybmIyWkEbK4+XGABjnnPQabbGr2R0uwSTLNdaPdQzKR8xRXJx0z5ZbIHbPSpL1YL63aGaC8A6qy28qsh7Mp25BHYiuN/wCE81IsWmh1MHPHkWDomPo0bN/49+VNf4jakpwLG9Kjgk2D5Pv0/pS5H2K5mbfhfVU0zWPErazcEM9xbt5zQOm7MKRruGPlY7OnfPFdH/wk+nM7rCt7cFDhvIsppAD6EqpAP1rzG28WSJrWq3NwL5ftdtau6Jb/ADH5p1BZTG+MiPHQdK0oPG1tDCIo5dYhjX7qR2oVVHoALeqlF3M0jY1u/n0i4XV9P06/OkuxbUYTAVMI/wCe6JjJxyXA6j5hyCG2EulvreKQafPPazKHSRVSRGUjIYEMQQR3FcafHlo5IeHXJRnODLJF+qouPzrFsvEVpot3NJZWmoJ4ecNK1p9ueI2UhyS6bWGYmOSwI+Qndnbu2ig2ttSuZxO81DQ7G7jAgtr3Tp1bcstpC8Zz/tBRhh9f0rP8vWLFNkZ1yXHCyWkrtk+6XCPtH0Y1hX3xB1WzYLpOm3skmceVdXEU6Ae5U7h+LVtWHxRQxY1LSLuCdFG8Ro7hjjnbhSPzIpcsuw27klvYarbx28TeItQjhWMJs/s1NxI44Yx9PTjPvU3kI0Ukk2v66ojYq8skIiVD7/ugo69/al/4WfpmM/ZbpeM4aCYH/wBFkfrVOb4tWCcppl846AeW4bPqcrjH459qXK+xXO+xbtrnWYIfOtNQsdbtGOEYxsj8dQXiDL/46KltvFtubkWt9azWt102F0Yn6Lu3n8VFcf4h8RabrU4vbe21HT7wfxRxTAMfVtiA54A4YZAGc4GMweLNVsx9muJv7YtGU5WfS5WAHoS2GP4hqOV9ilJdT1eTWrCEqLmf7NuOFNwjQgn2LACtBSGUMpBU8gjvXllh4gX7FES0unJI2x7SRnuo1B45Rk4X2VxgVJaa/baXrEH9nRRR25R/PZEuILZ/TCeWwDZ7rnjOT0o5H2HzI9QorkP+Ezt2QE3OnRA/xE3D4/8AII/nUf8Awk0E3P8Awk1nEnfydGuJD/30Wx+lP2UifaROzorjjq3hp1zqPivXLgdTHFbvAp/79xBv/HqSK8+F7XBkMTmZhgySw3RJH1YVaoPqyXWXY6GOC902eV9I+zNbytve1nLKofuyMM7c9xtIzzwSc1ZJdfs5L+/gttPvLieMYg8xkKbQdqqxB3DJJwdvLHkVmx6l8NHJWJZVYj/lnDdKfzAzTnu/h/8AKYrrVYHUYDxSXqkf4/jT9g+5HtIvobVsbG6uIYtR1e+lupB+7hmZrQMe4VVCb/x3Yqjf6Z4fgu5Ek1/yLgnLR3F1HOw/7/BmA46AjpWHea1oQX7OfFSXdsSMwarpjScdvmVU/Mg1Na+KtB0+JY9Pk0dYyeI7WUx5P0Mar+tQ6ckNcvRmolnYSF/susW04PpZxy8/8AAp5sfkUG7t8cEkaPJk/wDj1Zp8fafG4W4stQQHo8aJOp/GNm/Wra+NdGYZBvjg4yLCcj8wmKnll2L07kjaVEykHVb+POAfJs3Tj244qN9DtSBu1zxTKRnhXZSfx2DH5imf8J3oO/Z590HzjabKbOf++Kjm8faLGrFBqEpBxhLGXr+KgUWl2DlXct6dZQ2MhMWn65eser6hfh1/75Mh/wDQa0d9weU0HTAD/wA9LjB/SI/zrlU+JFhJIUXTtSiA/juLdlU/98Bj+lTt46sXXAuYYG/vNbXUmPw8pf501CT6Cagjo1+3bsx6fpEB7Ebnx/46tS+brZGBeacg9rNz/wC1f6VykWu6TcsW1LxVqQXG7yrDS5IFx7lkdvxBFWxf+AyhSW/158ckvNf5/nVqjJkucF0Nm6t9YuIWUa5JbSHo1vbRgfk4Y/rVH7L4ogJMevrdnsJYI4vz2oc/hiqgv/AMXzLe62D7T6h/jUZ1PwsSostf8TWzHBH7meUfX97G3FHsZdw9pHsa1m2oWNwLu80/+0LsqY/Oiu9zLnkgI6qqrwM7eeBwadYy65Z2ixRWunjbJJM485mMu9y+0fKNpyx+Y56dOeMI+JILWXaniMXUeSAtxo06u3/A0wD/AN80XPj+xt1BCC5JGdlus28j1AeNR+tS6ckUuRnYSeIbdY9IdIpHXULs2eOA0LiORiGHsYypHvUXjJg1hZ2uctc3sC7e7Krh249NqHPtmvLr7xRbXl5bXFrNqlnHHfLeGKayAMbFDGzK3IY4JwpByW79K0rjxjZPPGbe41S9vdhjhu761Kw2xbALFUQZPI6KemMjNDg7LQlR97c2/h8wafxUykEf21NyP+ucVei+G/8AkXdK/wCvWL/0AV5L4P1rRtE/te2+03Twm8UxStaSkygW8KlzheMsrV2fh/xzoEWjWFvLdzJLFbxo4e1lXBCgEZK4rtjpFI55puTZ3FFUdJ1Sz1a3eawlMiI+xwUKMrYBwVYAjgg89iKvUyAooooAKKKKACiiigAritGUf8TIoME6hclvc+YRn8gPyrta5jQYVYalt5xfz547lyf604uzDoSiNsUeW1a6W4KjinfZh6VfOKxj+W1J5bVs/Zh6UfZh6Uc4WMby2o8tq2fsw9KPsw9KOcLHB+DUM0/iS6AP7/VpfxMccUH/ALR/z1PR+W1Q+B9IudO0Dy9Qh8q6lvLu6kTcGx51zJKORx0cfyrf+zD0oUgsY3ltR5bVs/Zh6UfZh6Uc4WMby2pfLatj7MPSj7MPSjnCxyfifUG0Tw7qWp7d7Wtu8qJj77gHao9y2APrS+GdHbRfD2m6bu3ta26RO/8Az0cD5mPuTkn61a8YaPc6r/Y1nBDvs21GGe9bIAWKLMq8ZycyRxLgZ4Y54rofsw9KObULGN5bUeW1bP2YelH2YelHOFjG8tqPLatn7MPSj7MPSjnCxjeW1HltWz9mHpR9mHpRzhYxvLaub+I8ZPgbWoj0ntzbnJ4/eYTn/vrp3rvfsw9KwPG+kXOpaElrYReZK19ZO4yBiJbqJpW5OOEVz744yeKHILD5rVJ33SxI5/2lBpwiIGAMAdhW19mHpR9mX0o5gsY3ltR5bVs/Zh6UfZh6Uc4WOEtUZfiLqo/56aTZZ9tk13/8X+ldF5bVD/ZFwPHf28Q/6E2m+QZdw/1gl3BSM56EnOMda3/sw9KFILGN5bUNCWUhgCDwQe9bP2YelH2YelHMFjzSNW8DXCQSkjwlKQsUh5/sxyeEY9oDn5T/AAHg4Ujb2XltWpc6fBdW8tvcwxzQSqUkjkUMrqRggg8EEdq5vw1pOpaDqkmkFXvPD/l+ZY3LyAyWmMA28mTll5yjcnAKt0BIpWCxoeW1HltWz9mHpR9mHpRzhYxvLajy2rZ+zD0o+zD0o5wsY3ltR5bVs/Zh6UfZh6Uc4WMby2o8tq2fsw9KPsw9KOcLGN5bUeW1bP2YelH2YelHOFjG8tqPLatn7MPSj7MPSjnCxjeU1HlN6Vs/Zh6UfZh6UcwWMfy2pPLatn7MPSj7MPSjnCxjeW1HltWz9mHpR9mHpRzhYxvLajy2rZ+zD0o+zD0o5wsY3ltR5bVs/Zh6UfZl9KOcLGN5bUeW1bH2YelL9mX0o5wsY3ltR5bVs/Zh6UfZh6Uc4WOE8dIyaXYSH7qatpwP/AruJB+rCui8tqi8baRc6joIh0+LzLlLyzuFXcFx5V1FITzxwEJx3xit77MPSjmCxj+U1BiYDmtgWy+lEluCOBRzhYwPC+8eIteUkbNtuQO+7a2T+QX8q6isnSNNaz1HU7pnDC7eMqO6hUC4/PJ/GtasymFFFFAgooooAKKKKACqdjYLZvdsjs/2mczkN/CSAMD24/WrlFAABgUUUUAFFFFAHHeI/GX9heONN0q6t7iWwutOuLpmtLCe7mEiSwqo2wqxCYkbJK9dvI6HnbT4wabZ+GNN1DXlVb3ULi+WC3R47QmKC5eIMftMkYVtoTKlgxJOF4IHfy6JbSeKLbXWeb7Xb2ctkqAjyykjxuxIxnOYlxzjBPHpz6/Dyxt47FtM1TVdOvbN7tory3eIyFbmYzSxsHjZGXeRjK5G0c55IBn3vxc8PWiaLNIk7WWrRwy29wJ7ZTiRgo/ctMJmwSM7Y2x74NM1Tx3cXniHw3baHaX8WmT65Jp8+oSJD5Fz5cNxvjTLGTiSMfNsA+QgN2Nm8+GFhdTTu+ta4BdLbC7XzYnN00BBjZ3aMvn5RkKwU+masW/w7sbfWbO8j1bVxaWeoS6nb6b5kX2aKeUSbyP3e/BMrnBfALHGBxQB21cz8Qdb1DQdDju9LgDu1wkc07W0lylpEclpmijIdwoHQEdckgA101ZniDSpNXtIoYdT1DTJYpVlW4sXRXyM8EOrKynPKspHT0oA83fx3q/l+HJ7a+sNdS51t7KSPRIPLeeMWsriN453PlOHVWOXHygHOCRW8vxN0+azhlsNH1u+uDDPPcWkEUXm2iQyNFJ5m6QLkOjqAhYttOAavWPgKwt9RtdRuL/Ur3Uob/8AtF7q4ePfNJ5DQAMERVChHOAoXkA+uacvw008LIbDV9Z06ab7Us81rLEHmjuJmmeNt0bAAM7bSoDAH71AFyT4gaMNO1O+hW6ntLCK1naSJFxKlwAYymWGeGGc4/GsrS/HE8F7f2Nza32salLq95b2VpZpCriCEIWJZ2RAq71GWbJLAc1Z1P4Y6VdiWG11DVdOsJoLa3msrR4hFItvxFnfGzDAwPlYAgDINWbj4f2TXv26y1PVNP1AXVzdLdWzxF188IJY8PGy7D5aHkZBUEGgDjtL+M+laP4V0Z/FFxJPq01kLy62yW0LIhd1B2vIm8/IfliDNx05Ge/0fxdbazrd5p2m2GoTJZzCG4vNsawIWhSZTkuGYMJAPlUkHqAME49n8M7LTYLdNG1vXdNkjs1sZpraWLfcxKzMu8tGwDAu+HQKw3Hmum0PQbbRrvVrm2luJJNSuFuZvNYNhlijiG3jONsannJyTz2oA1qKKKACiiigDyPxn8RNb0XxHr9va/ZPsWlNbfu5NIupRIjojSNJdo/lQhQzHLL0HeunufiNpFr4ztfDdxFKl1dyiKCVbm1kVyyFgfLWYzBTgjc0YGe/INLrngCDVr/WZm1zWrS11hUS/s7ZoFimVUEe3cYjIoKjB2uOp6VHbfDbTbXV47y21DU4raPUP7USwVovIE+0rnPl+YRgnguQO2KAMfxL8R5Z/CU2p6HZapZWjNby22rXEMX2aeI3cMTlfmYruVyRvVSVyw6ZrufDWvW/iGye9sYLlbHeVguJkCrcqP8AlpGM5KHsSBnqMggnmR8MdOOkPo8ur61LogVY4NOeWIw26LMkwVR5eWAMYUbyxCkgYzXSeGfD1t4ctri006a5+wPKZYbWRgY7UHqkXGQmckKSQM4GBgAA2a4/xZ4vPh3xdoGnTwTy2OoW15LKbaynupleIwBNqxBiF/etklT0HI79hWXeaJbXXiPTdakeYXVhBPbxIpGwrMYyxYYzkeUuMEdT17AHBaZ8SYprf+0tTN/FHE+sultb2yxrLBZyYBlWXEiy7cYUFRuLbgMADqvC/jCDXr97JtM1PTLoWsd7FHfJGPOgckB1KOw6jlWwwyMisfXPhvaXGk6kmnXNwL6aHVRB58g8sSXxLPuwudobGMcgZzurW8H+EhoMgvL3Ur3U9Ta1itDNcmPEUaZPlxiNEG3cSckFjxknFAHU1xvxM1TxBoWivquhXelRxQtFG8F5YyTM7PKqZDrMmAN2cbTnHUV2VZniTRbfxBo8um3rzJBK8bloiA2UdXGMgjqo7dKAOTXx/Hovia08MeJpIZtWuZ0hjubQQQxOXGUxbm5knA/hLFcZ54GDXK61481OLTLi70fUb6S3XRxdxtdW8HnGT7aIiSEXb93KgDjGD15rs5/h1YS66+orqeqxRPqUerPZRtF5L3CAAMSYzIRx93fj0AqKX4YaO+lvYi81JI2sjYh1kj3qnn+fuGUxu3cdMY7d6AJG+ItnF51vc6PrEGrpdQ2iaW6QmeV5UZ4ypEhj2lUkOS4A2NnGKhb4m2TS21taaFrt3qMq3Rksoo4RLbm3ZFlWQtKFz+8UjaxDA8E5GbD/AA8s5klmudX1abWHu4r1dVZoRcRyRIUQKFjEW0K7jaUIO9s5zVjRPAem6TqFvfx3V/cXscV1HJNPIrNcNcPG0kj4UDdmJANuFA4x0wAYGs/GrwnpUdnJLNLJHcWcN+SJII2jhlGUJSSRXc4ySsauR6cjPpasGUMpyCMg1wlp8NLLT7e2h0fXNe0wR2EGnTNazRBrmKEEIXLRna4BI3R7Dz9K7ygAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK47xH4y/sLxxpulXVvcS2F1p1xdM1pYT3cwkSWFVG2FWITEjZJXrt5HQ9jWXLoltJ4ottdZ5vtdvZy2SoCPLKSPG7EjGc5iXHOME8egB55a/GTTLLw5p97ryBb29mvfLt42itSIYLmSIMftMiYbCrlc7ic4UYIFzUvjT4SsJLQNcPJHPbwXTOJYIzFHMAyExySLI5wQSI1cjvWonw6srYWj6Vq+saZeW5uwLq2eIyOlxMZpEYPGyFQ7ZX5cjA56kzTeA4vthubHX9fsJZYIYLs29xGTeeUMK8jOjMHxwWQqSOtAFn4f6re6tZ6y+oTea1vrF7axHaq7Yo5mVF4AzgADJ59a6isvw/oltocN7HaPM63d5NfP5pBIeVy7AYA+XJ47+5rUoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACqmp6nY6Vb+fqd5b2kJOA88gQE+gJ7+1ZGt+Ihb350vS0juNU2eY+4ny7dT0aQjuey9T7DmuX060+16q88tx/bWqx58yeVtsNr/sIACEPsMt6npWM6qjojWFJyV3ojsR4l0xl3RyXEiHkNHayup+hC4NNfxLZAHZFfSEdhaSDP/fQFUFttQz80dr9RK3/AMTUT6XqMzkSahDBCe0Fv+8H/A2Yj/x2svbyL9nDuXG8VAEhdG1ZsdwkQz+cgqSHxTasCbi01G29N9sz5/797qz38OpH89nfX0VwP45J3mQ/VGOMfTB9xUF/LeaTYm5v4RcwxjMslopLAYyW8s5OPoWP9D28hqnBm/Z+JdEvJTFb6rZNMpw0RmCyKfQqeR+Va4IIBByD6V5NdHw7qt5b3+qWBtvNTdDc3sYjjuUHY7uD6gMAccjjmr2n6N4eu4mk0lY0QHBNjcNEFPUfcYY65/KqWI7oPq66M9LorhYrfVrIg6frt2QP+WV6q3CH6nh//H60/wC39Rtod1zpiXRXr9jmAZvcK+AP++jWirRZm6MkdPRWPo/iPTtVlMEUjwXgGTa3KGKUD1Cn7w91yPetitE77GbTWjCiiimIKKKKACiiigAoqpc6nYWsmy6vbWF+u2SVVP6mi21Oxun2W17bTP8A3Y5VY/oaALdFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWdrOtWGjRI+oXAjMh2xxgFpJT6IgyWP0FR+KNXGiaJcXvlmaVdqQxDrJIxCov4sRXKW0IslOpa9eRzaiy7ZLmTCqgJ/1cY/hXPbqe+TWVSryadTWnS59ehrpr2p3jF7eyisbf+A3fzyt7lFIC/8AfRPqBWFrmDtfXdY1GZZm2pa2xaNWPXaqRDew+pPvV1bu+usHT9MmkjPSW4YQKfwIL/8Ajv0rHWS/1jWIHsbe2kn01pPNlSdxA24bTCJCnJz8xwpA2KOp45nUlLdnQowiVobfQrOYXMJ1PR5jwLp2mhH0LP8AL+DVuy6j4msBF/Z8tvq9uwG5rrako9xsCqR+v1qKTXIIbj7Hqlpd2k7qTtkgMiOO+HTKkfUg+1ZOmy6NZQXETaxb2wkmMyRQTeSsKkAbVUngcZPHUngVKnKOzLcYy3DV/iF4g0i4YajaaLaQhdwEs5Mrj2RWJx19as/8LUgvLaystKhiufEN42zyIXaSG2BydzSYAbavJA78Z71NfSaZaWUdxNdXNyZ/lh8q4dnnJ6KgUjP4cevFV9H0RdGsrvUZY4VvzE7KkSAJbrjIjQD6DLdWIyewFqtIh0Ykn2PTrG3ntGZ7plD3uoMzfPMApOZWH94gcdwCMYBFaukaLe/ZYJ5dTuLSRo1ItbSONIIOM7VUoSfqefpVPQI7XVpbqyigkGj2qoH8xCpvZWGWd+5GNpw33t2TkYra8X3U9j4W1W6s5RDcQWzyRvgHBAzwDkZrMmTuy5p8sz/aIrhld4JBHvVdu4bFbOMn+9+lVr7xBpdlcC3mvIzck7fIiBlkzjONignoCenaucsra7lka0ttYuJY5YReQNIRm5OcMHkUBtoBTGMfeHUDFNhhjhSEW1sLe1vVykWNv2e7C/KeOmcFT2JAH8RyBydzdt9ck1JmXS7OURoxSS4ul8tIyOo2EhyfbAHvR9nTUrUXcutSSWTpuBtJFiiK/wB7euW/8eqpC9s7296hP2S+VYpgeFkVxhCR652rn0bB7YyrPTobWS78MXMjR291C8UeOj5BKMB03FVk3dmMecc8gONmdpb2dtbWcVpBBGltGoRIwPlAHTiqmoaHY390LiZJVm2hGaGZ4t6g5AbaRuAyevqfU1yWn2n9vaF9jk+XVtLk82FHY4VxlCuf7u5ZFB6qMEYwKsf8JJqFvpcbW9s00trIr3MM+fNe2YkFlOfvoflbPdT6gkFZ9Det9HuLVGitr4tACSguUMrIP7u7cCQPfJ9zVBtQurXcmo6bdrIpOXtomnjYf3gVGfwIB+vWri+KLAzLEHLvMhktNnP2pQOQnbcDkFTz+dPg8TaXPC8sM0jxxttkbyXXZg4LEEA7QeCf4e+KQ1OSKc1vp2uWMTzRQ3du4Dxsy5x7g9QfyIqazfVdMgMVleJdwr/q4r0FmA/u+aDnHuwY/WkW20O4vmtvJ2SuWkjXLKkhPLPHg7SeeSORzmoYtP15I47VJrJUiG37ZKXmeRQOCY/l+Y9zux+fFKTjsU5Rl8Reg8b2cLiLXba50iU/xzjfCfpKuVH/AALafatmz1/R71ttnq2nzt6RXKMf0Ncl/ac1lK1lqUJfUf8AlisC4F2D0MeTwfUE/L1Jxg0y5a3kLJ4h0uC2j2NIr3TRSIQMBsnJwRkfn1rZV2t0Q6MXsz0MEEZBBHqKiubiG1gea6mjhhQZaSRgqqPcmvOdNsfD90zpp9iLY7Q/7uB7XeufvKcLuHuM9vUUtza6Gt2IJ7WTULmEBtrRS3jRemSQ20ntnFV9Y8ifq/mbT+L5r+XZoFi0lrnnULrMcOPVF+9J9flB/vVz95d2+rykXerXesZ5+x6ecRKPUrHyR/vsa37DRjc2m/WHllaYbmtidscan/lmVX72Bwck557cVo6neLptmHSB5WLCOKGLALE9AM4AAGST2ANYyqSkUlGPwo460HhODEMdtp0EjMFMUtuEkBOANysAwJyOvXNac/h3RZxibSbB/rbpkfjin3R1bUIpFmi022jddjQOpuRMPRzhMfQZ/GmaPFqEVxcfbNq2+1BEglMuGBbcQSA2CNvBJIOecVmbJvqhbPSn02VX0jUL20Vf+WDSmaE+2x84H+6Vq/N4i1TTnWS8sY72zz+8eyDCVPfyiTuHrhs+gNS0Vcako7MUqcZbo3dJ1Sy1eyW7025juIGONyHoe4I6gjuDyKuVw8+nssktxpd1Lp17IQzTQgESEdN6H5W9MnnHQimJ42vNKkW18Q6PezPjIvdMgaWFx7rnch9ufrXTCtGW5zToyWx3dFcx/wAJzoQQM815GDx+8sJ1/mlPXxx4dIUtqSxhjgeZE6fzUVpzx7mfJLsdJRXPx+NfDDkgeINLUjs9yi/zNXbbxBo10R9m1fT5ienl3KNn8jTTTE4tGnRQCGAIIIPcUUxBRRRQAUUUUAFFFUb7V9N09tt/qFnbN6TTqn8zQBeornn8a+GlJA1ywcjnEcwf/wBBzSDxt4a/i1m0Qf3nbaB+J4pXQ+V9joqKzbLXtIv2C2Oq2Fy3pDcI5/Q1pUxBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFI7KiM7sFRRkknAApaxPGsbT+FdSto2KNdR/ZQw/h8whM/huzSbsrjSu7HIazqsms3kWqgltBsnBs4VUbr2ZvkWTnouWwo7n5vSo7PQ9YvHu7bUb+G1ugVd7i2jLu6P2RmP7tRhlwBnjOcmtpLaKOXS7ZEAgjlAVAOAEjYr+RUflVjS72O98RayIeVtVhtnb1cBnI/ASL+Oa4JScndnXJcq5UOg0OPcr393d37LwBO4EYH/XNAEP4gmrEOp2OYIo2ZFkwsJMTIjcZAViADwOMHntT9atpb3R761tpBHPPBJHG5OArMpAPHuaxLvUE1KNdIj027S8yhKywlY7faQRJv+62CONpOSB05IRB09YWt+I49P1JNMtrWe91OS3a4WKLAVF3BVMjE/KGJODznY/pV3X9XtdC0m51G/fZbwIXYjk4Az/LJ/Cua8JWdyIbrV9VjMeq6q4uJoz1gjAxFB/wBevbeXPemlpdhFczsXdI037J5lxdeRJqM7F5pY4wgyf4V7hR+vU8k1bu7mO1jDSHljsRR1dj0VR3Jpt1diGSOGNHmuZf9XCnUgdSewUZ5J/mQDE0f2G8Vnb7Vq8yts4/d2yeuOw4Az1Y+gHyybuVtEPtpl0SxeJl+16tKTcSwwkZLNxkk9FAG0E8kLwCeKyLv+0tRkS5kmilYRx3thHDxC+D8yNu5Y/dG44xuBABBrZsrSO0iZULPI53SSucvI395j3P6AYAwABXK3Fw91cXFlo2pxWqQ3RVLt13JHK4O+AdiCecnhWIAycAMnltqyxf63p1ndxG2kVJRIt7bwLy+3O2ePYOQw/ecY6nj7pxprOt6NUigBdci4ttyFSVddysMj/noHwfas3S9PiSPVbK1tHj1iyljv8yNueYkEEb/AOIOFkGewk6AjAuaeYkt9BvLX/j1ljeyXjHyjLRE/QIw/wCB0AnqWIVtppbq0GHsL2IXdv6NG4+cD6Mc+28VT1N57zQrGQ/NqUBeBX6ZuYyGUn0DGL8nA71bsESOzslYBZLK5ls8/wB2NslF/ECKo7393Z6+Cfmgkh1Jf91QvH4+S350B09CvdahEuqx6pa5CLsu2OMbrdx5cqkeqFQ5HXIFO1WIx6pdhsYhdb2I9nt3G2ZPfo5x6shouIorS9ilVV8uK6aCSP8A6Z3O05/GUfqafJGtvZ6RPu8xbKRtLmDHJMblUXPvlYj9GNAWt+RnGxmZWhKxS3Ec32acTDKtIOYZz7uCqtjqHP8AdxUaxP5itB5odmKBfMxcxSDlo9x++yY3Lkncu8cjGbaW9w9jmOUiZB/ZlxKeSkiHME2P+BDI/wBtfSrRhj1bdcDdAb+Leyr96C5hYIXB9Qdo/wC2Y9aAM+G7ClbtbVJbKbEV7boNqCYMVWVAfuM2fbldpIYV0em67Cm61lW6mMKhvP8ALLZjbOxm754IPGcqeK5t5FHmXjxH7NdwSrqkUZ+UFXMcjr6HILD2V+7ZrZ8OQRrp8d0G8ye5RXllDEh2xyV9ATk4HHNAlG5u2es6ZeyrFaahazyPnascqtux1xjrjvVySGKUoZY0cqcqWUHB9qxrq3juYwkm4YIZWRirKR0II5BqqunzQszWepX8LOMOXmM+foJNwU/QfgaQOn2NrUNMtNQaNruLe8eQjKzKwBxkZBBwcDj2FT21vDawiK3jSKMdFUYFZXh24upZb+C5uRdJayLEshjCOSVDkNj5TgMvIA71t0Gb00CuU0ZY7gXN46mSdru4USudzBVmdVAPYbVHArq652PRL2zmuDYX0JgmmefyriDJRnYsQrKw4yScEE89aZUGk9SS5uobbyxM+1pG2RqAWZzjOFA5JwCePSq0wvtQmjtrGOe1gPM13JHsKL/dRWGSx9cYAz1OBWhpekPBdG9v51ur3aURlj2JEhxkKuT1wMknJx2HFVbCyi12zg1HUHnliuUEsdqZCscaMMgFVwGOMZ3Z56YFIp1OxHeWVxo6rcw3U1zYJkzxT/O8a/30YDJx3Bzx0xjBuI6uiujBkYZBByCKgl0Ka0mA0Ge3sbWSNkmgeIyJnjayJuAU9c9jxkHFRWWlX+kWSW8Mg1C2gQJErARzBQMAE/dY47/LQEJ9y9RVO11CG4lMJEkNyBkwTIUcD1APUe4yPerlBqFFFFADWVW+8AfqKiktLaT/AFlvC3+8gNT0UAUTpOnc4sLUE91iUH8wKhGktAxfTtT1Ozk/2blpU/74k3L+lalFNSa2E0nuU01HxLYn5XsNVi/uyg20g/4EoZT/AN8ipf8AhKtWAw/hicuP+ed5EVP0JIP6CoboS3l9Dp9tdfZ2ZTLM6YLiMEDC56Ekjkg8A9+lXWtNk0S3W+0u6uCBIiTxXUzzo6swXcNxyCCQcAgEAjHQjRVprqYyhTvZosy+L9cAbyvCM7Htuv4Rn68nFRi+8T6mgNzNa6NCw5itR58w/wC2jfKPwU/WjUtM8QNbMbbULMNuGY47YhimfmCszkBsZxkY9fWqgj8ORxlvttzp1+g+YS3Li5B9Cjk78npwwPbNDqzfUFGmtkW4dHtwSbqS5vnbqb2dph+Csdo/ACrUNlawDENtBGP9iMD+VY8d5bDKx+JJd2M/6ZZgEfgFSlfVoomAfxJovurW7IT+Pm/0rN3ZqpJG9jAwKWspNYtSdi6nojvx0vgM/hg4q7E1zMpa3WynUf8APK53H/0HH60g50LNZ2s/E1vDIP8AbQH+dVJdGtTg2jT2Eg6PZSmH8wvDf8CBqV7i/Q/No16w9UkhI/8ARgP6Uw6mqf66z1GM4zj7HI/6qCKE2tgvFkttrOu6ZiO7tk1i1HAmhZYrgD/aQ4Rj7gr9K3rbxDpk9xDb/aRDcynEcNwjRO59FDAbj9M1zL69psQzcXIt/wDrujREfXcBinSS6XrED2zTWl5E3VBIr9Poeo4raNeS3M5UYvY7qiuH09NU0iTFhftdWWP+PW+YuU/3JfvAezbvwq9P4l1O3GW0Frj/AK9btG/9DCVvGtFmDoyR1VFcl/wmUsePtHhvWk90EEg/8dkz+lKvjvTsHzLDW42H8J0yY/qqkVXtI9yfZy7HWUVyJ8cQyD/RNE124Pp9kEP6yMtJ/wAJnOGIPhzVSRyyJLbM6jsSvm0e0j3D2cux19FZWg69Z60kotxLDcQkCW2uE2Sx56Er6HsRkH1rVqk77EtW0YUUUUxBRRRQAUUUUAFFFFABRRRQAUVDd3VvZ27z3k8UECctJK4VV+pPFcpL4jl8QXMtn4YuEjtosCfUmQsBn+GEEbXPH3jwMjhqBpG1rPiHT9JkWCeV5bxxlLS3QyzOPUKOQPc4HvXG+IfGMospf7Rj0zT7eKSOR45L4SXG1ZAxGwAANgHgFq7DTNOtNPR/IQebId0szcySt/edupNZeunQtAs59VvbeCLB6xQgyyyMeEQAZZ2Y4AHJJo5bqzBNJ3OY1jxnpNnFaXtncxag0U2Ps9tIrSSM0Um1QPUnGc9AGY4Ckih8PfE2nWseseczXGoXN6biWPTrSeVAzRpkKSueGDDLYyQTgAgDodA8PHUZn1rxbbwvfXCbILB8SR2EJwfL9GkJALv3ICj5VGegluNJ0uJY2ltLWMfdUsqD8BWSwytuaOrzO9jLPiG9k/49PD2ouvZ5pIYgfwLlv0pjaxryozyaPp0EagszS6i3yj14i/rTr/xl4dso2efV9PAXqqzqzfgoJJP0Fc/4l1K7m06XUtQhkt9MjAW30tCPOvpWO2NJD2DMVGwevzHGQFKnThvqxx5pehnw3+oeN9dtLbUIEt9MsNl9cW6kkSOTm3R8gcnHmlcfKBHnO847S9unieOC2j868mz5cecDAxlmPZRkZPuAMkgVj6HaTaLpkVkDHea9eO1zcHdtEszY3yHuI14UeiqijJxW6gXQ7IPcyNeajOQgIAUyvydqj+FRz9ACSScmuWTvojdPlXmxsskejA8LdateH5FA2FwPz2ouck89e5IBS1tlgMsjMXnlbfLIerH+gHQDsKqyyw6fFNqWrzQJOwCyTYwAMnbGvcgZ4HUknuak8O2cniSP7feSiPTCWRLKM4dyDg+ceoOQfkH4k9A4Qc3ZA2oK8txthBL4n8xIvNg0XobpGKvc88rH6J2L9/4f7w1NS8C+GNRtFt7nRLIIq7VaKPy3UYx95cH9a3Ly6tNMs2mu5oLW1iABeRgiKOwyeK5qbXb7W/3fh5XtbU9dQuIfvj/pkhwT/vMMegbt2QpqKsjmlOUncc+naj4fs1/s/wAzVrOLA8mUj7SiD+6/AfHZWwf9o9KwNQ1HSbTQLWC3nmc3U8l1Zr5RB3pL5rxdAFK/N8h+bar4B2mt6bw7BdxBdRMuoHHJunLg/wDAfuj8ABXOeKfBts2jSw6RZG2m3rIgs3EO2RTlZAPuh1IBDYzxg5GQZlh09UCqWJ2mS50rUbi2kWSKXVbXy3RshgGtwSCPofyqbVvlXXVHWfTlj+h3SAf+h1k6X4ot5LSTSPFWm3NrqFoyPdyWkJMRbO5Jh5ZLBWIznkAhlJJU1YSSz1DT9UTTPEFrqV69v5dvEXSOQEEsA+COScDOBxXJKLi7M6FNNFnWbd5J9XWP70mnLKntJC7Mn6sPypV2TNqqRfNHd2seoxj0lTAB/wDHYvyonnvYbPVNVXTbpZnhjtYYnQSMgy26QhCcqNwJxydlLolpIbO7urCN5YYbAWVjuIDT7QctzgYJCgZx0J6EGkNvcms4FvNR1qzilKJd20F0jr1SQ7lDj8I4z+Fc5Z6pNLpIvLSFnvW1WMQWynCu8luhlTPZQWdiexXNdNpiw6Hp93qmuOtjGYliVHcFooIwdoJXqxJYnbnqBziufsvE2mGxjsvD8N3aadGT81rayTyuD1wVDBc/3id3oAeaEr7Cvrob+ixLFLdxrJ5wicxySAYVpC7yPt9g0hX22kdRWmqhFCoAqgYAHAArO0O/027tjFpci7YeGiKlHQ/7SthgT15HNadI1WwUUUUDK2iSR2Op3dlI6hrtzdQ5GC3ADr7kYB+je1dBWDdWsN0qrMmdjb0YEhkb1UjkH3FP0TUW83+zL92N7GuUkfA+0xj+MY4yMgMOMHnGCKDGcbam3RRWTqGu2tpcm2jSa7uwNzw2yhmQerEkBfYE5PbPNMztc1qx54rzS9LnOnmGVII3eGBozk4yQmQ34DiqVxrN5fIINMsrq0diBJc3KKoiXvtBJ3NjpwV7n0M2j6osUMtvqN3vlivPsiSS4DSMyh1BAAGcNjgdqCnFpXZnP4l1I3bR29tps8UUZmuJPtTIsKYyNzbCASOg/HpzV6x8UQy2yTX1hf6ejgEGaLcuD3JQnb/wILVOyiju5ZEtYxb6NBIUhgRdoncHLSN3I3ZAHQ4JOcjGvSNFBPUkzpGv23Bs9QhQ9isgRv6H9arN4ejQ/wCh6hqFqP7qyiUf+RA2PwxUVzp1ndSrLcWsEkqjCyMgLD6HqKetsqjCzXQHb/SJP8aBcjWzLA067UYF7E2O7wZP6MB+lNkstQVcxzWshz91o2T9cn+VU2tr7OYtZvkHZSkLD9Uz+tKG1lCNuo2jj/prZkk/98uKB2mOaHW1JxZ6c455+2OCfw8o/wA6RV1nA3adahu4F2T/AOyVHNqerWibrh9JK5+87PCCO/XdiqD+N4Y3Kvd+Hgw4IOq4x/45QHvmpHFrTkbrOwiUnkm6ZiB64EfP51Ym0m4uE2T6g0aZ+b7NH5bH23EtgfTB96zbTxDe6jn+zzokgwPmivWmx74CD+dTlNWnI+06osS/3bS3CZ+pcv8ApigVps1tM0uy0xHWygWMucyPyzyH1Zjyx9yTWX4tvbcmw0kzR/a766iCxbhu2K4dzj02oRn1Ip5tsrgXF2G/vC4f+WcfpWVfRW5nfTbO0S81GcLM/nEsEGcCSRzzgEcAc8YGMZALk6tnaVU1DT7XUYhHeQLKFO5SeGQ+qsOVPuCDXMz6Pr0ELiLVoBtGRctJKpT3KMzqce9J4de71DTkub3Ub2YsWUASKqEBiNyFEQlTjIJHQ0xKN9ma8ehyQNm21O82do59sqj8SN/5tUwsLzJzd2//AIDn/wCLqsbcEAGa6/C5k/8AiqoXN/pdk7rdauIHQ4YS6gykHGeQX9CKRfLLubDafdlCv2q359bckf8AodUZvDUM5Bli0x26lmsQT/6FxWP/AMJNoUmVg1O6ucHH+jPPNk+xTNPGsRyHMFl4hl64+WaPP/fbLVKLeyE7rdmn/wAIyyKRBfSW/oIXmRR/wES4/SnxaJqsTqY/EVyFHVGgRwfxbJ/WscXlyzELofiLA7m8QZ/Oela6l2kTaHrpB4w1wkn8pjVezn2J07o6yOK+VMNdQOf7xgOf0aqYii1i0S4RtOvYHB2s9vuDYJHUsfeub32LOjXXhq9ZAwYtNDG+3Hflj0rA8GDSYfCegNfaFPJeHT7dpbhNNaTLmJScMqkkZ4B9KPZytewrK9rnby6IAR5WhaIcdGVzEf0jNQHTBGcPo2o8/wDPnqbbf1kT+VUbfWtDEixG7ubBm+6lyZrTd7APtBPsK1jBLIiPZandwg8hlkEob/vsN+mKjYvkfRlNhoEYEeqrfRLn/V6k0xjJ9MsSjfmapHT3t2m1Dw9a3dtaR5mdLm5KRTgD7qRNnaD6/JjjqOK201TU7IYvbRb2Ef8ALa0O2THqY2/oxJ7DtVHxpqgvdFg0/S3SSbV1aOJycLt4Bz35LKpHUAse1BPvJjNPubbxNfJFDcSNpwtUuWEMhRmZydquVORwM4yM98jitibwzpTQKlvapaSoS0c9sAkqMep3d84GQcg9wa1ba2gtYVitoY4Yx0SNQoH4CqfiK1nvdFu7e0IE0i4ALbQwyCVz2yMjPvSE5Ns429u5rTTofESshv8ATbiSJpFG0XEAmMbK3sVG72bGK9WByK831S3g1LwhqNla2zW4+zyQi3aPYYnC8Db0GDgjHB4IyK9A02cXOnWs46SxK/5gGunDvdE11syxRRRXSc4UUUUAFFIWA6kVxF38RLOKETQWF1JbPIYoZ2KhZ2GfuKpaQ9D/AA+9JyUdyoxctjuKK8i1b4p6j+9istOtbKaPGTdu8rc9P3aAFf8Age0VgQeIda1iYvq17fXdvJ8scNvcx2ETf7pRy0n58Z9azdaK2LVGXXQ9s1HW9K0z/kI6lZWp6YnnVP5mqyeJtKkXdDcSTJ/eht5JFP4qpFedaPPpUaR/Y49B0q43+UXkmjmlB9whye3LMOetbDTaYfNW78VNMY+JILV41PXGAEBkz24Oaydd9EX7KK3YeLdTtE1W31dDNdxRxiB7SS3kVk+YnzYt4ALc4I6kAYPGDc/t2J4FktLTUbgsMhFtnjP5yBQPzrHkvdOinjjtvGUcNqwJ2zFJJUYdi7DheRww3Zxg84pRqu0MZPECLbICxuDpMoG0dT5hOzHXnGKaxE1okP2UHvcm1HU9ajsZr28nsND0+FC8jz5uJFX3wQoPsN341l6BoV3rTpqvieS+cAlrGzuH2PADkea4TAWVhxtH3FO3ks5OVDdHXJ1vdVGu3mkQOJdPghs8NcngrcP8oUDg+Wh5Gd5527dtbzTJYcvo+pOWGduoR3VxtPum1l/I1M6k9mxxjHdLQ0nTw5BJ5Ux03zR/DK6M/wCuTVqCHTAN1vYKV/vRWbEH8QtY/wDaOopEqadeWenx8YWLw/ckj9cfpUb3WtMnz+LbqM9f3fhyTA/MGsTTmfY6ZTDH/q7Scem21cf+y1yN1/aHibW5Lq0t2TTtDl8ra7De1yRiWRAMhmijYqvP3pHzygFU9W1XVdOtklsvFNzc3ty/2eCCXTGiV3YE7235wqKrSEKASEI6kVq2L29ho9toeja5Hcqo8pYLaMLO2SS8kjsWIySzM2Ack45IqkuVXIcnJ2OxSXT9M05J7KNZElUNEIfmefjIwf4iR3J9ye9Yc17cpNI5tze6vIoK28RwkCHopc8AcEknljnA4AHOXVtLql9FHZ3obWdOURx6jax+Xb2oAAMRTJEm4jLR9MY5UqhrS8JaxZ6dbXVhqqppur2w8+9M8uVnyceekjY3oeB6rwpAOBW1KhzWb2IlPkdupuaVpTRt9r1Yw3GoMc7wnyxDsqZ5A9+p6n0GFqMn2vxdb2Oj3i2Eiq8t3cW7ASSj7pi443fMGJPK/KR61uW9hqHiWcSfaZbHQe3lq0Vxcn2J5RPcAMccYGCeiuvDekXOmQ2EljEtvBzCIxsaFv7yMOVb3BzXVdJcqWhjd3u9zHsPD9hDcx3LJJNcIPlluJnmcfi5JroY1RRxiuQlttW8LW08+pXz6tpanPneUFnt0xyWVRh1HdhyPQjpqWGpRXlulxZzxzwOMq8bBlP4irVnsSze3Ad6YxQjBxWd9qOOlRm4YmnyiuZXi/Q5pTb6xoQT+3LDJjQttW6iP37dz6NgFSfusFPTINvR5dK8S6Pb6hBGssEwOUmjG+NgcMjqfuspBUjsQatC4auS1WVvCmsza7ACNFvWX+1Yh0gfgLdAdhjCyewV/wCFsjTQXOq/4R7S+1jZj/tiv+FRXHhjSLlVWewtWVW3AeWBz+HWra3eQDjI9QaeLsehpcoXI7fQtMtyDBY2sRHQpCq4/IVd+zxD0qD7UPSmNdegNNJhcZqGi2F8Va5tbedk+6ZIwxX6E9K5iTQL/S7l5NE1SQRE5+x3uZovorZ3J+ZHtW7qGrQWFu097cRW8K9XkcKP1qpBp+oeJIopjK+naVJkkBSLi4T8f9Wp9eWwf4TUTjF/EVGUlsyhoevSapBM7aTqETQStBLsjEyB1+8FZM5HPXArTee4/wCWOmahMfaHZ/6GVrq7GzttPtI7Wxgjt7aMYSONQqqPoKnrm+rxNvrEux53qN14nRc6Z4TnmH/Te9giP4AM2fxIqxJIbm3C6lo+owuOdjWzSlT6ho9wB9wa7yij2EQ+sSPMBehwLSTXrqW1zgwmAiZh/cLgbvY8bj61s280MMQS2sb1EHRUsJVH/oOK7ail9XXcPb22R5lq/iW4sZxbW+halc3ZXeIhsUgZwCRuLAH1IxXN69Y61dwW+qautrp6y39hCLWBRJIm+6ijDO5+ViN2MYxg/gfR73w9fQ61e6hplxbyJeFXmt7kFSGVQoKyDOBhR8pU85wRmuS8ZazbNos1heK1nqkF3aTm3l4YiO6icvGejgBd2V9OQDxWkKMI69RSqykrGtF4XZkVJNW1eRQAoCzLCAB2HlquKtR+EbMHLSai5/29Qnb+b10Czp2GKVpwK29nFbIy9pLuYR8J2R2/LcgqMArdyj+TUx/CdqOhv/8AwPn/APi63hcjNTpcA0ci7IOeXc5ePwxZxE/ubhz3MlzK/wD6ExqUaFYqMf2dbH6xKa6beppflNNWXQV33Odh0SzU5SwtVPqIVH9Kvx2BVcKiqvoBitPCimvMq96d+wjEutFtpuZ7O3l/34wf6VgTW8/h24NxAbu50p8+bb/NM8Bxw0fVtvYrzjIIwM12jXAasnVdRjint7O2jFxqFw2IrdXAJHdj6KByT+HJIBmcIzVpFwm4vQzLe81XUoY5NG0Z5IZFDLcXVwkURB6EbS7H/vmo7rRfFMjF7jT/AA9dgfcUXEqOo74YoefyrpPCej3Okx3xvJ0drq4M6wxEmOAEDIUnk5OWJwMk9K3q51QiaOvI8e8LWGsTLqNtbaRbyywX86vLfXhZLdmfzNuMEsQJB8wxuyDmusHhK6eJ5td8R3jIgLNHZKtrGoHJ5GX/APHqteDv3fiPxvBzgarHKvoA9lbZ/wDHg5/GurqvZRvcn2srWR45FpZ12FLjSEuLXTpRmO5vtRuLqSRezCHfsXP+0T7jtW9oXg/RdKTMVhDPcE5aeeNXcn8sL9AAK3dT8JwiY3nh9odLvmbdJtizDOO4dARz/tDB+vSs6bxBFo9y1tr6jT5QeJX3GCQHoVlIA/A4I9MYJ1goR6akylKXU2YrVtoCptUdABjFSGzeq9trun3CqYL22kDdCkqnP5GrS3oPTkeorS7IGfZXzUiWf940pu1xVS81WC2XM80US+sjhR+tGoFHxyU0/wAE+IbzIzbadcTc8/diY/0rR0rTEs9Ks7U8GCFIsccbVA7fSuO8faxZX3g/VLSG9tZWuoxbbElVifMYR9Af9r6evFdCNdsXfC39oSTwBMv+NHUDUnskdCGCsp7EZFcj4n8LTSwifQLqXS72P5sW7bI5/ZxgjPo2DjPfpXSQahFKT5c0b467WBqlq2uRQTRWkEUt3fyjMdrbjc5GcZPZV/2mIFKSTXvDi2noc5pGp6zBcw2l5bzXjupbynVUuUCkBiCP3cwGRypVsEfLWnImn3SLqWn28M9xbTByY0Ak3KfnQ9w2MjBxzit7RvD9wmsDVtVmR7hI2jt7eL/VwBsbjuPLMcDnAAHAHcx+JtF8maTXNJjIvYkLXMES/wDH6gH3SP74/hbr26HjjqUVvE6YVr6SNG1uIru2jnt3DxSKGVh3FTVy3hO9h89oLZxJZXqtfWjDoFJXzFx/vNu/4GR2rqa5gas7GEv/ACENS/67r/6KjrQ8CT+f4VsRnmANbH6xsU/9lrMtoVhvNSRSzA3Jf5jk5ZFY8/jx6DA6CrHw0z/wjMh42m/vCuPT7TJW1D4h1fgR1VFFFdZyhWD45muIPDN21nNJBOzRxpJGcMhaRVyPzrerB8bgtoSqpwXvLNM47G5iB/nSY1uYP9kToSo1vWSP9qdW/mtYcPgDTobg3EV9qiXAdpI3WcKIi33tqBdvOecg13ottz9Kf9iyTxWrjF7oSlJbM87uPh3pd0kq3N3qExll85zI6MC+MbtpTbnHfH1qS2+Huk28TxLLeeW42uqsiBx77FFehCxx1FIbP2pckOw+efc4YeDYFjCRapqiIE8vAkjbK+nzIeKcng+1HlbtR1VvK/1f+kbdnGOAoAFdv9j9qT7H7UckOwc8+5xw8KwB941HV9x4J+1nJHpXN6bokHim6kkiutQl8LxnCma6eUajIpOSAxI8lSBjj52H90fP1uv6Rf8AiDVDo7RS2ugIge9uAdrXhPIt0wchMffbuDtHViOmi09IokjhjWONFCoiKAFAGAAB0A9KXLC+wc8urOVXw1ahcG81Vj6m/l5/8eo/4Rm23Z+2apj0+2yf411os/al+x+1Plh2Dnl3OPPhe0LhmvNVOOwv5QP0aj/hE9PYndJqb7ux1K4x+j12P2Melc/4z0/ULzTodL0tJEbUZRbz3ScfZYCCZHz/AHioKLjozqexo5Ydg55dzi/D3hzTdeur7VGW5Ol5a107/S5SzIpAkm37t3zugAGcbYlP8ZrfHhG18loTqGsGFgVKG+kxj0znP6119ppcNnaw21rEsVvBGsUcajhEUYCj2AAFTC0A7UcsOqBSktmcFY+AtKsoVjtbnVokX7oS/kUL9ACBS3vgWxudkn2/VVvITvtrl7tpHt3/ALy7sj6jow4IIrvfso9KPsvtT90V2eeaLcXJ1E6P4ivdSg1gKXikivZUgvUHV4fm4IyNyEllz1ZcMeh/so9tR1Yf9v0n+NaOveHLLXLA2l/GxUMJIpY22yQSD7skbDlXHYj+WRVDw0usw3E2l69AbiSBd8OqRIFiukzj5lB+SUdxjaeq9SqpcoXZFJo5kAB1TWQP9m+kH9aw/wDhXmiC4kmja/jlk5do7p0LfXFeg/ZR6UfZR6U7R7BdnCjwTYhdq6jrgXGMDUZcfzqM+A9O7X+tD6X8n+Nd99lHpR9l9qLRC7OCHgWwCkf2jreT3/tCTj9asL4QtFXb/aGssmMFHv5GUj0KkkEexrtfsvtR9lHpR7oXZ5VZ6Gmka/Fot7qGrR6fOD/ZMkV7Ii4UEtbMAfvKoJU/xID3Qk9KPC9uFA/tDWSfU6hL/jW/4g8PW+uaVLY3W+MMQ8c0RxJDIpykiHsykAg+3pUPhYanPpZj162EOpW0hglkQYjuNuMTR+isCDg8qcrzjJNAuzIHhqEKQNR1jB/6fpD/AFpB4Yt8/PqGssPT+0JR/Ig11/2UelH2UelPQV2cRH4K0lL6O9Bv2u4/uTPeSO6fQsSR+Fa66aQGB1DVWB9b2Tj8jXQfZR6UfZR6UrR7DuznP7IX/n/1f/wYz/8AxVOTS9jZXUNVz730p/m1dD9lHpR9lHpRaPYLswXsHcYOo6mB/s3TimPpSu2TfasD7ahMP5NXQ/ZR6UfZR6Ue6K7Oc/slf+f/AFf/AMGM3/xVL/ZQ7ahq3/gfL/8AFV0X2UelH2UelFo9h3Zzv9lt21PVx/2+yf41g/EOyKeDNXupby9mNpayXKiWTcqlFLZIx2xXoH2UelYnjjSJdR8E+IbG3jZ5rrTrmCNE+8zPEygD3yaHyhdmHb+CrCyJW0vdYgUHhI7+QKPwzirJ8NoQR/aus/8Aga1dXBA8kMbzIFkZQWUdjjkU/wCyj0o90Ls4tvCcRGP7Y14Z9L96gfwRZSyF7jUdZnyMbZb1mH5Gu7+yj0o+y+1FohdnBf8ACA6MMlftSE9SkgUn8QKfF4I06NQBeawQOn/EwlGPyNd19lHpR9lHpRaPYOaXc4V/A+mPjdc6sccDOoSnH/j1IngXSlOTNqjD0N/L/Rq7v7KPSj7KPSi0ewc0u5xg8I2AAC3WsAD01O4/+LpdN8J2WlSSyaXcX1rLKf3kqTlnf6s2SRXZfZR6UfZR6UWiF2c99gudoH9s6rnGM+cP/iaUacx2+bqGqyEdzeSJn/vkgV0H2X2o+y+1HuhdnAaVp0aeNNdt/tGoDbbWlwCL6cMwczJ8zB8uP3RxknHOOK3pNJgkI3XGqcemp3I/lJTodLuI/Hl5d+S32S40yCEy9t8csxCn3xMT+db/ANl9qFy9guzn10qBQAJ9T49dSuD/AO1KbJpEEi7WuNU29x/adzz/AORK6L7KPSj7L7Ue72C7OHuPAfh64LtPZSyM/wB4vdSsT9SWqK3+Hnhm3BEWnygHsLuYfyeu9+yj0o+yj0otHsHNLucXH4I8PxghbGTn1upj/N6hPw+8LM4dtHjZh3aWQ/8As1d19l9qPso9KLR7BeXc8v8AE/hHQbC1sDYaZDBPNqdlHuUsTtFzG7Dr3VCD7Zrc/wCEG8MYx/Ylpj6H/GtbxPpdxd6h4aWCFnhj1PzbhgOERbecgn23+WPqwNb32UelK0ewXfc4tPBHhhDldDss+6E/zNTJ4Q8PRljHpFqhbrtUjP61132UelH2UelO0ewXfc5ePw1osYwumW+OvKk/zpZPDWiSYL6TaMR0yma6gWo9KJLYADAo93sF33PN4po/DHik2sNrJ/Zccf2tTGOLcSFw8aj+78hkx6K2Owr0ZHWRFeNgyMMgg5BFc3faXLqWp65BaSeVex2dpLbSHosge4xn2PKn2JpPAF61xpUtu8Zi+zSFUiY/NGv/ADzP+4wdPogrz60eWV0dCfNEl8wxeIb+0PzBo47oPnkbtybT9PL4+vtk2fhgEj8JJboAPs11dQH6rO/P9axPGOpR2eqDyIPJvIUhke7kcJE0ZkYbJCMnb9/DEEKzAnGSatfDC7C3Gs6cuWi81dRhY8ny7gFsH3DB/wAMUUXaRVTWmd7RRRXYcoVHPDHPHsmjSRdysAwyNykEH6ggEe4qSigCIRgEECpcD0oooAKiuZUt7eWZwSkaFyB1wBmpagv4WuLG4hQgNJGyAnpkjFAGDZ+L9Ou7XwnPFDdBPEqh7MMi5jBt2uP3nzcfIhHGecduatx+KfDsj36R67pLPp6l7xVvIybZR1MnPyAe+K4bQfhVa6PF4ElsrDRbPU9HiMep3lpAI5bgmykhYq4QF8yOG+bHTPXisfRfhh4j0jSY7awnsrfUbHT3srTVP7XvZnYFkzthcGO3DKmDs34OCoGMUAeoReK/DcukSatFr2kPpUT+W94t5GYUbj5S+7aDyOM96i8E+JYPFek3Go2iRC2S9ubWJ4phKkyxStGJFYADDBdwxnr1PWvPNO+HXiKw1P8AtiJdNkvItUi1CKyu9VubpJFW1eBg9xLGX3jfuU7SBgDA7d38OtE1HQtCuYNZNmb251C7vnFo7NGvnTvIFBZQeN2OlAHUYHpRgelFFAHNXHi6ys/E11o+p21xp6wWT3/2+5eFbZ4VZFZgwkLLguAd6r0PbGb+meJNC1VIH0vWdMvUnkaGJre6jkEjqu5kXaTlgoLEDkDmuQ8ReGvFWsazqmp2txp+k3S6c+nae8F08jOGnSQu7GJfKJWML8ofaWJycDPOSfC/X5tK1porq0sdWub+2vLKVtRub4w7YfIk3TSqHYmN5McY5A4FAHrNjq+mX7QCw1CzuTPCbiIQzq/mRA4Lrg8rkgZHGTV/A9K4D4deAW8Ia9rM6zRPpjKlvpUCk5trfc8roQRjmSRsYz8qr06V39ABgelZXinWrbw34c1HWr6OWS1sIHuJUhALlVGSFBIGfqRWrXO/ETRLnxJ4F13RbF4Y7q/s5LeJpiQgZlwCxAJx9AaAM++8ZXdlFaPeeF9TsBcX9rYqb2e2wfOkCbl8mST7uc4OM+tTeCvHOkeJ7bal3YQaorziTThdpJNGscrR7yvDAEKG6cbu/Wucj8DXLxWq2nhbwl4caHUrK9d9LnLGdIZd7K2LaPnH3eoyT061lxfDTXL3SING1KTS7GztX1OWO9sp5JJ5Wu0nQblMaBAonycM2Si9KAPSrDxR4e1GJ5NP13SbqNJkt2aC8jcCVzhEJB+8x4A6k9KtRavpk0yQw6hZySvLJbqiTqWaWPPmIBnllwcjqMHNebXHgDXtVstQk1BdE0+/TSYLDT0spJHiM0EgljlkJRSoDquFAbaC3JzVnwL8Nrrw34uh1Ke9iuLJLIuYgSGOoSiNbibGMYYRKRznLNx3oA9PwPSuY8S+LU0XWLbS4dG1PVLya1lvdtmYFCRRsiszGWVB1kXgZNdPXnvj7wfc654s0vVl0Pw9rtpa2M9q1nrMpRVeSSJlkX9zKCQI2HQH5utAHRad4v0G907TLw6la2g1GGGe3hu5VhlYTcRjYxzliCB6kHGaki8WeG5lvmi8QaO62A3XZW9jItxnGZPm+TnjnFch4Q+Ht/pN0JNSvbec/wBhjTBNGWMkTmaaQhNwzsVZVVTnJCDIFc/pHwz8S6ZpHkWUtjZ6pbacthb6ims30zyKJYmZVSQFLZXSMg7A5UsCuAMEA9P/AOEs8N/2P/a//CQaP/ZQk8r7b9tj8jf/AHfM3bc+2awNS+KHhu3l161s76zutR0zT/7QjgF3GBeL5LzBYiCS3yJknbwGU8g1ycHw38QwxX0wi083M2qrqMA/ty8M1vi1WHK3bxs5bhgdyMCrY+XAxdsvAfie007W7J5dHuv7a0NdPuLjzGgME6RzqCsaRbXQmVcn5CME4PSgDudH8Y+HtU0WXUoNZ0o29tGr3jJeRutqSM4kYHC9xzjpUsvi3w1FpkGoy+INHTTpyyw3TXsQikIzkK+7Bxg5we1efXPw+1/UTBfXUWhWt9p8FjBa2cU0ktvcC2l8z985iUqD0UBG29fm6Vo6V4F1Q+KLHXNU/sxJDrE+qXFpA7yRw7rQQIIyyDe+VV2YheSSBxyAdneeKPD1lY2d7e65pVvZ3mPs1xLdxpHPkZ+RicNx6ZrYUqyhlIKkZBHQ14u/ws1iCGxeJrO8eO2vLOW1/ta7sIwkty8yMHgGXGHCsjLg4GDxXreg2X9m6Hp1jsjT7LbRwbYmZkXaoXCliWI44ySfWgC9gelGB6UUUAGB6UYHpRRQAYHpXMQeMtOm0TTNUWC7FvqF8NPiUou5ZDK0WWG7G3cp5BJx27V09eV6d8KrWz0vQ5E03Q01+z1db+41BIAJZIxO0hUSbNxO0gYPHGM4oA68eMdEs7GGbXdb0CwklaQIP7TRo2CyFMq7BMnIAYY+Vsrk4ybPjDX4/Dnhe71oQrcxwKjbfM2Bgzqud2Dx82eleY2XhPxJo3iHTrSy03TL+QaVqUUk91LIltH596JFG8RNufa3KELkbvmwOey1nwdcyfCWLwlYTwz3MFlb2iS3ZKpIYtnLYDEA7D2PWgDdj8V+HJdJl1SPX9IfTIn8uS8W8jMKN/dL7toPI4zSXni7w1ZWdrd3viDR7e1ukMlvNLexIkyAgFkYthhll5HqPWuIn8EeILjxD/wlDxaLHq0d/BcppguZGtXSO3khBabygwk/fFg3lnGxBz1E3hn4fX9jrGn6hqTaa5SDVDPBDuMcMt3NHIFiBX7gCuCTgktnHJAAO3v/ABJoWnS2kWoazplrLeAG2Se6jQzg9NgJ+bqOla2B6V4aPhJrMWnWttINP1JZNEs9LuYpdXvbSKN4VKk7YQBPGd2dr7Dx1GTXuKqFUKOgGBQAuB6UYHpRRQAYHpRgelFFABgelGB6UUUAU9Yv4dJ0i+1G4V2gs4HuJFjALFUUsQMkDOB61h23jbSLi6kjQyLbW9qt1eXkhRLezDqGVJXZgA5BztGcDBOAVzq+KdPl1bwzq+nWzIs93ZzW8bSEhQzoVBOATjJ9K86n+G2p2PgvVPDGgT2X9l6lY7XiuppCbe7woZ0baxZHIJIbkHkZ3EAA7+28UeHrrTbvUbbXNKm0+0bbcXUd3G0UJ44dwcKeR1PemzeK/DkGkw6pNr+kR6ZM2yO8e8jELt6K5baTwehrifF/w6v9W1XVrzT5rWFJJdNntoFuJbbebbzQyO8QDRgiRdrJkgqOOKym+GGqrc2WowW9olxHJdmayTxFqKBxMIv3hvADKz/ugCCu0g9ARmgD2OGSOaFJYXSSKRQyOhyGB5BB7in4HpWR4Q0r+w/DGmaZ5UEP2SBYvLt3d40wOitISxA7FjmtegAwPSjA9KKKADA9K5KXxrGdTu7Ww0HW9Rt7O6Fnc3trFE0UUvy5G0yCRgu4ZKoR78Gutry/xH4I1jVfEU97bafoWn3L3KPHrdneTw3aRKw+/CqbZX2grlnwQcEY4oA6Twv430nXNRvtMe6sbbVre9ubRbE3aNPIsLsvmBOGwdpPQ455NTReM9Ct7Gxk1vXPD9jc3UayKi6nG8bhiQDG7BC6kqQDtGcH0rn7bwJewyWcm+xEkPim41x2BbJhkEwC52/fxIoI6cHnpWPpfwx1O30C8srmXTZJ5fCp0JG3MQJi0zFslM7P3ic9eOnAoA9ewPSjA9Kq6VbvaaXZ20xVpIYUjYqcgkKAcflVqgAwPSkIB7UtFAEEdpDHeS3SJieSNInbJ5VSxUY6dXb8642Ux6X8TZYFURRatYicdg80TYbHvsKn8K7muD+LUZsrHSfEcSFpNGvElcKMs0MhCSKPc5X8qzqq8WXTepxvjW+05dQvL2C4uo5IpQDJA5iY7v3cijOMMpRmBPBCsM4Uleu+EEBNjrF5IzyyS3nlCZ337kRFAVW7qp3DvyDzXBTa2mrXaXtzp1xPay3EMkUlkoUSb2GyJg/By0aBsHhh7mvavDNgdL8PadZOqI8ECIyp0DAc4/HNYUY3lc3qu0LGnRRRXWcoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUEgDJOAKACis6513SLU7brVLCE9MSXCL/M1XXxV4eYkLrulEjqBdx/40rodmbNFULXWdMuzi11KynPpHOrfyNXwQRkdKYrBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWf4g0uLWtEvdNnZkjuYmiLr1XI4Ye4OD+FaFFAHG6d4JA1SG/1bUJbowlXjtYQYrcOucSFMnLd+uPY4zXZUUVMYqOxUpOW4UUUVRIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFUdZ1Wz0aya61CZYohwo6s7dlUdWY9gOaNg3L1FcZP4wuhZNcvZW2mQ52q+o3QDA9souRn23ZrEuNf8SXirLpWp2d7CSQ/9m20R8o+hMk3JrJ1oo1VGTPTqK8q/trxRFzNPrSj30+1kH4iNifyqWPxzeWas2oavp4RRkrd6ZPav+ZbB/AUvbxH7CR6hRXnFt8UrG5JW3bTZ5BztS7dc/wDfUQA/Or9v8QbWfaB/ZisRnB1OPI/IVXtYdyfZT7HcUVykHix7j/j3h06X/rnqG7+SVYbxBeoMnSDJx/yyuVP/AKEFo9rDuHsp9jo6K5j/AIS9Yz/pei6xAv8AeESTD8o3Y/pU1v4z8PyuEfU4raQ9EvFa3Y/hIFqlOL2YnCS6HQ0VQv8AWdNsLAXt5e28VqfuyFwQ57BcfePsMmsO417UNRtm/sq3Wzjk4S4uwfMA/vCLH5biD6jtSlOMdwjCUtjoNR1Kz02JZL+5igVjtXe2CzeijqT7DmsPUvEly5EWhae88h6z3YaCJPwI3sfYDHuKxlsbDSma/unkuLs/Kbq4JlmYn+Fe/PZVA9hVxbfUdRhGwNpsTHl5AGmK+y8hSfU5x3WueVdvY3VGMdZMzrg3l7Oy6vrF9M6Y3W+lxyQxx55AYx5fp/ebn0q1bafpc9vHLHb29wjqGWV1EhYHvuOSfzre02wttNthBaR7EyWYklmdj1ZieST6msa8iuNImuJxGZ9NkkMhEY+e3J5Y4/iTOW45GTwR0xbb3LjJXtYmjtLaP/V28K/7qAU8xxgElEAHUkCs59f09mSOxmTULl/uQWbrI7ep64A9yQPxxRpZvdftTeWl0llbb3jSJ4N7kqxU+YCRt5H3RyO57BGjkluQFJNX2HRbKxktmG5ry6jPltnpsAGX9c5A9z2T+wdS2Y/szQgR3jkeMt9CEyv5mt3TorXw3ocUN5exJBESPOmYRoNzEhRk4AGcAZ4AArTgljniSWCRJInGVdGBDD1BFMxc2cdbpcQTpHY6xqen3hXcLW8kNwjY68SZLAeqMPrWxZ+IdYtHVNX06G5h6G409zke5ibnH0Zj7VpajZRX9sYpsgg7kkXAaNh0ZT2P+elY8xvNLgD6gVuIFOGuIUIYDszoM4HqQffAGcUqko7MdoT3R02m6vZai8kdpNuljALxOjI6g9CVYA4ODzjtV+uGuLKy1QQXStmRVzBdW8m11B/uuvY+nQ+9XrLUtXsojHceTqSr92QnyZSPRsAqx9xtHtXRCun8RlOg18J1dFY2k+JNN1KcWyStb32Mm0uV8uUeuAfvD3XI962a2TT2MWmtGFFFFMQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFZGu+I9L0N4o9Quds8ozFBGjSSyfRFBJ+uMUN2BK+xr0VyEniy9mBaw0Vo4z919RuBb7voqh2/MCnrrmsSBjHBpZPZRO5x6ZO3+lZurBdTRUpvodZRXHDxNrkU4W58PQyxE48y0vwxHuQ6p/M1bbxb5akz6LqseBk8QsB+IkNCqwfUHSmuh01Fcnofji01u6ii0/TNXlhkOPtQtwYF9y4bB/DNdZVp32Iaa3CiiimIp6xqNvpOl3V/esVt7eMyOQMkgdh6k9APWvN783E9+9/PtuNaW2abMv8AqtOjxwqL/eJ4z1bBOQBitbxleG81xre4UjRdJh+13R7SzfeRD67FG/HqyVzy27atqcempwGkVrjHO4xkedM3r8wESA/dIJHQY5K07vlR1Uo8q5jofCWh6dY6lq0ltbgtFdbI5nJdiTFHvO49y2cn1yPatnU9EsdRlWaeJkuVGFuIJGikA9NykEj2ORVjTbNbG3eJGLBppZiSO7uzkfhuxVusRXMFPDxBxLq+qSoOil41x+KoCfxNO/sq9ghZIL4XIwdq3cYJP+yWXHHvtJ+tXtT1Ww0uEy6jeW9sgGcyyBcj2Hf8K5M6rqOuXM9zvbT/AA/Zg+Yqf666ftHu/h7ZC85IGc5ChSlLcor/AMI3fwLPNYxJfLuEosI3eaJlJDfPCNwGQcHjPWnWmyRFn0a/1y7tz38nz48f70i7j9AxPrT9OtC+mtdXVuj6ax8u00y1HlwzMeBwMAoMHlgc4Z+m0BWE2pxF7/zL6FiY7e3ikaGGVx1OF6RJ03HJYk4H3QQ05mS+Rb34AmOlPISR5V3p5STIPOVZgf0qCXQpo8/Z9E0VwcZMVw9uT/3yh/nUD6ZbmcebHHcjzCohtlCfaZRjcD12xJwCxJbPGeAGSSTUki8q0+ywxMpitmjeYnzAeBGu8iRV6FmVVGPTigfMS/YdaQr9kspLc8fM2tSOo9sPGwx+FWLHTvEUuRqWoW4i7xsi3G4fURx4/WunXO0biC2OSBgUtIow9G8M6dpdw90kSS3jsWM7RqpGf7qqAq/gMnuTWpfXH2aFSo3SyOsUa/3nY4H4dz6AE1YrNuuPEmhs/wDqy8yKO3mGMkH67Q/50CbsrmnY6LBBd/bLl2ur3nbLIBiIeka9FHv1PcmtaiimczdwooooAjSKOMsURVLdSBjNZktndWd1c3WlLFKbllaW3mkKKWAxvVgpwSAARjBwOnOdes7VdTTTxGggmubiXPlwwgbiB1JJIAAyOSR1oGjmdV1gSalbxa3HFpn2KUTxo0nmvNlGXcuBwgDNk89DnAGTp2MElnLPLps0CW9ztk8sxllDY5ZcMByMZ+me9aGk3730sqXVkbWeIAgM6vlWz0I/3TkfzrOtl+x6reacFVYEVJ7cKMBUbIKD6MpPsGUUjSNvhaLM+oX9tG0jLZzIgLNljDgDqcncPzxT7bxBaPsF0stkz42m4ACNnpiQEoc+mc+1Z3iSPz9Du7cf8vCi3/77IT/2atEopj2FQUIxtI4x6UFOmhz6PGlw0+nSC1MnLxhA0Tk/xFeMN7gjPfPFUJb5rGQx6rEbYZwtx1hf0+b+E+zY56Z61LFYxW8ZSyL2Y6gQHaqn1C/d/SnrqF5arsvrf7Zb9DNCBvx/tR9/+A5z/doFaURt9ZW1/AI7qJZFB3KehU9mUjkH3HNFm+q6dEyW1+b2MfcjvxuI9hIuGx7sGNSJYW1zZrLod0Icfc2EvFx/CUJ4HsNpFVmvJrMhdXgFsOguFfdCx9N3BU/7wHoCacZOOzC8Z6M0LTxfbxsItfgOkzE4DyPvgf6SgAD6NtPtXSxuskavGyujDIZTkEVyzBXQqwDKwwQeQRVOLTYrWIppks+nAksBavsQE9Ts5TP1Wt44j+Yzlh19k7eiuOh1rXrBsXdrb6pbj/lpbt5M+PdG+Vj9GX6VtaR4i0zVZjBa3O27UZa2mUxTAeuxsHHuOPet41Iy2MJU5R3NeiiirICiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoornvHGoTWeiNb2Moi1K/b7Lasf4WYHLf8BUM34Um7K7Gld2RR8R6uL1ZbayvHtrKHd9svIzt+6cGNH7Hg7mHTGBgnilp+jm7jcKJ9Osj8oWPCTT/wC0zcso/Ju5IosNLAGkafKytFaoJXCptWQoABx2G5g31UV1VcM5ubuzqtyLlRQt9I0+3RVis4Pl/iZAzH3LHkn3JqVrCzf71pbt9Y1P9KtUVJBny6Pp8ikfZIkz3iHln81waqv4csChETXkLdnju5QQfXlsH8QRW1RQO7OPtrC3lhu7aRYZLy3kaF5pIELf3lYgAAkqyk9OtcRf6JrWnymW+Nlqqj5o7OCxdEY+h8tRn6MwHrXoOu+ZpmrxX6xl7K62QXJXH7p84R/cHdtPp8p6A07WNRh0rTpry4DssakhEGWc/wB1R3NCbRvF8yJfhpeX95pl0dRFjbtBKIRZWdq0KWx2hsZb7xIZTxx7mtDxVrFxaoLDSFD6rOBhmGUt0OR5r/kcD+Ij0BI4/wAGavqcmmX0unwOrX0zXCT3UYSCLOBhFzvk4A5O0HHGO+hGkWh2sks8lxfX91IC7n5pbmUjgKOg4HAGAoHYZNdEq1o2W5gqPvXexXvba3sLPTrCScmKW5ElxNPJ8zqmZXdyeudnPbBx7Vj6Df3+h3ssMFtBO9zJJdXNs+FlhU4Yu0o45LFgrD5QRllyBUQgOoeJbzW7/ZPZ6YqwCGJyySzFhiIE8YVtm44+97cVowwPZ2ErAo19qcRvZ3yeIVwSg9Sxc57DcfRQec0lqzcl8WI1k72em38t6GWMWskewh2AYBm5UYByeSQOcVgarcXt5P513qRZYdxW3t90VuWU4cuc5aOPgtk4Y/KMHINi4gntbk6dHcsJ4ljUPjDSyzth7jn+6NwUdsEdMVp3mhzPdxWFtbrHpYjhQylhgRoxLR4zuLN0J6YPXIwQVoo5m0smR4bS3th9suGac+agzI5OEaQcfKifvCnABdAMHFa0q/2lfR2sI26baqAC33Ui53TN/tNtKr6Dc3erltYX7DxLqLI6ao/n29mcYAQD5GUe+Eye+wVLBo93b+F5IbaNRfXMqSSxswX5Nygx556RDZ+FAcxQurpNS1RpLqOb7BbYC26qRlf4VK/3pDg7eyLzgMQWXLclbycrcS7Tcx27EtGn8FvFjoW6Z4yA7ccY1k0O+t0tTBPBLNulmuGkyoeZwAHGASQq7lC5HBHPFMuPDDG1tbaC4x8zvc3LH967tgM646MV3KDn5QeOlAcyRz8VzbqVuLxIp7mXC2mm24IRuuN2Blo1wQBjB2uwByMEFnqGpy8fuIMnfKF8sNg9MZJYf3UzsUYyXOVrevdCntE1K40qKM3c6rBCytta3t1RV2x54DcEjoM7cnis2eC/sYdPvIYNSSIyhBaRRhkt7dVxtZFySx6gjpkDgA5BxaN6ws4bC0jtrZSsSZwCSTyckknqSSTU+4BguRuIzjvisuw0W5cLqkkSrqcszOUmkI2QlSqx5GQMfKxAGN2evWgaDftqbamxtluvNACeYxHkCMgx7tvHznf07UiudF4Xdubo2wuIjcgbjFvG8D1x1xVW4kttTie3hmXz1xLG2DlWB+Vx6gMOo47UDQ70Xttet9ledGmZ13lQC+wJhtpzhFI6DrU/9gypYaaLWeKG9sozErlC6MhxlCMg44Ug5zlR7igPaItabrcNw0dveKLS/Y7TA7feYDJ2N0bjnjnHUCr11eQ2rIspfcwJASNnOBjJ4BwORz71y83glJrRf9OaDUXlaS4u7ePYZQz78YJJBXjYckrtHuD0GnaZ9jmMst5d3kmzYrXDKdi5yQNoHXAyTk8CmYu3Qxp7rTtU1sBbmC6jEGI4xIGXcGPmZXONwBj6jIz71J9lurR2k0u7dATk20/zwt7D+JP+AnA9DWhq2g2GqTxXM8bR3sQIiuYWKSJxjgjr1PByOTxzVKSHVbG23ypFfrH99ocpKw/vBOhPsCPbsKRpGUbWZqaTqKahC2UaG5jwJoH+9GT/ADHoRwaxdDCvFdznLTPd3CyO3LHbM6gZ9AAAPaqWnavAfGlnCY7i1ubm1kjeG4iKM+0qyEdiAPM6HvzWxN4bt5byZzcXK2czGSSzVgI2c9TkDdg9SoOCe3JyCTUGO0ZkutSuLmBt8McYhDr91m3HcAe+MAcdyR2NVpN954klugGW2tITaxkniR2YGQ49BsUZ9d34vnvmuYprHQwtvDEfINyFwsZBwyxrjDEYxn7oPrgipLeKKytFjU7Yol+87ZOB1JJ6nuSaCopt8zMvU53udf07ToDlYj9rusfwoARGD9X5H+4a26xfDVuxS61Oc5n1FxMB/ciCgRp+C8n3Y1tUGgUUUUAV57SGYliuyQ/8tYztcfRhzSR3Go2YxIRqUHQghUm/PhG+mF+pqzRQJxT3Kk0Wl3MsQguJNMvH4QL+6Ln02MNrn8D7GjGo2kmy6t/tUXa4thj/AL6jJyP+A7s+3Sp54o54minjSSNhhkdQQR7g1FapdWDBbOUPa/8APvMSdv8Auv1A9iCPTFBPK47BDe2007QJMn2hRloidrqPUqeR+VST28NwoW4hjlUcgOoYfrUF9f6Zd7YNdsmgCt8ksyAxg/3lkX7h9CdpqU6LcxYbT9Vl2do7pBOmPYja/wCJY0Bz23KUum3MJL6Lql3psh6ouJYT/wBs3yB/wHbToPEfiTT5xBqGmWepoR8txaTiB29jG5Iz9GxVxrDVmXat1Yxt3fyGb/x3cP5mhPDGmyRP/aMEeoXDnL3FxGpf2CkAbQOwGPXqSauNSUdmRLkfQnHjK3Ro0u9K1i3d+32bzcfUxlqsL4qtWJ22WpkZxk2xXP54rm7/AEv+ztZsk8PBvPdJJLm2knYpJGBgMSd2H3lcHv8ANnOOJ9Mhu9aso71dWFtbyLkR20K74z3V2fcMg5BG0YIrT28iPZ09zoY/E1mzESW9/F7tau3/AKCDUjeJdKQZlnkiX1mgkjH5sorDt0u1kkhF5Y38iDdtQ+VIo7ZGWB+vyimpqMImEF2Gs7ljgRXGFLf7pBIb8CaPbyGqMHszptP1rS9SJFhqNnckcERTKxH1ANaFcRf6Tp2oc3tjbTt/ekjBYfQ9RUFvYX+mkHRtXukQH/j2vGNzER6fMd4/BvwqliF1Qnh+zO+orlj4rNgY/wC3bT7PAwwbuBjLEh/2+AUHvggdzXSW1xDdQJPbSxzQuMo8bBlYeoIreM1LYwlBx3JaKKKokKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArgtZEl18ScTkmGx05Xt1HTdK7B2PviMD6E13tct4iVf+Em04lVDfZJ9pxyfnizz7cfnWVb4DWj8YzTWL63cqwG2K3jKn3dnz/wCgLW1WLYrs1osCf31uQwzx8jDH/oZrariNp/EFFFFMgKKKKAOa8cTzrZWtrDbS3C3U21liClmKAyBRuZRzs556AgckVwOoaZdnVtOv/El3cRXEsoENteNCLdfUYVskDgkkDtnJxXeeJdTg07XtHN6lw8GyZ4lhiaQtONirwo/uNJ145PpWR4s8R2l7B9kinu4oJX8lfJjXdeMQBsQk5Ujdk5ABIAz1yFxbWxqDSNbutkj6qloJA2+K3VJBEONhRmTLHg5yMYbgDGaSx8P6m6XF1qWoINRktnt4fKXclsWABdDhSSSu45HfA4HNiLxRZyLapZQSsJreOdWYqkcaMpYbyTxhVY9COPcZo/8ACZC4tbs2sEaztOLTT1dzm4kYcErgbVAKsevyn14oBuTNSw8OwWmgrpnmswLo8kgULuKlTgDsMKFHsOpPNWp9EsbiOyWeJpDZrsibzGU44yDtIyDtGQeDjpXOazd6y93YWdrfeVKsyQTSxRqPOkYh3CqwOFWIOe5zjng1EuqajNq99ey3TJY2kG6O0jGEZ2dli3N1JO0kjgfMvHBJBWZ2Utlay3cN3LbQvdQgiOZkBdAeoB6jNPubmC1i8y6mihjyF3SMFGScAZPcmvN71pYPDkKCed9Q1eI3QPmHIJ2LEOOh8yVGOOMg9sCtfxVbxap4k0zT5yH8oK5J6KoO+Rj74REz2EhoDlOvuLy2tmiW5uIYWlcRxiRwpdj0Az1PtUizRtK8SyIZUALIGGVBzgkds4P5VwUAg17WbO7eCNVuSb6SRuWFtEQIlz2DNsfHswqXR4xGPEFwgKSNp0TzH+KSUrKxc+vUD/gOO1AONjt4JoriJZYJElibo6MGB/EVLXE6dGsbXtpBugthqfl+TExQKv2YPgY6Asd3HWql5ql7b6BHJFeTrLHe3SI2dxbZI4RGz1HAHr0oHyHbX+o2enRh766ht1b7vmOF3H0HqfpUM2taZBaQXU99BFBN/q3d9u716+nf0qi0ET6xfXDxo06usayEZYKEU7QewyxOPc1BBpqxai92Z5pBhhFE23ZFvIL7cDPJUHkn2pDVO6udBa3MF5bpPaTRzwOMrJGwZW+hFJ9qt9krefFth/1h3jCfX0/GuY/sqQ3M0bywvpcsxuGtmiOdxTaRnOCpOXwR940l3osbS2y2cdtbWoZTPGkQHmKjBlHHHDA9fU0B7M6e0u7a8gE1pcQzwk4EkThlJ9MjipJpooVBmkSMHgFmAzXLT6NHd3c5vzHc2Tksls8fyhyFBZucMcLxwMZPrVC9sgl1bxXxTVpyht7C2liBKrkFmcnOcYXL4HAAwWPIHsztJby1ikhjluYUebiJWcAyf7o79R0qxXIaN4It7WCBdUvrrUHhiWGNWPlRxopBCqq84GB1JJwM1rSQarZ3D/2e8F3bSYIju5mVoT3wwViwPoeRzyRwGQbNVdRvYrC0e4mPAwqqOrsThVHuSQB9a5ae71y41mO1h1a0WJFc3Is7cEwNxtUs5bJOScYHTPcZvJplmlwt3LDHNeKObqVFMh9Tuxx+GB6cUFRg2Z+sXN1rF5p+l3elx24uJG3XBdJTGFQtuj4yDkAEkDGeM9povAOkpZSxO109w7tItz5zJIjEAcFSOBjODnkmn6XcpKLzxC6NJaxxNDZKgy0i5+Zl/wB9goHqFB70yWTVbTT21GS5LXse6eW3LZiKckxD0wOA/XIycgkUD5bu0TI0DQ5YIGittV1SzurZzHPA0onTd1yBID8rAhhgjr65rN8e6R4ku7Bh/aaT6VlftNvbQeXKY8/MRyd3HJUYz0rtb25Da3pssX+pvLSRiSOSVKFP0d6uUGkXdHIWXhV4BHPpOry2gfEhaIySCXPcrJI68+uK3Es9RXGdU34GPmt159+KreHJHguNS0uUk/Y5Q0Of+eDjcg+gO5foorcpNlFFYdRUAfbLZvdrY/0emSDVkGY3sZj6Mjx/rlq0aoNeXM13LbabZ/aXhwJZHkEcaEjO3OCS2CDgDuMkZoBu25Rl1fUrON5NQ0VzCgLPJZ3CzBQO+GCsfwBNRw+K7W4RXtdP1iZGGdy2Mij82Az+FWdUg12z0u61D7ZZB4o2l+y+QzrwMhA+4HJ6E7e/AFWtmvFcjT9PUgZIa8bJPoMR/r+lBPOiiPE9gn/H5HfWXvc2kiL/AN9Y2/rWlYajZajH5lhdwXKDqYpA2Pyo0+8S9hZlRo5Y3McsT/ejcdVP6H0III4IqG80bTb2cT3VjbSTjpKYxvH0bqKCi+RkYNU4LAWU3m6Y5tSc7ohkwtn1jyAD3yMH1zVW60m4ADabqd3ayDosjefG3+8HycfRhVc63c6apPiK0S2gUc3sD+ZD/wACBAZPxBHvQDVzotM1J57h7S8jSK7UF1CNlZUzjcvfjIBHbI5OQTqVxE2s6JqkaGz1qxW6Q7oJUnQtG3TIGeR2I7jitCLUtaiTzWj07UImGf3LtAV+mdwYd+ox70GMqfYn8MQmS81nUpWczXF28IVmyEjhYooHpnDN/wACq3eaBpt5cPNcW5Jk/wBaqyOqS8Y+dAQr8f3gaxtB1UaXDNDrMD20ks8tx9ojBkgYO5YfOB8uAQPmA6ZFdTHPFJAs0cqPCw3B1YFSPUGmQ00znG8IWVuHGmJHDHuLpAy/LG3cxsMMmfYkDsBVV7i402J7bWMpasMZuwbqDH/XXggf9dPwroZtb0qFts2p2MZ9HnQf1qNfEGjOcLq2nkk4x9pT/Ggab6mBBLHaHd5k9pan7jIBPaEHuMfOg9iQo9a0JLi5tlEtxAs1meRc2rbwB6svUD6bvcitGPS9NlRpLWNI1kO4tbOUDE9/lOCfesoeHLmxLtpd2pDEs0ci+SWP+/FgfiUakWply3nhuYhLbyxyxHoyMGB/EVTtLGfS7l5dEuhaxSHc9o0YeBm7sFGCpPfBAPUgmsuZdQ02aSe90ya638SSwgeYf+BwgFgOwdB/vU/TdaSdglneRXTkkC2upEiuQfQY+R/wxjuSaabWqKumrM6PTfF9sblLHXE/s3UGbYnmZ8mc9vLkPBz/AHThvauorg5b3TrwGx1ARpJL8ptLsAM3sFPDfUZHvT2srq3Rf7I1O6s3T7qOxniPsUc9P90r9a3jXt8RlKgnrE7miuMt9b8TRHbc6dpNyP8AnpFdSQk/8BKNj/vqnt4s1O2bde+HJmhHVrK6SZgPXawQn8MmtlWg+pk6M+x2FFZ+jazYazbCbT7lJR/EnR0PoynlT7EVoVoncyatuFFFRxzRSOyxyIzL1CsCRQBJRRRQAUUUUAFFFFABRRRQAUUUUAFcz47MVvZWd+zlZ7a4XYiLueZWBDoAOT8uWwP7g9K6C9uY7Kznup8iKGNpHwMnAGTXDSWmo6xqH9qX8i2s6RFLK2AEi2m4fM7f3nPT0AyBnkkcebQcXyu4n29b+1ttU0KZLvyJN21G/wBauMPGc9Dg5AOPmUZro7C+tr+N3tZA+xtjqQQyN1wwPIPI4NcbZeCZ4NRur6PWb6Ce6A88WscUSOf720q3Pv196mm8M6xFex3dp4juknQYJmt43Dr/AHWChAw5PXkdiMmuV4afQ6JVYS1O3orn7a51uEEXI066PZk3wfod9RPrmrpdpCdB3IxOZo7xSg475Ab9Kl0ai6EKSfU6WormeK2gea4kWOKMbmdjgAVif21qAYhtDmPutxGR+pFZ2pXN/qVzbmTSLxbeE7/JaaEK7g5VmIckgY4Hryc4GJ9lPsUmu4y/1BptYW7vYLsWtsD9jiitpJGZmGC74X5TjIAPQMc8nAwPC2k2l9rUupWkk1sttMyy2yzSMWfGdkhOFAGQdi5AOOe1dLdW2sagnlGaHTYW4d4D5sxHoCQFQ++G9vWqXhUR6RI/h540jlt086J1GBcRFiN5/wBsHhvfB705UpxXM0bQnFvlQviiwt49Mm8iKCEvHKn8MaMzJkbj0GWRRk+tZSiSc38lpa3EySyfarS4W3dlLKySoMgHgsWUkf3PpXQww2134rmW9hW5WKOBIFkG5InPnMzYPG7CLz6YrrazFKVmcO2p213OuoWUm9La6ju5Ix95I2jMbll65GZCR1yp71BabHtdUhU5GyC4HzdTA+2RR/umMZ/3hXV3+hWV3ctdBXt71lCm4gO1yB0DdmHswIrCh8LX1vMCl3BInl+W42GPflQrE9cFlAzjjcqtgYIILmVjCu0+ytpk2NqaZLJby8fcjS4hlX8oQW+ldFrQS38YWt7IB9na2FnMT/CsjNhv++kRf+Be1Yt+bzSL2P8A4SCCJrK6aISXETZiaUq0JyDgjKuh5GAEPJq3NC4gt7bUN0kMCHTZn3cvHJt8qX65XYf9ok9KB2uVLe1mg0y3tZ2MRktJNEuD2V8bYn9gT0/66LWw+1pLK92YtrmA210AOkbrlWP+63HsHY1n/aFku5dG1eWNp72MjergOzoqKXC9QCDGQRwGyM/dzJptyqLLZXRPkTzSQ5PBhlIy0R9A2S6H+6QOMDIVuRW9rc3zBGlEF/JGIJm/u3cB3xtj+6w359VKiqsitd2kzvbsbcym7kgByygqYrmMY7o2H45JJxV2dZpbly86QaipijmfGFaUcwzD/ZfDIw/4CDxkuiEtxfTTWbC3uvPNwsTNkRTKAssbf7DqVYH/AGy2OBQLUk0y9minje9mR0kRIZpAQR5oOI5PpKpXHYFcdTXQVyEVtBJ5dvFG9usyPbpFcfddMktbsR0ZDkoR/Dgrkbq6ixSaKyt47qQS3CxqsjgYDMByfxNIqJPRRRQUQXt1FZW7TTkhQQoCjJZiQAoHckkAD3q1oVkbe2NxcxBL65/eTZO4rnomfRRgccdT3rE8Qqpk0mSY4tIr+KSY+gGdh+nmGPPtXR32oW9jLZR3LlWvJ/s8OFJy+xnwcdOEbmhK5lVfQuVDdw/aLWaEO0ZkRk3qcFcjGR71NRTMjlLa21mxtYrSLTbOQooRZI7jZGcdyNuVz1wA31rSsNDiUGbUwl7ePyzOMxp7IpyFHv1Petmq95d21jAZ724ht4RwZJXCKPxNBTm2NvrRbuwltdzRB12q0eAUPYj3BwfwrBh0jVLxli1yWz+xRncwti2bnB4Dhh8q9yoJz0zjIN2fxLpwkWKzdtQlKeZss8S4X1JztHQ4ycnHFVroya1Gq3dvLbWXJa3dxul9A4XI29flyc556YKHFS6Dnnh1LUorq2bfbQRMkcgHyuzkZKnuAFGCODuNW6QAKoAACgdB0AqgNTSZmXT7e4vmBwTboNnv+8YhM+2c0GySiilNmLxvanoLnT5VPuY5EI/9GGti5nhtoHmuZY4YUGWeRgqge5NYU1rqN94ziSI29s9nYMzMSZdnnOuOPl5xC3fHP56klrpWlXEc2qXkt5e9YlmPmNn1SFBjI9QufeglzXQHe8vtkWmIURxlruRcKg9VB++fT+HuT2O5YWkdlaR28JYqg+85yzHuxPck8mqCavNMC0GnTKnYzusZb3AGSPxANRnxDDBKE1K2uLJSQoncBoSfd1J2j3YLQZy5pB4ka4+06LHC6LBLfKJwRksArOB7fMo/StyuVvPEmmXoSGNn8+LUBCVZP9WY59jMSOFU7WAJIzn8K17nXdLt5DE99A04OPIibzJSfQIuWP4CnaxA3VNMe5mW5sp/s12o2kldySD0deM47EEEfTINOOW6jBW/spI5F/ihBmR/cEDP5gfjTbPxVBeeZ9n07UmEb7JA0aoyN6MrMGH5dxVoeIrAD98LyH18y0lAH/AtuP1pFpyRWg1GyuJzBDdQtOv3ot43r9V6irRGRg1Dcar4c1ICC6vdLn7iOaRCQfoeQaF0OAqJNLv7qAHptm85D+D7sD/dxQWqnczrzRFMon0uYWFwOoWJXik/34zwfqMN71PZXUUb+Trvhq1dh/y92UCSRMPdD86n2Ab61cisNUj/ANZc2VwPaJoj+e5v5VJ9n1DHENr/AN/2/wDiKuM5RFLkkZt/Z6EVD6PcXuj3CjCCC1lETezQldpH0APuKxrW/KXnlaloW/OT9stLSRkJ91ZA4P0DfWuiuNLv5g8k+pfZI0XcqW0YOCO7swO4ewC/U1X0y11bVdNsZr2ZdOMkYlkFthnJIyF+dSF689T70SlzdAi1HqMk1nSbRlS4uYbMv90XCmDd9NwGa0IpYbiIPC8csZ6MpDA1FJo+pBGhXULeeE9Dd2u58eh2sqn64H41mTeELMv5j6BpDyjktH8hY+v3P61BfOjVe0tcl3t4M9yUFZ95PpEJzLqENmR3ju/J/MBgD+NQr4NsZPnfw/pXPaV936bCKt2/hqG2wbfRdGiOf4AF/lHQHNEoHxHa2vMPi3THB6LeSROB9ChQ/mTUcvi3QrphHqyaLeFuN8N3BKv4hyp/AZrdOlTbCosNO2nqN5wf/HK5TUvCVva6sbyRNRsoZAGKaW2+33Du8YTOT64I46+rRL5XsX3l8JXCs1nqRtO+2KV/JU+8ZzHj8Knt7FtXXFlqfhyeHGDLa2IaQfQ+aQD71z1zqulaJPFHfQW2tmcAJp91pqR3u3ONwOxRs5xmQKv+1nitK1+F8es3Ml9rdrZ6JE6lY9O0gAFQR1mmx8555RAqdm3ito0uZXTMZS5XYsy6Xp8Hh2KPRdQN5qLXYgi1ATCWQS7/AJgzA8qgDZQ9lx15reTw1b+V+/vNRmnPWb7W6HPqFUhR9MYrktZ8M654T0q2n07VLe407TZBPFaNGsOAARtGWxjDHgFR6Lmuj8H+MtM8UW261cRXI6wOw3e5HqP19uRnOcXF6lKTaumVbjT7pX8m60RdUmT5UvG8kK47F8kFT64Uj09KadB1Dbxpejg9hHdSRge3EfP14rbbxLoiyFG1axVgdpzOowfTOa1twyBkZPIqR88jjE06Z1WM+GEMmfma4miZB9GyzEf8BH4U5vDNzfAJc2ul6bEOptoxPIfoWRQv5H8K7OigOdnlmuW95o7x2aWUCpGpY38Ujq7rztBO6P5uBkhzj05re8MeMZ7O4ttM1cS3MVxLHHa3pdMkOBhWyQz4bI3KDkcnua6zUbc3VjPAJ5rcyIV82A4dPdTzzXk95pAuLaO8gsLd3jxPHcRxiGY4537luclhyckgjP1q4TcWFlNWZ7nRXBfC/wARXt/YtZa6l1Fe+Y7W32iNsyQgAjMmNrEZPfOADzya72u2MlJXRzSi4uzCiiimSFFFFABRRRQBS1myOoabParKYWkAw4GcEEEZHcccj0zXG3Wralo1xBFrOjzKk0qxJdWjiaHcTgbidrLk+o9gTXf1z2oa/wCHbqO9sb66t5o1JhnidCwz3U8cn6UXa2GtSRLwjggVejKypnArgtRvI9LfzdE1Br22b/lzu0myn/XOUIx/B8/UVFZ+PIllEV1purWz+q2rSofoUyf0Bq+aLFys72W2U81H9lWudTxnp5IUyXQbptazmBz6YKZqtdePbGAEpa6tOR2j06YZ/wC+lAp3t1Cz7HWiyXvTxaRgVwsfxHtWPz6Zrkfu1g/9M1aXxzZSoWSHVWwcELptwSPySlzX6hyvsdXOkUanHWuH8XyRW+ueGLkMVuTemBcH70boQwPtkJ+OKivPHUanEGja7cSE4H+gui/iWxgVYsholxY3EuuXt1JqlyuBLHaTD7IMhlWL5ONrKp3EZYjJ4wBNRpxcSoJxkmy/oWBqNyJP+Pj+1GLn+8v2b5Me23A+oNbesarBpSWhnSVzdXUdpGsYBO5zjJyRwBlj7A9eleeXGrLYXglv4rjVFG0C80+KaGQ4ztZ4iBggMwyrHr0A6VdR8TJNrWiFLqc29rJPfqupW7x+UyRiEAkLlh/pWR1OVPPpwKDvZo6JK+qZ69VDVNX0/So9+oXcMGRlVZvmb/dXqT9BXCx+IPDF3EDrGu2F/Pk7jOwVB7LGeFHbufUnrTB4n8GaakosfsrNINrJZWhYyD0O1cH8TUWZXs+7LPizxIl5p91a3enSW2m71huri5I8y33YZZBEOcdwxI5XoTxU97dNCjx3phuRPB5ZWNsC/hPO+I5/1igsdoz19wRz1l4w0d3eSXRdYskUeVHMIHOU9Pl6DP8ADyKmTXfDYtGt49ZmtYZGLNDeWn7kknujx7Rzz8uOTzTs+w0rDPGBgbS7bU2njubjSiszXCkI09k/yvJnHGziQ46PCOBwK17ieOYTNculvfeSQUdgq3ca/MrrngOp/FGyDkYJowjwrdW0cH9u6c6gsTFG0Cp8wwQqEEICOu3BPcmm+DbW0l0FtOkvpFutOuWt5JA6uJduGjl2uGXLxtE5IHVjzT3j6Bqn6lq81C31CxE1yIW3oUin3GFLhcglNx/1UqsAQrchl4OM4q3N/FcvZ3lhcxX07iM7Icx3mR91vKwVPys+WJVCG6jgjphY6bF5pDlGnOZWE7Ayn1Y5+Y/WpLZtMs2llilhV5MeZI0u5mxwMsTnjtUl2ZkyW99qr3EcQaC1nUGSSe2MZjlX7rxrvLbxhfm4XgferpkDBFDtuYDBOMZPrWfPruk24zPqdjEPV51X+Zqq/ijSsMbeaa8wM/6HbyT5+hRSKLNj0RuUVxMnja7nuBBY+HdUizx51/bSxRj/AL4R2/SrEc9zfYOp+IpbGPvFpulTbj9ZJUP6KKpU5Ml1Io6qeKOeF4pkWSKRSrIwyGB6g1zHimW4sLXRUmXzLS11Sy8q5L5ZA86Q7XzyfllPzZ57+9uCPRIU2jxL4iPcl4CT+sNYnjeW0j8M6jNbeIr66S3QXRgurMLnymEnDiNQMbM856YrSNKSZnOpGSPUqgvLqCztnuLqVIoUGWdzgCvM5td1zTJSunul1FH8rRRwzygY/wBmRFI+glx7VLYeK7e6dZtYtNdadG3oJ9McJG2MfIqBsHrySTyeazcJLoJRv1Oxh1O+vA0lvAlpB/yz+0oWdx6lQRt+h59QOlVdIePUdeuX1MxnUbMBIYP4URhnzUB5JbJUt22keuchvG2kA7UXUXcdVWwmyPzWqWpeKfDN9aKusQTpuJWGO70+Te7+kQ2ks/Q4XLUlF9i3GNtzs9T0W3nZLi0t7WK/jcOs5iGfcEjnBGRUC+G4Jmkm1Ce4munORJFNJCIxjhUCtwO565PXsByPhvxzezXlrBq8R06zt4AspmtpZ57p9uN25BsjGecZcnodpyKv+IPiHpcDrbWt3Lb7huku5LSQqi+igry31GB3z0I4NEJt6I6JPDOnnm88++x/DdymRP8Avj7v44psutIP9H0WzN0Y/k3D91bpjjG/Bzjp8obHQ4rim8beG7mAJNc6jqgIyyvbSsr/AFTaE/SnH4iabGwhtdK1QhRgfuFRAPqW/pRyvsXy/wAzOht9NvZbm+uL69MTXcgMkdplPkUbVXefmHAzxg5Y84rQs7C0st32W3iiLfeZV+Zvqep/GuTj8ZG4I/f6XYof4pjcTMP+ArEB/wCPVZt9a0Z3VtS8ZSMB1jtLIwIfxZXb8mFUqcmPnjHY6p3WNC7sFRRkknAFZL6qb9ZIdG06fVycozIoW39CDK3yn3C7j7Uw6z8PZCn2q6gu9hyv2wSzgH1AcECtuDx14WCrFBqluFUYVFRgAPYYrSNBdWZyrPojhNDttft4dYtbLQ7G9srfUJY7q2W55BZEkZYwyhSP3nfGTngVf8OzWen3t0uh2v2G8nxJLpV7F9nJIABZPlz0x03L9M5q/wCGvFOjWXiDxdJLefubzUYriF0idtw+x2yHoD3j7+/pWvqPibwlqcSxX8yTorblElrKSreoO3IPuKudJPVMiNV2s1oZ2omLUJklvvDly06gIJ4Z40kUdflcOrYz7iqxSdCBbxeJIUH8Hm2kn6uzN+tLfah4fkwdK1/U7Nx1228tyjfUOjH8iKotr9xDkJqWm3QHRnsrq3J+o2vWLpSRrGUS+zajIm37NfMO/n/ZufyJ5/Cs+XQbmRty6bp0bn+NZFR/++hDTl8SXbRkoNMYjqytdnH4C3/rQmuTSgeZq1pa+uzR7yU/mdvv2pezl2K549yOPR/EMD77LUZrfH8H9oGVfyeEgfgK27fUddto1S7t1nx1li2yn6kZj/ILVCK/0xnDXviTV5ecCK10t41P4eUzfka0BqfhVVwz64T6mC/BP/jtUqMnuRKcexVuvFLTwBbCGXVYZGlt5/sts8T25VmRiQ5wSGBG3g9+RW/4d1KO+sUjKmG8gVUuLd8bomx+oPYjgivO728sNM8WvJo2qX9jpeqJvYy2Uzqt6idGWRdzCSJP4TkGHr81E/isTEPJplpPdoDGtxHPJECp64LRhwD3GPzpSpNPQUeWS8z1RbiB5TEs0bSjqgYEj8KmryGzu7e4iBkn8I268GKKC3mmlTHuoUgjjkDirUmp3SDzrWWS8ZuGaLTNQQn/ALaZJP5UvZyCy7nqlFePf8Jj4hsgWksNckSMZytmZIgo7nfFG/TuW/xq1F8Qde1DTvO0XSmu0fgXospGhT/dCO/mn/dYJ/tg8UKnJ9BPQ9H1rV9P0Sxa81a7itbcELukP3mPRVHVmPZRknsK4vxC+v8AijTJJbZB4f0eH97517KYrmdR1JXDLEmMn94rnplFOCOZ03W7vT7v+0rrwh4i1nXgpUX99Ew8sHqsShNsS+ygE/xE9am1bxfr17PbSf8ACPeIFjUhZoooZESRCfmBXbndjIB349u1PlcdkJRb3MbRtLksri/mhvLCS3ntZC6r5kgkY7VG55FVnkIPDEsTwOARXqPim31UavBBeXF6NAkVIIpLO48plkxj98Rh+TwCrY5AI71zXhy3sI7+y1LVLDUUFu7XFvZW+lXDLDIwwSzsCScdlCjPPJ5rtdR8TaTqFlLa3NlrnlSAZK6ZcBgQcgghOCCAQfUVvSi1rIVR7JGTpvgjRrW4kn+xi6kkAybsmcjryC+SM55o8Q+C7DV5oZ38y2liG3MCptcDoHVlKsB2yOMmspPFGsaXKYU0vVNZth9yYWMkE2O24FdrH3BX6VqW/jh3A87w14kjPGQbHOPyNdF4tWsZWkncstaapb2oit5bGcKu1UlhMeR6EqSPyX8KxYNFvgFZ9E0Ys2CXlvZJHjwMAKTGSAOgAIA7VsHxnAc7vD3iP6/2c3+NMPjG0HXQPEY/7hr1n7Kl2L9pUM6K48R6NMzwaQs9sRho4b8zj6qsgUqR6A4PpWlpXjKO4d472yuIZExvEcbuye7RlQ4HuAy/7VK/iq3ZMroXiAZ/6h71lX+q2N88b3XhzW3kiOY5P7OcOn+6w5H4Golh4P4XYam/tI6ifxJpC20rjUrZHUAbW5dSTtGY+G6kcVwl3bJdXZIOjz3Uz7VSD7KrMx6EpLFvB743N+NW5L20eRWbTvFQC8gG2nOPxOSPwNUtav4JdPuIbfSvGDO6EDEEzgnHGRISOvtWX1drqilNLoaPgJ7iHxPHZ3MibUnkeSHaI3gnMRwuwfKEZRI2VJBYfhXrFee/DlNDjextY7W8g1uOzE8iXEM0SA4VZCiuAv3mxkDODXoVbUo8sbGdWXMwooorQzCiiigAooooAK4rRoig1JguPM1C5b6/vCM/pXa1Q/s5FZvKCIrOzkAd2JJP4kk046O4dDLCP6Gl2P6GtgWmB1FH2X3FXzisY+x/Q0bH9DWx9l9xR9l9xRzhYxtj570FH9DWz9k56ij7IPUUc4WMYK3oaXY/oa1xaDPUUv2X3FHOFjH2P6Gua0xTd+PNdnGStla21iP9lzvmf81kg/Ku9+y+4rmPh/ZvLp+p6hNG0cmoapdT4dSpKK/kxkg+scUZ/GjmCxca3DHLRqT6kU7y39DWz9l9xR9l9xRzBYx9j+hpNj+hrZ+y+4o+y+4o5wsYMllFL/rLeN/95Aa5LUdLstO8a6fJNZWzWOrxGzKtEpVLiMNJGQCONyecCe+xBXpf2X3FYXjjQp9U8M3cVgQNSh23VkTxi4iYPH+BZQD7EjvSckwKY0DTFORpdiD7W6f4U9dGsF+7p9oPpCv+FbOiTR6to9jqMcbxJdQJMI5VKum5QdrA8gjOCKu/ZfcU+ZBqYMVnHEP3UEaf7qAVNsf0NbH2X3FH2X3FHMgsY+x/Q0bH9DWx9l9xR9l9xRzhYx9j+hrJ8XWLX/hPW7IqSLmxnhI6/ejZf61132QeooNmrAq4VlPBBGQRRzBY5nRLh9Q0XT7wEkXNvHNnOc7lB/rUmpXltpdlLealdQ2lpEMvNPIERfqTxXI+A9X1e68HaLpHh7SZJbuxtI7K5v8AUVaG1heNdh/2pm+XkJ8ueC6mur0vwRBHexalrt3JrWrxndHPcqBHAf8ApjEPlj+vL+rGjnCxgjUtc1/5fD9q2m6ef+YnqEJDuPWG3OG+jSbR32uK0tF8M2elXD3iia71OVdst/dv5k7j03dFX/ZQKvtXY/ZfcUfZfcUuZBYx9j+ho2P6Gtj7L7ij7L7inzhYx9j+ho2P6Gtj7L7ij7L7ijnCxj7H9DRsf0NbH2X3FH2X3FHOFjH2P6GjY/oa2PsvuKPsvuKOcLHCaSrJ458RQ85a1srjB/2jOmfp+6/Q10ex/Q1Rgs3j+Jd82xhFcaRbrvx8pMc0/GfX97+prpvsvuKFILGPsf0NGx/Q1sfZfcUfZfcUc4WMfY/oaNj+hrY+y+4o+y+4o5wsY+x/Q0bH9DWx9l9xR9l9xRzhY5PxLoza1o09mr+TcZWW2nIz5M6MHjf8HVTjuMjvR4a1P+29Gt70RmGVt0c8OcmGZGKyRn3V1YZ74zXWfZfcVwOq3EfgjxbcTzw3Uuka6vmIlrbvM63yAAqqKCf3sYU+mYmJI3Zo5gsdNsf0Nc9qviWG3v30zS7eXVtYXG+0tSMQ56GaQ/LEPr8x7K1TppXiHxR82qSSeHtIbpZW0o+2TL/01mU4i/3YyW/2x0rptI0Gw0exjstLtYbW1TJEcS7Rk9SfUnqSeT3o5wscSnha61d1n8YXCXwBDJpkIK2cZHI3KeZj7v8ALxkIprqVjZQFUYAGAB2FbP2X3FH2X3FCkgsY+x/Q0bH9DWx9l9xR9l9xRzhYx9j+ho2P6Gtj7L7ij7L7ijnCxj7H9DRsf0NbH2X3FH2X3FHOFjH2P6GjY/oa2PsvuKPsvuKOcLGPsf0NGx/Q1sfZfcUfZfcUc4WMfY/oaDG4HetkWo9RQ9ruHBFHOFjBsEL+Lrdm5MNhKPpvkj/n5f6V09Ztnpn2fV7m+MgbzoIoAgH3djSNnPvv/T3rSrPqUFFFFAgooooAKKKKACiiigAooooAKKKKACiiigDmbjxzoEGqtp73VyZluVs2ljsp3gSdsARtOqGMNkgYLZBODWl4c1u21+wlu7NJkjjup7QiUAHfDK0THgngshI9sdOleeX2ja/B4mnm8M6TrekzS6kJZJxqUEumTxlx5krws5kDOm7Kog+bBznLVmW/w61S2+xX2l2EWn6/JrOrSXOoI6CRbadbrySzA5ZdzwNsGSDzgEGgD2qszXNat9G/s/7Ukz/bbyOyj8sA4d84JyRxx2yfavGofAmsvo+oxaV4XXQj/Y0VtNbG5hP9pXiTJIJMoxBICOPMk2sfN5AArfbQ/EGreKLjVptDuLCGXWNOuViuLiBpBDDG6ux2OwGCRwCTzxmgD0a+1m3s9d0zSZUlNxqCTPEygbFEQUtuOcj7wxgH8K06+f7X4f8AiP7LaQWWhDStfi0vULa88QefBuvbmVQEl3o5lIJBOWAK7uBxU+nfDzUo9Ku4LTRtXszcXWlyTRXNxp8SP5N0kkrotoqDIQMfMYh24GMgUAe80VW03T7PS7KOz0y0t7O0izsgt4xGi5JJwo4GSSfqas0AUNe1iy0HSZ9S1SVorOHbvdInkPzMFACoCxJJAwAetZ+m+KrHV7e4fR4b28mtp0guLVoDbTwlsHc8c/lkDad3uPugniqvxO0m91zwTfadpas15K8BTYyKV2zIxYF/lyACefToelcVd+EPEUS6tZzRTavcXOsadqK6u8sSNNBFcxExvGCoVo0Rj8ihWHT5iRQB6V4c1u21+wlu7NJkjjup7QiUAHfDK0THgngshI9sdOlaleHaP4I1W31dZrfwu9hqUOralez6uLmBGvLaUz+XArI7SfN5kR+dQE2561v/AAY8L6h4butTW50UabZvbwRpJMtutzM6l87/ALO7JJgFf3jBXYlsjGAAD1KiiigArGn8T6RBp2qX8t3ttNMmNvdv5TnynG3IxjJ+8vIyOa2a8f1/4d3uoaJ42kEOo/2nfai89lDHqsscMseIsFohKIj91vvrnjntQB6xaTyTNcCW0ntxFKY0MpQiZcA712scLyR82GyDxjBKapex6bpl3fTh2itoXmcIAWKqpJxnvxXifibQpbfxfYLrPh5tYtb/AMS3t3FYKYHNzEdPVQ2JHVMBkJw5H3eh4B7vw74f1Kx+FF1o08IW+kt7xYbQSBhAsjSGKANnHyKyJnOPl4OKAOx0u9j1LTLS+gDrFcwpMgcAMFZQRnHfmrNeC23gHWG00jTPDLaLBHYWVvf6e08CHWHjuEkmy0TsvMayJvcgt5mDgCtC0+H9zf39gLnwzDYeGv8AhIDejRZXhZLaAWUkZZkRimHlIPloWHOT1agD2qivAdS+HWuPZaXaXel313o1m+pRR6fZPYyNCr3TNbuFug0e3ysKMEOgwB3Fe0+FLOXTvC+kWVx54mt7SKJxPMJpAyoAQzgAOfVgBnrigDVooooAKKKKACiiigDmb7x14fsdTlsZ7q4MsUy28skVlPLBFI2MI8yoY0b5hwzAjIzW9ZzyXCymW0ntSkrxqJShLqDgONrN8rdRnBx1APFeYazo2vp4jvZ/DOk63pN5PerJ9qj1KB9NmGVDTSwO+8EoCCqJngc5+YZsvg7VYtX+06t4XHiHSTf6tMNNaW3Kh5p0eC4KyOEI2B15yy78hc5oA9V8La3beJPDmna1YpNHa38CXESTABwrDIDAEjP0JrUr50k+GniGTRdCttX03U7uK30K3s47awmsN1ldIX3ktcK2zO5P3sJ3Db0OFx6x8QtFvtV8K6faw2b6mkF1by3unvMoN7Cv34yzbUY5w2GIVtuDjNAGxr/iGPR7/TbFLG8v77UGcQwWvlghUALuxkdVCjcO+eRgGtuvGfDXw9mPirRdQ1Pw3Z2+lW9zqE9vZTiCX+zkfyDAgAJUHeksgCEhC+ARXs1ABRRRQAVgeIPF2jaBdfZtQmumuBD9oaK0sp7p44skeY4iRii5BGWwDg+hrfrznx9pN7ceIheaZomvtcmzEK6nouqQ27NhmIiljldQVBbcGw5GSMdQQDuNN1FdR/eW8EpsnhimguyU8u4VwT8gDbhgYzuVfvDGecRaJrVvrEmpJbJKpsLx7KXzABudVViVwTxhh1x34rym/wDCPiq7a6udbsI9WaZNHOoW8EsaLqPkibz4wrMq4DOjYbarYx04rHuPh9rM9vD/AMU5cWWh/wBrXly+iWf9nSOEkjhELiObfbnaUkBXORv+UnuAfQNZPifXbfw9pf225huLgvNFbxQW4UyTSyOERF3ELklhySAOpNcw/hzVB8G5PD+nm6t9T/s9reFbq7VpR1wjSxgAHHy5UYHbpmuLm+HtxqcpEPg630nQW1HS5f7FnNs65ikf7RcFUZoxmNwhAJZwpyOcUAe2Wkrz2sMssEttJIis0MpUvGSMlWKkrkdDgkehNS1HbwxW1vFBbxJFBEoSOONQqooGAABwAB2qSgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooApa3PJbaNfzwNtlit5HRsA4IUkHmuB8P/ABNtf+ECtdXvINQ1L7NY2Zvru0hjKPdTeWpiT5l3OGkBYKNq9Mg/LXot7bJeWc9tKWEc0bRsV6gEYOPzriLT4W6HZaS2l2E9/a6fJFarLbwvGElkt3RkmI2cSHy1DFcBh1GcEADL/wCKui6XY3UusWl9pt7b3i2LWN49vHJ5jRCVf3hl8kKUOcmQDt1wDn3Pxu8Jw6bZ3aySSNcJLIYftNrG0axuUY7nmVH+YHAjZy3UZHNdDqvgLTr/AFS71NL3ULTUpryK+jubd0D28qQeQNgZCCCmQVYMDk1HN4CV5oLuLxJ4gg1VIpLeTUElhM08btv2MGiKAA8rtVSueMUAdVpd9BqmmWl/ZPvtbqFJ4mxjcjKGU4+hFWahs4Ps1pBAJJZREip5krbnbAxlj3J7mpqACiiigAqO4lEFvLKVLCNS20EAnAzjJIH5kCpKpa3plvrWjX+l3wc2t7BJbTBG2sUdSrYPY4JoA4O1+MGhXNpqUsdnfyT2EltFJbW8trcuxnl8pNrQzOmd/VSwYenIzFrfxIiiudFmka50O3g1mTT9Xgv0i3oFspZguUZ1Of3TAoxJ6eorQt/hhp6SNJd6xrF7LtsY1aZoF2JaTedEirHEqgbuDxyPQ81b1f4b6DrF7cT6ok13Hcaj/aUttLsaJ5Psv2baRtzt2c9c7uc9qAMrUPiCul61Jf6yLvTdCTRVvWtrqONJRI1wI0J5+UtuUYZgBn5tpzjf8CeN9K8awXz6VuV7KRYpozNDNgsoZSHhkkjYEejHBBBxVG4+G+l3do1vf3+rXY+xLYpJNOvmIiTCaNg4UEujKuGOT8ozk5J6LQNIm0pZ/tOsanqsszAmS+aPKgDACrGiKB9Fye+aANWiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These drawings show the most common places that people get pressure sores.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Taylor CR, Lillis C, LeMone P, Lynn P. Fundamentals of Nursing: The Art And Science Of Nursing Care, Sixth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6871=[""].join("\n");
var outline_f6_45_6871=null;
var title_f6_45_6872="Variable AV block tutorial";
var content_f6_45_6872=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F74851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F74851&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1046px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Variable atrioventricular (AV) block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 134px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Atrial flutter is commonly associated with variable AV block. The AV conduction ratio varies between 2:1 and 3:1 in this case.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 456px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 103px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6872=[""].join("\n");
var outline_f6_45_6872=null;
var title_f6_45_6873="Pediculosis pubis";
var content_f6_45_6873=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55191%7EDERM%2F58267&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55191%7EDERM%2F58267&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediculosis pubis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous lice and nits located around the pubic hair.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediculosis pubis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A small brown living crab louse is seen at the base of hairs (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6873=[""].join("\n");
var outline_f6_45_6873=null;
var title_f6_45_6874="Vulvar lichen sclerosus";
var content_f6_45_6874=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Vulvar lichen sclerosus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Elizabeth Gunther Stewart, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Jeffrey Callen, MD, FACP, FAAD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?6/45/6874/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?6/45/6874/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 25, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen sclerosus (LS) refers to a benign, chronic, progressive dermatologic condition characterized by marked inflammation, epithelial thinning, and distinctive dermal changes accompanied by symptoms of pruritus and pain (",
"    <a class=\"graphic graphic_picture graphicRef78574 graphicRef62753 graphicRef59461 \" href=\"UTD.htm?26/43/27322\">",
"     picture 1A-C",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/1\">",
"     1",
"    </a>",
"    ]. The previous designation was lichen sclerosus et atrophicus; the \"et atrophicus\" was dropped because areas of thickening and hyperplasia often occur. LS usually occurs in the anogenital region (85 to 98 percent of cases), but can develop on any skin surface [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Extragenital lesions are present in 15 to 20 percent of patients.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, and management of vulvar LS will be reviewed here. Extragenital LS and LS involving the male genitalia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28952?source=see_link\">",
"     \"Extragenital lichen sclerosus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=see_link&amp;anchor=H16#H16\">",
"     \"Balanitis and balanoposthitis in adults\", section on 'Lichen sclerosus or balanitis xerotica obliterans'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvar LS can occur at any age but tends to have two peaks of onset: prepubertal girls and perimenopausal or postmenopausal women [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/4\">",
"     4",
"    </a>",
"    ]. It is one of the most common conditions treated in vulvar clinics. The true prevalence is not known; estimates range from 1 in 30 elderly women to 1 in 59 women in a general gynecology practice to 1 in 300 to 1000 patients referred to dermatologists [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/5-9\">",
"     5-9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of LS is unknown. A number of mechanisms have been proposed based upon epidemiologic data:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Genetic factors &mdash;",
"      </strong>",
"      Familial aggregations of LS among fathers and daughters, mothers and daughters, sisters, and twins (identical and fraternal) have been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. Trauma, injury, and sexual abuse may trigger symptoms in genetically predisposed individuals, which suggests presence of the Koebner phenomenon (ie, development of isomorphic pathologic lesions in the traumatized uninvolved skin of patients who have a cutaneous disease) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Local factors &mdash;",
"      </strong>",
"      An interesting study using skin grafts showed that a graft placed on the vulva developed LS and skin with LS from the vulva became normal when grafted to the thigh [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/14\">",
"       14",
"      </a>",
"      ]. This suggests local vulvar factors facilitate disease expression.",
"     </li>",
"     <li>",
"      <strong>",
"       Immunological abnormality &mdash;",
"      </strong>",
"      Disorders of the immune system are more common among patients with LS, suggesting autoimmune mechanisms and immune dysregulation may be involved in the etiology of the disease [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/15-23\">",
"       15-23",
"      </a>",
"      ]. For example:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      LS has been associated with autoimmune diseases such as alopecia areata, vitiligo, thyroid disorders, pernicious anemia, and diabetes mellitus. In one study of 350 women with histologically confirmed LS (of which 98 percent had vulvar disease), 22 percent had an autoimmune disorder and 42 percent had one or more autoantibodies (anti-thyroid, anti-gastric parietal cell, antinuclear, anti-smooth muscle, or antimitochondrial antibodies) with titers greater than 1:20 [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/24\">",
"       24",
"      </a>",
"      ]. A separate study of 190 women with vulvar LS and 922 female controls also found an increased likelihood for autoimmune disorders among patients with vulvar LS (28 versus 9 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/23\">",
"       23",
"      </a>",
"      ]. However, an increase in the prevalence of a similar panel of autoantibodies was not detected.",
"     </li>",
"     <li>",
"      Antibody formation against extracellular matrix protein 1 (a key component of the dermis) may contribute to disease progression [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/15\">",
"       15",
"      </a>",
"      ]. Antibodies directed against extracellular matrix protein 1 have been detected in roughly 75 percent of women and men with LS [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/15,25\">",
"       15,25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The lack of correlation between the duration of symptoms and histologic appearance is consistent with an ongoing inflammatory process with involvement of activated Langerhans cells [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/19\">",
"       19",
"      </a>",
"      ]. Increased numbers of CD1a-positive Langerhans cells have been found in the epidermis in all stages of LS [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/20\">",
"       20",
"      </a>",
"      ]. The persistently abnormal peripheral lymphocyte pattern may indicate that topical steroids improve symptoms by impeding the action of pruritic factors such as prostaglandins and leukotrienes, not by blocking the local inflammatory process.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Hormonal factors &mdash;",
"      </strong>",
"      The highest incidence of LS in women is observed during low estrogen physiological states, such as the premenarchal child and the postmenopausal women [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/24\">",
"       24",
"      </a>",
"      ]. While a hormonal hypothesis for the etiology of LS has been postulated, no association between LS and pregnancy, hysterectomy, contraceptive use, or postmenopausal hormone therapy has been found [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/26\">",
"       26",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Androgen levels do not appear to be related to LS. An early, poorly designed study noted that patients with vulvar LS have decreased serum levels of dihydrotestosterone, free testosterone, and androstenedione compared with age-matched controls without the disease [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/27\">",
"       27",
"      </a>",
"      ]. However, many subsequent studies have been unable to confirm these findings, and testosterone is not an effective treatment for the disease (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Medical therapy'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      <strong>",
"       Infection &mdash;",
"      </strong>",
"      Infectious agents (eg, Borrelia burgdorferi, variably acid fast bacteria, human papillomavirus [HPV]) have been purported to induce LS [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/28-32\">",
"       28-32",
"      </a>",
"      ]. However, such a relationship has not been conclusively demonstrated [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/33\">",
"       33",
"      </a>",
"      ]. Some of these organisms can be difficult to identify.",
"     </li>",
"     <li>",
"      <strong>",
"       Cell kinetics &mdash;",
"      </strong>",
"      An elastase-type enzyme produced by vulvar fibroblasts may lead to the destruction of connective tissue in patients with LS [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/34\">",
"       34",
"      </a>",
"      ]. Despite this destruction, there appears to be active regeneration with significant collagen synthesis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/35\">",
"       35",
"      </a>",
"      ]. In a study of keratin differentiation markers using specific monoclonal antibodies, keratins 6 and 16 were associated with increased cell turnover in LS, consistent with a hyperproliferative state [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/36\">",
"       36",
"      </a>",
"      ]. This was confirmed in another study using flow cytometry analysis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/37\">",
"       37",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Vulvar skin affected by LS has a wide range of proliferative capacity [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/38\">",
"       38",
"      </a>",
"      ]. The p53 and proliferating cell nuclear antigens are altered in vulvar LS, compared to normal vulvar skin and extragenital LS, resulting in changes of the epidermal cell proliferative capacity [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/38,39\">",
"       38,39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND NATURAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pruritus and soreness or irritation are the most common symptoms of vulvar LS. In some women, nonspecific, dull, vulvar discomfort is a prodrome of the gross lesions. Other women are asymptomatic; in these patients, LS is detected by careful inspection of the vulva for the characteristic thin, white, wrinkled skin (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Physical examination'",
"    </a>",
"    below). Most of these patients had childhood disease, which has become inactive except for chronic atrophic architectural changes [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major symptoms of vulvar LS are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vulvar pruritus, which is the hallmark of the disease, is often so intense that it interferes with sleep. However, this is not specific to LS as pruritus is a feature of most vulvar disorders (",
"      <a class=\"graphic graphic_table graphicRef55449 \" href=\"UTD.htm?5/25/5532\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Pruritus ani, painful defecation, anal fissures, and rectal bleeding are common complaints that have led to extensive gastrointestinal evaluation and, sometimes, hemorrhoidectomy or repair of an anal fissure.",
"     </li>",
"     <li>",
"      Dyspareunia is often a late symptom associated with introital stenosis, fissures, or posterior deflection of fused labial tissues at the time of intromission. Fusion over the clitoris can also cause diminished sexual sensation or even anorgasmia, although this is not common. Marked dyspareunia may occur in perimenopausal or postmenopausal women with estrogen deficiency in addition to LS.",
"     </li>",
"     <li>",
"      Dysuria and difficulty voiding can occur, especially when there is fusion of the labia minora over the urethra with advanced disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Lichen sclerosus can be completely asymptomatic, but still lead to whitening, scarring and loss of architecture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic vulvar LS is expressed as white, atrophic papules that may coalesce into plaques; follicular plugging may be observed in early lesions. LS can also be hemorrhagic, purpuric, hyperkeratotic, bullous, eroded, or ulcerated [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/41\">",
"     41",
"    </a>",
"    ]. The lesions most frequently affect the labia minora",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    labia majora (",
"    <a class=\"graphic graphic_picture graphicRef78574 \" href=\"UTD.htm?41/38/42597\">",
"     picture 1A",
"    </a>",
"    ), although the whitening may extend over the perineum and around the anus in a keyhole fashion (",
"    <a class=\"graphic graphic_picture graphicRef62753 graphicRef59461 \" href=\"UTD.htm?20/29/20952\">",
"     picture 1B-C",
"    </a>",
"    ). Fissuring is frequently seen perianally, in the intralabial folds, or around the clitoris. The introitus may have a yellow, waxy appearance. Fordyce spots (small raised papules along the inner aspect of the labia minora, which represent normal sebaceous glands) disappear.",
"   </p>",
"   <p>",
"    Scratching may result in excoriations and secondary mild lichenification (thickening of the epidermis with exaggeration of normal skin lines), often associated with edema of the labia minora and the prepuce. Relatively minor rubbing or intercourse may lead to hemorrhage",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    petechiae with purpura and ecchymoses due to the fragility of the involved skin (",
"    <a class=\"graphic graphic_picture graphicRef75883 graphicRef80900 \" href=\"UTD.htm?42/9/43160\">",
"     picture 2A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The vulvar architecture remains intact early in the course of the disease (",
"    <a class=\"graphic graphic_picture graphicRef60960 \" href=\"UTD.htm?43/35/44594\">",
"     picture 3",
"    </a>",
"    ). As the disease progresses, the distinction between the labia majora and minora is lost and the clitoris becomes buried under the fused prepuce (",
"    <a class=\"graphic graphic_picture graphicRef57562 graphicRef54149 graphicRef70014 \" href=\"UTD.htm?23/35/24122\">",
"     picture 4A-C",
"    </a>",
"    ). Shrinkage of the introitus and perineum causes dyspareunia and more fissuring upon intercourse or insertion of a speculum. At the end-stages of LS, the vulva is pallid and featureless due to midline fusion, which leaves only a posterior pinhole orifice. The vagina and cervix are not involved.",
"   </p>",
"   <p>",
"    Lesions of the genitocrural folds, thighs, and buttocks are common, but blistering is not [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/42\">",
"     42",
"    </a>",
"    ]. Extragenital lesions consist of white papules or plaques [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/3\">",
"     3",
"    </a>",
"    ]. These lesions are not as pruritic as genital lesions. They occur on the thighs, breasts, wrists, shoulders, neck, and, rarely, the oral cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28952?source=see_link\">",
"     \"Extragenital lichen sclerosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of vulvar LS is based upon the presence of characteristic clinical manifestations, ideally with histological confirmation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/41\">",
"     41",
"    </a>",
"    ]. We perform a 3 mm vulvar punch biopsy both to confirm the diagnosis, and to document whether atypical histological features are present. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Associated malignancy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    We favor routine biopsy rather than biopsy only after failure of empiric therapy because of the broad differential diagnosis of vulvar whitening, the possibility of underlying atypia or malignancy, and because biopsy should not be performed in women who have been on glucocorticoids within the previous two weeks.",
"   </p>",
"   <p>",
"    On histological examination, the epidermis is typically thinned (accounting for the older nomenclature \"lichen sclerosus et atrophicus\"), although areas of hyperkeratosis may be observed, and there is acanthosis and elongation of the rete pegs (",
"    <a class=\"graphic graphic_picture graphicRef58841 \" href=\"UTD.htm?8/37/8789\">",
"     picture 5",
"    </a>",
"    ). The upper dermis is hyalinized with a band of lymphocytes below this region. Hyperkeratosis is believed to be related to lichenification that occurs as a result of scratching.",
"   </p>",
"   <p>",
"    If LS has been present for a long period of time (especially since childhood), characteristic histological findings may be absent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/44\">",
"     44",
"    </a>",
"    ]. This can occur if the biopsy misses the area of active pathology by a few millimeters, or if the biopsy report indicates hyperplasia or lichen simplex chronicus, both of which are associated with lichen sclerosus, but not diagnostic of the disorder. Clinical judgment should guide the diagnosis and treatment of LS when biopsy results are not specific. For example, when clinical signs that strongly suggest vulvar LS (eg, local pruritus plus depigmentation or loss of vulvar architecture) are present in conjunction with inconclusive biopsy results, we proceed with treatment. Review of the pathology specimen by a dermatopathologist can be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since disorders of the immune system are more common among patients with LS (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Etiology'",
"    </a>",
"    above), a review of systems should be performed in patients with this disease. When clinical signs or symptoms suggestive of autoimmune disease are evident, we select additional diagnostic studies based upon the suspected autoimmune disease (eg, thyroid disease, diabetes, pernicious anemia).",
"   </p>",
"   <p>",
"    Clinicians must also remain astute to the possibility of coexisting bacterial or fungal infections. Investigative studies (eg, microscopy or culture) to diagnose infection should be performed if signs suggestive of vulvar or vaginal infection are present. Candida infection is not uncommon in LS patients who are taking estrogen and progestin preparations (eg, contraception, replacement therapy), or who are diabetic [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"     \"Approach to women with symptoms of vaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;LS and lichen planus share several common features and may occur together on the vulva [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/46\">",
"     46",
"    </a>",
"    ]. Both disorders produce intense itching and loss of architecture, but lichen planus usually also involves the vagina (inflammation and synechiae), whereas the vagina is not affected by LS. A punch biopsy is required to make the diagnosis and review by a dermatopathologist is helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36952?source=see_link\">",
"     \"Vulvar lichen planus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variety of other disorders may be confused with LS, which is one of the reasons we recommend diagnostic biopsy in all patients with whitening:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lichen simplex chronicus or squamous cell hyperplasia, does not denote a specific entity, but describes a nonneoplastic morphologic alteration of vulvar skin related to chronic irritation (",
"      <a class=\"graphic graphic_picture graphicRef72766 \" href=\"UTD.htm?27/23/28018\">",
"       picture 6",
"      </a>",
"      ). The histology consists of elongation, widening of the rete ridges and irregular thickening of the Malpighian layer of rete ridges (acanthosis), hyperkeratosis, and parakeratosis with a mid-dermal inflammatory infiltrate. Lichen simplex",
"      <span class=\"nowrap\">",
"       chronicus/squamous",
"      </span>",
"      cell hyperplasia is diagnosed when anatomic and clinical findings have excluded specific causes of hyperplastic epithelial changes, such as lichen sclerosus, psoriasis, lichen planus, lichen simplex chronicus, eczema, seborrheic dermatosis, HPV infection, and Candida infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5336?source=see_link\">",
"       \"Dermatitis of the vulva\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vitiligo produces whitening and can be confused with LS if other manifestations of LS are minimal. The coexistence of vitiligo and vulvar LS has been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/23,47\">",
"       23,47",
"      </a>",
"      ] (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=see_link\">",
"       \"Vitiligo\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cicatricial pemphigoid, an uncommon bullous disease, should be considered, particularly if there is marked labial adhesion. Biopsy will distinguish between LS and this disorder. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22714?source=see_link&amp;anchor=H53290512#H53290512\">",
"       \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\", section on 'Mucous membrane pemphigoid'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      LS with anal involvement is sometimes confused with anal fissures or hemorrhoids, leading to unnecessary surgery as management of anal LS is similar to that for vulvar LS. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/24/34181?source=see_link\">",
"       \"Anal fissure: Clinical manifestations, diagnosis, prevention\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Like LS, vulvovaginal candidiasis is characterized by chronic vulvar itching or burning [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/45\">",
"       45",
"      </a>",
"      ]. A wet mount is performed to look for hyphae. If the wet mount is negative, then culture is indicated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/1/15386?source=see_link\">",
"       \"Candida vulvovaginitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Psoriasis can occur in genital locations and is pruritic, but usually appears red rather than white. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=see_link\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Premature ovarian failure should be considered in a woman with hot flashes and oligomenorrhea or amenorrhea prior to age 45. Estrogen deficiency can lead to a thinned epidermis and labial adhesion, as well as dyspareunia. These changes should respond to topical estrogen within two weeks of treatment. Failure of a response should prompt a vulvar biopsy to exclude LS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     ASSOCIATED MALIGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with vulvar LS are at increased risk of developing squamous cell cancer (SCC) of the vulva (",
"    <a class=\"graphic graphic_picture graphicRef71222 graphicRef50192 \" href=\"UTD.htm?5/34/5671\">",
"     picture 7A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/3,6,48-50\">",
"     3,6,48-50",
"    </a>",
"    ]. Indeed, it is not uncommon for women who present with vulvar SCC to also have LS that has been undiagnosed, untreated, and asymptomatic.",
"   </p>",
"   <p>",
"    There have been case reports of verrucous carcinoma and basal cell carcinoma with LS, but a relationship between LS and these cancers has not been established [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/40\">",
"     40",
"    </a>",
"    ]. A relationship between LS and melanoma has been reported in girls under age 16 years [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Differentiated vulvar intraepithelial neoplasia (VIN) is a precursor to SCC and is often associated with LS (",
"    <a class=\"graphic graphic_picture graphicRef54596 \" href=\"UTD.htm?42/50/43809\">",
"     picture 8",
"    </a>",
"    ) but not HPV infection. Usual type VIN, which is also a premalignant lesion, is mediated by HPV but is less likely to be associated with LS. Determining those cases of LS with a high likelihood of evolving into SCC is an active area of investigation [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32952?source=see_link\">",
"     \"Vulvar intraepithelial neoplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the risk of SCC in women with vulvar LS is increased, this risk is estimated to be less than 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/53\">",
"     53",
"    </a>",
"    ]. Much of the available evidence of the relationship between LS and SCC is based on historical studies and retrospective case series. Risk has never been defined in terms of treated versus nontreated or unrecognized disease, or to the length of time the disease has been present. Earlier detection, the introduction of potent topical glucocorticoids, the more liberal use of biopsy, and excision of abnormally thickened skin resistant to treatment may lead to a reduction in risk of SCC for women diagnosed with LS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/5\">",
"     5",
"    </a>",
"    ]. Nevertheless, we believe the skin of patients with vulvar LS should be examined at least yearly for the remainder of the patient's life and nonresolving lesions (eg, persistent localized hyperkeratosis) should be biopsied.",
"   </p>",
"   <p>",
"    In contrast to vulvar LS, extragenital LS lesions are",
"    <strong>",
"     NOT",
"    </strong>",
"    associated with an increased risk of associated malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/43\">",
"     43",
"    </a>",
"    ]. However, men with penile LS may have an increased risk of penile SCC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no universally accepted management plan for women with LS. Management of LS involves education and support, behavioral modification to ensure good vulvar hygiene, medication, and, in a small subset of cases, surgery. Comorbid symptoms should be treated, if present. As an example, women with dyspareunia may benefit from use of a vaginal lubricant. Estrogen is an effective treatment for postmenopausal vulvovaginal atrophy and should be considered in women with dyspareunia, labial fusion, or epidermal thinning due to estrogen deficiency, but not as a primary therapy of LS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=see_link\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Only one study has examined patients' views of their sexual and obstetrical problems following the diagnosis of LS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/54\">",
"     54",
"    </a>",
"    ]. The majority of women (at all ages) described detrimental effects on sexual function, including dyspareunia, apareunia, and difficulty achieving orgasm [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/54\">",
"     54",
"    </a>",
"    ]. These symptoms appeared to be due to continuing inflammation and anatomic changes and scarring from long-standing active disease [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/54\">",
"     54",
"    </a>",
"    ]. Major obstetrical problems were not reported in this small study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Patient education",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient education is a key component in management of chronic, progressive diseases, such as LS. We educate women regarding the chronicity of LS, the frequent recurrences and remission of signs and symptoms, and provide reassurance that the condition is manageable, despite its potential to destroy vulvar anatomy. We review the components of good vulvar hygiene (",
"    <a class=\"graphic graphic_table graphicRef64538 \" href=\"UTD.htm?35/49/36635\">",
"     table 2",
"    </a>",
"    ), including cessation of scratching. We also discuss the increased risk of malignancy and the need for yearly monitoring, especially self-monitoring with mirror and fingertips for thickened lumps or sores that do not heal. Lastly, we provide written Information sheets. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?26/30/27106?source=see_link\">",
"     \"Patient information: Lichen sclerosus (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few randomized clinical trials upon which to base therapeutic decisions on medical management of LS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/55\">",
"     55",
"    </a>",
"    ]. Symptomatic patients should be treated to relieve pruritus and pain. The probability of improvement or remission (not cure) appears to be associated with age. In one prospective study, no patient over age 70 years had a remission; complete remission occurred in younger women, but was temporary [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We suggest treatment of all women with LS, including those who are asymptomatic, to try to prevent progression of the disease. Some studies have suggested that distortion of vulvar anatomy can be prevented if treatment is initiated early in the course of the disease (ie, within two years of diagnosis), before significant scarring has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/44,56-59\">",
"     44,56-59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not known whether medical therapy prevents development of SCC.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend initiating medical therapy with a superpotent topical corticosteroid ointment.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Superpotent topical ointments &mdash;",
"      </strong>",
"      The treatment with the best evidence of efficacy is superpotent topical corticosteroid ointment [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/53,55,58,60-63\">",
"       53,55,58,60-63",
"      </a>",
"      ]. Approximately 95 percent of women will achieve complete or partial relief of symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/57,60\">",
"       57,60",
"      </a>",
"      ]. No specific superpotent steroid or regimen has been shown to be superior to another. We use",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/44/9925?source=see_link\">",
"       halobetasol",
"      </a>",
"      propionate 0.05% ointment daily at night for 6 to 12 weeks and then one to three times per week for maintenance. The ointment is applied sparingly (a dot 3 mm wide) in a thin film over the affected area; a 15 g tube of ointment should be prescribed. Before the woman leaves the office, she should be shown (via a large mirror) exactly where to apply the ointment.",
"      <br/>",
"      <br/>",
"      Successful treatment is characterized by relief of pruritus and pain and resolution of hyperkeratosis, fissuring, and ecchymoses; however, atrophy, whiteness, and scarring, if present, will remain [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/40\">",
"       40",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      We like to see the patient before and after tapering steroids to monitor her response. If symptoms recur as the dose is tapered, we increase the frequency of dosing until improvement occurs.",
"      <br/>",
"      <br/>",
"      Vulvar LS is a chronic skin disorder, and we routinely advise maintenance therapy with superpotent steroid ointment, as symptoms often recur in women who terminate therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/56,59-61,64,65\">",
"       56,59-61,64,65",
"      </a>",
"      ]. Over-use of superpotent and potent topical corticosteroids may induce atrophy, telangiectasia, and striae as early as two to three weeks following daily application; however, long-term follow-up of LS patients has not generally demonstrated these steroid-induced changes since the modified mucous membranes of the labia and clitoris are relatively resistant to the side effects of topical corticosteroids [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/62,64,66\">",
"       62,64,66",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link\">",
"       \"General principles of dermatologic therapy and topical corticosteroid use\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      If the patient is unwilling to take maintenance therapy, then we examine her every three to six months because asymptomatic recurrence resulting in scarring and loss of architecture can occur over a relatively short period of time. Some patients will achieve long-term remission without maintenance therapy, but it is impossible to predict who these patients are.",
"      <br/>",
"      <br/>",
"      Corticosteroid creams should be avoided because they can contain irritants not found in ointments. Oral glucocorticoids are not indicated given the risk of systemic side effects and the high efficacy of topical steroids. Vulvar steroid insensitivity or allergy rarely occur; consultation with a dermatologist is necessary if one of these disorders is suspected.",
"      <br/>",
"      <br/>",
"      Although the modified mucous membranes of the vulva and thickened or lichenified skin are somewhat steroid resistant, the groin fold creases, hair bearing skin of the labia majora, and perianal skin need to be monitored carefully for steroid related problems [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/66\">",
"       66",
"      </a>",
"      ].",
"      <br/>",
"     </li>",
"     <li>",
"      <strong>",
"       Intralesional steroids &mdash;",
"      </strong>",
"      Thickened hypertrophic plaques may respond poorly to topical steroids. In these cases, we suggest injection of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      hexacetonide (5 to 20 mg) directly into the area of involvement once per month for three months [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/67\">",
"       67",
"      </a>",
"      ]. Pretreatment with a small amount of a topical anesthetic (eg, EMLA which is a eutectic mixture of",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"        lidocaine",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?6/32/6660?source=see_link\">",
"        prilocaine",
"       </a>",
"       )",
"      </span>",
"      and use of a small gauge needle help to minimize patient discomfort.",
"      <br/>",
"      <br/>",
"      For small lesions (no more than 2 x 2 cm), we add 2 mL saline to a vial of triamcinolone acetate (10",
"      <span class=\"nowrap\">",
"       mg/mL)",
"      </span>",
"      to make a solution of 3.3",
"      <span class=\"nowrap\">",
"       mg/mL.",
"      </span>",
"      We then inject 1 to 2 mL under the lesion using a 25 to 30 gauge needle. For lesions covering a larger area, we perform several injections arcing out from one or two injection sites.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no well-studied therapies in women who fail to respond to corticosteroids. Given the high therapeutic efficacy of these agents, we investigate causes of steroid failure in women who have persistent symptoms before resorting to a trial of an alternative drug (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Persistent symptoms'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Progesterone and testosterone &mdash;",
"      </strong>",
"      Small randomized trials have generally shown that progesterone and testosterone creams are less effective than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/59,68,69\">",
"       59,68,69",
"      </a>",
"      ]. Testosterone was associated with more side effects and less histological improvement than clobetasol [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/69\">",
"       69",
"      </a>",
"      ] and testosterone maintenance therapy worsened symptoms after initial clobetasol therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/70\">",
"       70",
"      </a>",
"      ]. Placebo controlled trials of testosterone cream have reported conflicting results regarding efficacy [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/55,58,71,72\">",
"       55,58,71,72",
"      </a>",
"      ]. We do not prescribe these hormones.",
"     </li>",
"     <li>",
"      <strong>",
"       Retinoids &mdash;",
"      </strong>",
"      Retinoids appear to reduce connective tissue degeneration in LS [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/73\">",
"       73",
"      </a>",
"      ]. Treatment with oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/1/39958?source=see_link\">",
"       acitretin",
"      </a>",
"      (20 to 30 mg per day for 16 weeks) was effective in one randomized trial [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/74\">",
"       74",
"      </a>",
"      ]. Doses of 8 to 30 mg daily for four months have been used. In an observational series, topical use of tretinoin improved the symptoms, gross appearance, and histopathologic features of LS with minimal side effects [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/65\">",
"       65",
"      </a>",
"      ]. However, use of these agents is limited by significant and potentially harmful side effects including cheilitis, xerosis, teratogenicity, elevated liver enzymes, hypertriglyceridemia, abdominal pain, and alopecia. If a trial of retinoids is being considered, consultation with a dermatologist is recommended before initiating therapy.",
"     </li>",
"     <li>",
"      <strong>",
"       Topical",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      <strong>",
"       and",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/41/29332?source=see_link\">",
"       pimecrolimus",
"      </a>",
"      <strong>",
"       &mdash;",
"      </strong>",
"      Topical calcineurin inhibitors appear to have some efficacy for vulvar LS, and may be useful as alternative treatment options. In a 12-week randomized trial of 38 patients with vulvar LS that compared pimecrolimus 1% cream to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      0.05% cream, both agents significantly reduced patient symptoms and improved histopathologic inflammation [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/63\">",
"       63",
"      </a>",
"      ]. The degree of improvement in histopathologic inflammation with clobetasol was superior, supporting the status of superpotent topical corticosteroids as the preferred choice for initial therapy.",
"      <br/>",
"      <br/>",
"      Additional support for the utility of topical calcineurin inhibitors comes from uncontrolled studies and case reports. Patients with vulvar LS, including some with topical corticosteroid-refractory disease, have exhibited improvement with pimecrolimus cream [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/75-79\">",
"       75-79",
"      </a>",
"      ] or tacrolimus ointment [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/76,80-84\">",
"       76,80-84",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Tacrolimus burns on application, and is often discontinued by patients for this reason. Although the US Food and Drug Administration has issued a &ldquo;black box&rdquo; warning for topical calcineurin inhibitors due to concern regarding an elevated risk for internal malignancy, a definitive relationship between these agents and internal malignancy has not been established. The impact of topical calcineurin inhibitor therapy on risk for vulvar SCC in patients with vulvar LS is unknown. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10842?source=see_link&amp;anchor=H10#H10\">",
"       \"Treatment of atopic dermatitis (eczema)\", section on 'Safety'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       Cyclosporine",
"      </a>",
"      <strong>",
"       &mdash;",
"      </strong>",
"      Cyclosporine has been used in only 10 patients with vulvar lichen sclerosus [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/85,86\">",
"       85,86",
"      </a>",
"      ]. Three patients had a significant improvement, five had some response, and two had no response.",
"     </li>",
"     <li>",
"      <strong>",
"       Supportive therapies &mdash;",
"      </strong>",
"      Topical oxatomide may help relieve pruritus through its antihistamine effects, but the course of disease is not affected [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/87\">",
"       87",
"      </a>",
"      ]. A trial of photodynamic therapy with 20% 5-aminolevulinic acid caused significant burning [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/88\">",
"       88",
"      </a>",
"      ]. Although itching improved in 8 of 12 women, the course of the disease was not changed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Persistent symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, it is important to make sure the patient is complying with the prescribed corticosteroid therapy if symptoms persist or recur, given the high efficacy of these agents. We undertake the following interventions in patients with persistent symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Make sure the patient is applying the steroid to the right place and in the right amount (a thin layer to the affected area) and frequency. Women often are unclear as to where to put the ointment unless they are shown repeatedly with a mirror. If they use too much steroid, their symptoms may not abate.",
"     </li>",
"     <li>",
"      A small number of women initially have a partial response to medical treatment, but have ongoing burning, irritation, and pain. In these cases, we obtain cultures to exclude superinfection by staphylococcus, streptococcus, or candida. The patient may have bacterial cellulitis, vulvar candidiasis, or vaginal candidiasis [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/45\">",
"       45",
"      </a>",
"      ]. We treat infected patients with appropriate antibiotics or antimycotic drugs.",
"     </li>",
"     <li>",
"      Menopausal women may have symptoms related to atrophy, which will respond to topical estrogen cream.",
"     </li>",
"     <li>",
"      A diagnosis of superimposed vulvodynia should be considered if pain persists despite resolution of pruritus and dermal changes. It is likely that vulvodynia represents neuropathic pain, which is pain arising from abnormal neural activity secondary to disease, irritation, or injury of the nervous system that persists in the absence of ongoing disease or acute injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8295?source=see_link\">",
"       \"Clinical manifestations and diagnosis of generalized vulvodynia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An allergy to the topical medication may be present. A topical steroid with a different base or consultation with an allergy specialist should be considered.",
"     </li>",
"     <li>",
"      Very thickened areas may not respond to topical steroids, but may respond to intralesional injection; however, malignancy should be excluded by biopsy (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Corticosteroids'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      We consider repeating the biopsy to confirm the diagnosis or exclude an alternative diagnosis, especially to exclude malignancy (see",
"      <a class=\"local\" href=\"#H10\">",
"       'Differential diagnosis'",
"      </a>",
"      above). We send the biopsy specimen to a dermatopathologist for review.",
"     </li>",
"     <li>",
"      We try",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      cream if the patient has fissuring that fails to respond to the measures described above. We prescribe a tiny amount of 0.03% cream twice daily for a month and then reevaluate. Application of a base of petrolatum ointment or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      first may help to prevent burning. Burning often resolves after a week or two.",
"     </li>",
"     <li>",
"      In cases of true treatment failure, we suggest consultation with a dermatologist who has expertise in management of vulvar disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Ablative and excisional procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Excisional procedures are indicated for diagnosis and treatment of a suspected associated malignancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/5/9303?source=see_link\">",
"     \"Vulvar cancer: Clinical manifestations, diagnosis, and pathology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20714?source=see_link\">",
"     \"Vulvar cancer: Staging, treatment, and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ablative and excisional procedures (eg, cryotherapy, carbon dioxide laser, radiotherapy, cold knife, focused ultrasound) have a limited role in management of LS [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/2,89-91\">",
"     2,89-91",
"    </a>",
"    ]. We reserve surgical intervention for managing postinflammatory sequelae (ie, severe adhesions) of the disease. We try to defer surgery until the disease has been controlled with medication because these interventions tend to irritate the skin and exacerbate symptoms.",
"   </p>",
"   <p>",
"    Introital stenosis, posterior fissuring, and scarring at the fourchette can be treated by vulvoperineoplasty (",
"    <a class=\"graphic graphic_figure graphicRef79506 \" href=\"UTD.htm?29/56/30593\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. Since vaginal tissue is not affected by LS, part of the vaginal wall is used in the repair to prevent recurrent adhesions and fissuring at the introitus.",
"   </p>",
"   <p>",
"    Adhesions at the fourchette which cause dyspareunia can be extirpated. Adhesions burying the clitoris can result in formation of painful pseudocysts. Clitoral adhesions are released with delicate knife strokes and use of a lacrimal duct probe to free the hood from the glans [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/94\">",
"     94",
"    </a>",
"    ]. Reformation of adhesions can be prevented by resection of a fragment of the clitoral hood in the shape of a tricorn hat (",
"    <a class=\"graphic graphic_figure graphicRef77280 \" href=\"UTD.htm?1/36/1600\">",
"     figure 2",
"    </a>",
"    ), excision of the clitoral hood (equivalent to a circumcision), or suturing Interceed&trade; mesh along the edges of the incision [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postoperatively, we prescribe a superpotent topical steroid nightly for eight weeks followed by maintenance therapy (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Corticosteroids'",
"    </a>",
"    above), since LS symptoms are often reactivated following surgery and adhesions can reform [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/96\">",
"     96",
"    </a>",
"    ]. Immediately after surgery, we have the patient apply",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10964?source=see_link\">",
"     silver sulfadiazine",
"    </a>",
"    cream to the operative sites twice per day and follow-up in one week. If any adhesions are forming, we apply a topical anesthetic and manually separate them. We continue this regimen for another week, at which time we start the patient on a superpotent steroid nightly and petrolatum ointment applied as a thin film each morning. She should be shown (with a mirror) exactly where to apply the topical agents. After a week, the steroid is decreased to twice weekly and the patient is told to apply petrolatum ointment twice per day. At the same time steroids are begun, we also have the patient begin to dilate her vaginal opening nightly, for 30 to 60 minutes, using a small, medium, or large Syracuse dilator after applying some",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    . The size of the dilator is increased gradually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5838076\">",
"    <span class=\"h2\">",
"     Photodynamic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful treatment of vulvar LS with photodynamic therapy (PDT) has been reported in case reports and small pilot studies [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/88,97-101\">",
"     88,97-101",
"    </a>",
"    ]. In an open study of 10 patients treated with two sessions of PTD, all patients reported some improvement in symptoms of vulvar LS (itching, burning, pain) [",
"    <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/101\">",
"     101",
"    </a>",
"    ]. However, improvements in objective measures of disease activity were minor. Additional studies are necessary to evaluate the role of PDT in this disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Referral to a specialist is indicated in the following settings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women whose symptoms are not controlled with potent topical corticosteroids applied three or more times weekly or after using &gt;30 g over six months.",
"     </li>",
"     <li>",
"      Women with localized skin",
"      <span class=\"nowrap\">",
"       thickening/hyperkeratosis",
"      </span>",
"      unresponsive to topical steroids.",
"     </li>",
"     <li>",
"      Women previously treated for usual or differentiated type VIN",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      SCC. Differentiated VIN requires excision. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32952?source=see_link\">",
"       \"Vulvar intraepithelial neoplasia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Women with vulvar biopsy showing carcinoma or precancerous changes. Biopsy should be performed in women with clinical evidence of localized skin",
"      <span class=\"nowrap\">",
"       thickening/hyperkeratosis.",
"      </span>",
"     </li>",
"     <li>",
"      Women with biopsies where the pathologist expresses concern, but cannot make a definite diagnosis of differentiated VIN [",
"      <a class=\"abstract\" href=\"UTD.htm?6/45/6874/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14530?source=see_link\">",
"       \"Patient information: Lichen sclerosus (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?26/30/27106?source=see_link\">",
"       \"Patient information: Lichen sclerosus (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lichen sclerosus refers to a benign, chronic, progressive dermatologic condition characterized by marked inflammation, epithelial thinning and distinctive dermal changes accompanied by pruritus and pain. Areas of epithelial hyperplasia from rubbing are often seen. Lichen sclerosus usually occurs in the anogenital region, but can develop on any skin surface and in both women and men (",
"      <a class=\"graphic graphic_picture graphicRef78574 \" href=\"UTD.htm?41/38/42597\">",
"       picture 1A",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef62753 \" href=\"UTD.htm?11/42/11941\">",
"       picture 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology is unknown. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vulvar pruritus is common and can be so intense that it interferes with sleep. Other symptoms include pruritus ani, painful defecation, rectal bleeding, dyspareunia, and dysuria. However, some patients are asymptomatic. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The classic appearance is thin, white, wrinkled skin localized to the labia minora",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      labia majora (",
"      <a class=\"graphic graphic_picture graphicRef78574 \" href=\"UTD.htm?41/38/42597\">",
"       picture 1A",
"      </a>",
"      ), although the whitening may extend over the perineum and around the anus in a keyhole fashion (",
"      <a class=\"graphic graphic_picture graphicRef62753 \" href=\"UTD.htm?11/42/11941\">",
"       picture 1B",
"      </a>",
"      ). Fissuring is frequently seen perianally, in the intralabial folds, or around the clitoris. At the end-stages, the vulva is pallid and featureless due to midline fusion. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is based upon the presence of characteristic clinical manifestations plus histological confirmation via vulvar biopsy with immunofluorescent staining. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is a small increased risk of squamous cell cancer of the vulva in patients with lichen sclerosus. For this reason, the skin of patients with vulvar lichen sclerosus should be examined at least yearly, with biopsy of suspicious lesions, and women themselves should look at their skin and touch with fingertips every month or so to search for thickened lumps or sores that do not heal. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Associated malignancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Educating women with vulvar disorders about vulvar hygiene is important with any chronic vulvar condition, including lichen sclerosus (",
"      <a class=\"graphic graphic_table graphicRef64538 \" href=\"UTD.htm?35/49/36635\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Patient education'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medical therapy of lichen sclerosus will lead to symptomatic relief in most women; however, the effectiveness of medical therapy for preventing long-term sequelae, such as scarring and squamous cell cancer, is unclear. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Medical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend initial treatment of vulvar lichen sclerosus with a superpotent topical corticosteroid ointment (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We typically administer",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/16/10502?source=see_link\">",
"       clobetasol",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/44/9925?source=see_link\">",
"       halobetasol",
"      </a>",
"      propionate 0.05% ointment daily at night for 6 to 12 weeks, followed by maintenance therapy one to three times per week if symptoms improve. If symptoms do not improve and thickened hypertrophic plaques are present, we inject",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      hexacetonide directly into the area of involvement. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients with persistent symptoms, we suggest a careful evaluation for causes of treatment failure. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Persistent symptoms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical intervention is indicated for treating the postinflammatory sequelae of lichen sclerosus, and for diagnosis and treatment of an associated malignancy. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Ablative and excisional procedures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Black, MM, McKay, M, Braude, PR. Color atlas and text of obstetric and gynecologic dermatology. Mosby Wolfe, London 1995. p.119.",
"    </li>",
"    <li>",
"     Ridley CM, Neill SM. Non-infective cutaneous conditions of the vulva. In: The Vulva, Ridley CM, Neill SM (Eds), Blackwell Science, Oxford 1999. p.121.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/3\">",
"      Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J R Soc Med 1996; 89:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/4\">",
"      McPherson T, Cooper S. Vulval lichen sclerosus and lichen planus. Dermatol Ther 2010; 23:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/5\">",
"      Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008; 198:496.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/6\">",
"      Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971; 57:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/7\">",
"      Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas J Dermatol 1996; 37:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/8\">",
"      Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005; 50:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/9\">",
"      Leibovitz A, Kaplun V V, Saposhnicov N, Habot B. Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr 2000; 31:1.",
"     </a>",
"    </li>",
"    <li>",
"     Ridley, CM. General dermatologic conditions and dermatoses of the vulva. In: The Vulva, Ridley, CM (Ed), Churchill Livingstone, Edinburgh 1988. p.138.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/11\">",
"      Meyrick Thomas RH, Kennedy CT. The development of lichen sclerosus et atrophicus in monozygotic twin girls. Br J Dermatol 1986; 114:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/12\">",
"      Cox NH, Mitchell JN, Morley WN. Lichen sclerosus et atrophicus in non-identical female twins. Br J Dermatol 1986; 115:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/13\">",
"      Todd P, Halpern S, Kirby J, Pembroke A. Lichen sclerosus and the K&ouml;bner phenomenon. Clin Exp Dermatol 1994; 19:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/14\">",
"      Whimster IW. An experimental approach to the problem of spottiness. Br J Dermatol 1965; 77:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/15\">",
"      Chan I, Oyama N, Neill SM, et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004; 29:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/16\">",
"      Oyama N, Chan I, Neill SM, et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 2004; 113:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/17\">",
"      Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/18\">",
"      Purcell KG, Spencer LV, Simpson PM, et al. HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol 1990; 126:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/19\">",
"      Marren, PM, Millard, PR, Wojnarowska, F. Vulval lichen sclerosus: Lack of correlation between duration of clinical symptoms and histological appearances. J Eur Acad Dermatol Venereol 1997; 8:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/20\">",
"      Carli P, Cattaneo A, Pimpinelli N, et al. Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991; 182:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/21\">",
"      Scrimin F, Rustja S, Radillo O, et al. Vulvar lichen sclerosus: an immunologic study. Obstet Gynecol 2000; 95:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/22\">",
"      Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol 2005; 84:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/23\">",
"      Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144:1432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/24\">",
"      Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity--a study of 350 women. Br J Dermatol 1988; 118:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/25\">",
"      Edmonds EV, Oyama N, Chan I, et al. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus. Br J Dermatol 2011; 165:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/26\">",
"      Yesudian PD, Sugunendran H, Bates CM, O'Mahony C. Lichen sclerosus. Int J STD AIDS 2005; 16:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/27\">",
"      Friedrich EG Jr, Kalra PS. Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone. N Engl J Med 1984; 310:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/28\">",
"      Cantwell AR Jr. Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea, and lichen sclerosus et atrophicus. Int J Dermatol 1984; 23:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/29\">",
"      Alonso-Llamazares J, Persing DH, Anda P, et al. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm Venereol 1997; 77:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/30\">",
"      Kiene P, Milde-Langosch K, L&ouml;ning T. Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus. Arch Dermatol Res 1991; 283:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/31\">",
"      Drut RM, G&oacute;mez MA, Drut R, Lojo MM. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr Dermatol 1998; 15:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/32\">",
"      Eisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol 2008; 144:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/33\">",
"      Farrell, AM, Millard, PR, Schomberg, KH, et al. An infective aetiology for lichen sclerosus: Myth or reality? Br J Dermatol 1997; 50:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/34\">",
"      Godeau G, Frances C, Hornebeck W, et al. Isolation and partial characterization of an elastase-type protease in human vulva fibroblasts: its possible involvement in vulvar elastic tissue destruction of patients with lichen sclerosus et atrophicus. J Invest Dermatol 1982; 78:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/35\">",
"      Oikarinen A, Sandberg M, Hurskainen T, et al. Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques. Acta Derm Venereol Suppl (Stockh) 1991; 162:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/36\">",
"      Neill, SM, Staughn, RCD, Lane, EB, et al. The cytokeratin profile of normal vulval epithelium and vulval lichen sclerosus. Br J Dermatol 1990; 123:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/37\">",
"      Lessana-Leibowitch, M, Poot, M, Rizk-Rabin, M, et al. Flow cytometric analysis of lichen sclerosus compared with normal vulvar skin and carcinoma in situ. Eur J Dermatol 1992; 2:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/38\">",
"      Soini Y, P&auml;&auml;kk&ouml; P, V&auml;h&auml;kangas K, et al. Expression of p53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features. Int J Gynecol Pathol 1994; 13:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/39\">",
"      Tan SH, Derrick E, McKee PH, et al. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol 1994; 21:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/40\">",
"      Neill SM, Tatnall FM, Cox NH, British Association of Dermatologists. Guidelines for the management of lichen sclerosus. Br J Dermatol 2002; 147:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/41\">",
"      Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther 2004; 17:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/42\">",
"      Hallel-Halevy D, Grunwald MH, Yerushalmi J, Halevy S. Bullous lichen sclerosus et atrophicus. J Am Acad Dermatol 1998; 39:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/43\">",
"      Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777.",
"     </a>",
"    </li>",
"    <li>",
"     Margesson, LJ. Lichen sclerosus: Treatment and prognosis. Post-graduate course, International Society for the Study of Vulvovaginal Disease, Sante Fe, NM, October, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/45\">",
"      Nyirjesy P. Lichen Sclerosus and Other Conditions Mimicking Vulvovaginal Candidiasis. Curr Infect Dis Rep 2002; 4:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/46\">",
"      Lessani T, Gallego H, Lynch PJ. Lichen planus and lichen sclerosus overlap. Cutis 1998; 61:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/47\">",
"      Weisberg EL, Le LQ, Cohen JB. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis. Int J Dermatol 2008; 47:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/48\">",
"      Carli P, Cattaneo A, De Magnis A, et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995; 4:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/49\">",
"      Leibowitch M, Neill S, Pelisse M, Moyal-Baracco M. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/50\">",
"      Zaki, I, Dalziel, KL, Solomons, FA. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin Exper Dermatol 1997; 21:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/51\">",
"      Rosamilia LL, Schwartz JL, Lowe L, et al. Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus. J Am Acad Dermatol 2006; 54:S52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/52\">",
"      Raspollini MR, Asirelli G, Moncini D, Taddei GL. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007; 197:592.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/53\">",
"      Neill SM, Lewis FM, Tatnall FM, et al. British Association of Dermatologists' guidelines for the management of lichen sclerosus 2010. Br J Dermatol 2010; 163:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/54\">",
"      Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995; 40:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/55\">",
"      Chi CC, Kirtschig G, Baldo M, et al. Topical interventions for genital lichen sclerosus. Cochrane Database Syst Rev 2011; :CD008240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/56\">",
"      Renaud-Vilmer C, Cavelier-Balloy B, Porcher R, Dubertret L. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 2004; 140:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/57\">",
"      Cooper SM, Gao XH, Powell JJ, Wojnarowska F. Does treatment of vulvar lichen sclerosus influence its prognosis? Arch Dermatol 2004; 140:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/58\">",
"      Zellis S, Pincus SH. Treatment of vulvar dermatoses. Semin Dermatol 1996; 15:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/59\">",
"      Bracco GL, Carli P, Sonni L, et al. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med 1993; 38:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/60\">",
"      Lorenz B, Kaufman RH, Kutzner SK. Lichen sclerosus. Therapy with clobetasol propionate. J Reprod Med 1998; 43:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/61\">",
"      Dalziel KL, Millard PR, Wojnarowska F. The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol 1991; 124:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/62\">",
"      Diakomanolis ES, Haidopoulos D, Syndos M, et al. Vulvar lichen sclerosus in postmenopausal women: a comparative study for treating advanced disease with clobetasol propionate 0.05%. Eur J Gynaecol Oncol 2002; 23:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/63\">",
"      Goldstein AT, Creasey A, Pfau R, et al. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol 2011; 64:e99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/64\">",
"      Dalziel KL, Wojnarowska F. Long-term control of vulval lichen sclerosus after treatment with a potent topical steroid cream. J Reprod Med 1993; 38:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/65\">",
"      Virgili A, Corazza M, Bianchi A, et al. Open study of topical 0.025% tretinoin in the treatment of vulvar lichen sclerosus. One year of therapy. J Reprod Med 1995; 40:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/66\">",
"      Moyal-Barracco M, Edwards L. Diagnosis and therapy of anogenital lichen planus. Dermatol Ther 2004; 17:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/67\">",
"      Mazdisnian F, Degregorio F, Mazdisnian F, Palmieri A. Intralesional injection of triamcinolone in the treatment of lichen sclerosus. J Reprod Med 1999; 44:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/68\">",
"      Bornstein J, Heifetz S, Kellner Y, et al. Clobetasol dipropionate 0.05% versus testosterone propionate 2% topical application for severe vulvar lichen sclerosus. Am J Obstet Gynecol 1998; 178:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/69\">",
"      Cattaneo A, De Marco A, Sonni L, et al. [Clobetasol vs. testosterone in the treatment of lichen sclerosus of the vulvar region]. Minerva Ginecol 1992; 44:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/70\">",
"      Cattaneo A, Carli P, De Marco A, et al. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate. J Reprod Med 1996; 41:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/71\">",
"      Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1994; 46:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/72\">",
"      Paslin D. Treatment of lichen sclerosus with topical dihydrotestosterone. Obstet Gynecol 1991; 78:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/73\">",
"      Niinim&auml;ki A, Kallioinen M, Oikarinen A. Etretinate reduces connective tissue degeneration in lichen sclerosus et atrophicus. Acta Derm Venereol 1989; 69:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/74\">",
"      Bousema MT, Romppanen U, Geiger JM, et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/75\">",
"      Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases. J Reprod Med 2004; 49:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/76\">",
"      Luesley DM, Downey GP. Topical tacrolimus in the management of lichen sclerosus. BJOG 2006; 113:832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/77\">",
"      Nissi R, Eriksen H, Risteli J, Niemimaa M. Pimecrolimus cream 1% in the treatment of lichen sclerosus. Gynecol Obstet Invest 2007; 63:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/78\">",
"      Oskay T, Sezer HK, Gen&ccedil; C, Kutluay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol 2007; 46:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/79\">",
"      Kauppila S, Kotila V, Knuuti E, et al. The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus. Am J Obstet Gynecol 2010; 202:181.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/80\">",
"      Assmann T, Becker-Wegerich P, Grewe M, et al. Tacrolimus ointment for the treatment of vulvar lichen sclerosus. J Am Acad Dermatol 2003; 48:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/81\">",
"      Kunstfeld R, Kirnbauer R, Stingl G, Karlhofer FM. Successful treatment of vulvar lichen sclerosus with topical tacrolimus. Arch Dermatol 2003; 139:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/82\">",
"      Hengge UR, Krause W, Hofmann H, et al. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol 2006; 155:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/83\">",
"      Matsumoto Y, Yamamoto T, Isobe T, et al. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment. J Dermatol 2007; 34:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/84\">",
"      Virgili A, Lauriola MM, Mantovani L, Corazza M. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment. Acta Derm Venereol 2007; 87:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/85\">",
"      Carli P, Cattaneo A, Taddei G, Giannotti B. Topical cyclosporine in the treatment of vulvar lichen sclerosus: clinical, histologic, and immunohistochemical findings. Arch Dermatol 1992; 128:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/86\">",
"      Bulbul Baskan E, Turan H, Tunali S, et al. Open-label trial of cyclosporine for vulvar lichen sclerosus. J Am Acad Dermatol 2007; 57:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/87\">",
"      Origoni M, Ferrari D, Rossi M, et al. Topical oxatomide: an alternative approach for the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet 1996; 55:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/88\">",
"      Hillemanns P, Untch M, Pr&ouml;ve F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999; 93:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/89\">",
"      Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 1997; 136:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/90\">",
"      Abramov Y, Elchalal U, Abramov D, et al. Surgical treatment of vulvar lichen sclerosus: a review. Obstet Gynecol Surv 1996; 51:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/91\">",
"      Li C, Bian D, Chen W, et al. Focused ultrasound therapy of vulvar dystrophies: a feasibility study. Obstet Gynecol 2004; 104:915.",
"     </a>",
"    </li>",
"    <li>",
"     Paniel, BJ. Surgical procedures in benign vulval disease. In: The Vulva, Ridley, CM, Neill, SM, (Eds) Blackwell Science, Oxford 1999. p.277.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/93\">",
"      Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol 2002; 186:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/94\">",
"      Goldstein AT, Burrows LJ. Surgical treatment of clitoral phimosis caused by lichen sclerosus. Am J Obstet Gynecol 2007; 196:126.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/95\">",
"      Breech LL, Laufer MR. Surgicel in the management of labial and clitoral hood adhesions in adolescents with lichen sclerosus. J Pediatr Adolesc Gynecol 2000; 13:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/96\">",
"      Smith YR, Haefner HK. Vulvar lichen sclerosus : pathophysiology and treatment. Am J Clin Dermatol 2004; 5:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/97\">",
"      Zawislak AA, McCluggage WG, Donnelly RF, et al. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed 2009; 25:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/98\">",
"      Sotiriou E, Apalla Z, Patsatsi A, Panagiotidou D. Recalcitrant vulvar lichen sclerosis treated with aminolevulinic acid-photodynamic therapy: a report of five cases. J Eur Acad Dermatol Venereol 2008; 22:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/99\">",
"      Vano-Galvan S, Fernandez-Guarino M, Be&agrave;-Ardebol S, et al. Successful treatment of erosive vulvar lichen sclerosus with methylaminolaevulinic acid and laser-mediated photodynamic therapy. J Eur Acad Dermatol Venereol 2009; 23:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/100\">",
"      Schl&ouml;sser T, Wiesenburg A, G&auml;tgens C, et al. Growth stress triggers riboflavin overproduction in Ashbya gossypii. Appl Microbiol Biotechnol 2007; 76:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?6/45/6874/abstract/101\">",
"      Sotiriou E, Panagiotidou D, Ioannidis D. An open trial of 5-aminolevulinic acid photodynamic therapy for vulvar lichen sclerosus. Eur J Obstet Gynecol Reprod Biol 2008; 141:187.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5558 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-210.101.131.231-DF96EE1385-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6874=[""].join("\n");
var outline_f6_45_6874=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS AND NATURAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      ASSOCIATED MALIGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Patient education",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Persistent symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Ablative and excisional procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5838076\">",
"      Photodynamic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/5558\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5558|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/56/30593\" title=\"figure 1\">",
"      Vulvoperineoplasty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/36/1600\" title=\"figure 2\">",
"      Prevention readhesion clitoris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5558|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/38/42597\" title=\"picture 1A\">",
"      Lichen sclerosus vulva",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/42/11941\" title=\"picture 1B\">",
"      Lichen sclerosus perianal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/4/16449\" title=\"picture 1C\">",
"      Vulvar lichen sclerosis with purpura 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/9/41108\" title=\"picture 2A\">",
"      Lichen sclerosis with ecchymosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/12/9411\" title=\"picture 2B\">",
"      Vulvar lichen sclerosis with purpura 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/35/44594\" title=\"picture 3\">",
"      LS early adult",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/13/39125\" title=\"picture 4A\">",
"      Lichen sclers lost archectectur",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/26/5538\" title=\"picture 4B\">",
"      LS 55 yrs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/36/31299\" title=\"picture 4C\">",
"      LS adult 45 yrs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/37/8789\" title=\"picture 5\">",
"      Lichen sclerosus - histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/23/28018\" title=\"picture 6\">",
"      LS LSC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/23/31089\" title=\"picture 7A\">",
"      LS SCC 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/26/40353\" title=\"picture 7B\">",
"      LS SCC 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/50/43809\" title=\"picture 8\">",
"      VIN 3 LS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/5558|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/25/5532\" title=\"table 1\">",
"      Diagnosis of vulvar pruritus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/49/36635\" title=\"table 2\">",
"      Healthy vulval hygiene practice",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/24/34181?source=related_link\">",
"      Anal fissure: Clinical manifestations, diagnosis, prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/33/14872?source=related_link\">",
"      Balanitis and balanoposthitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/1/15386?source=related_link\">",
"      Candida vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22714?source=related_link\">",
"      Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/6/8295?source=related_link\">",
"      Clinical manifestations and diagnosis of generalized vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5336?source=related_link\">",
"      Dermatitis of the vulva",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28952?source=related_link\">",
"      Extragenital lichen sclerosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/30/27106?source=related_link\">",
"      Patient information: Lichen sclerosus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/12/14530?source=related_link\">",
"      Patient information: Lichen sclerosus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10842?source=related_link\">",
"      Treatment of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21193?source=related_link\">",
"      Vitiligo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/5/9303?source=related_link\">",
"      Vulvar cancer: Clinical manifestations, diagnosis, and pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/14/20714?source=related_link\">",
"      Vulvar cancer: Staging, treatment, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32952?source=related_link\">",
"      Vulvar intraepithelial neoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/5/36952?source=related_link\">",
"      Vulvar lichen planus",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f6_45_6875="Complications of oophorectomy";
var content_f6_45_6875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Complications of laparoscopic oophorectomy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Injection of air into the vascular system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Burns",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumomediastinum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perforation of viscera or blood vessels with the Verres needle or trocar",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nerve injury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ureteral injuries",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spillage of malignant cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Problems with bleeding from the infundibulopelvic ligament pedicle,&nbsp; along the mesoovarium, or in the broad ligament",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6875=[""].join("\n");
var outline_f6_45_6875=null;
var title_f6_45_6876="Rx prosthetic valve thrombosis";
var content_f6_45_6876=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F71538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F71538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    ACC/AHA guideline summary: Treatment of prosthetic heart valve thrombosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Class IIa - The weight of evidence or",
"opinion is in favor of the usefulness of the following modalities in",
"patients with prosthetic heart valve thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        &bull;&nbsp; Emergency surgery for thrombosis in a left-sided prosthetic heart valve in patients with New York Heart Association (NYHA) class III-IV symptoms.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        &bull;&nbsp; Emergency surgery for thrombosis in a left-sided prosthetic heart valve with a large clot burden.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        &bull;&nbsp; Fibrinolytic therapy for thrombosis in a right-sided prosthetic heart valve in patients with New York Heart Association (NYHA) class III-IV symptoms and/or a large clot burden.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"1\">",
"        Class IIb - The weight of",
"evidence or opinion is less well established for the usefulness of the",
"following modalities in patients with prosthetic heart valve thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        &bull;&nbsp; Fibrinolytic therapy as a first-line approach for thrombosis in a left-sided prosthetic heart valve in patients with NYHA class I-II symptoms and a small clot burden.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"1\">",
"        &bull;&nbsp; If surgery is either high risk or not available:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        1. Fibrinolytic therapy as a first-line approach for thrombosis in a left-sided prosthetic heart valve in patients with NYHA class III-IV symptoms and a small clot burden.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        2. Fibrinolytic therapy in patients with an obstructed, thrombosed left-sided prosthetic heart valve, class II-IV symptoms and, a large clot burden.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        &bull;&nbsp; Unfractionated heparin as an alternative to fibrinolytic therapy in patients with NYHA class I-II symptoms and a small clot burden.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2006; 48:e1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6876=[""].join("\n");
var outline_f6_45_6876=null;
var title_f6_45_6877="Neuraminidase inhibitor dosing for flu treatment in children";
var content_f6_45_6877=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70571&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dosing recommendations for neuraminidase inhibiting agents for treatment of influenza in children and adolescents*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug/formulation",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"5\">",
"        Dosing recommendations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        <p>",
"         <strong>",
"          Oseltamivir (Tamiflu",
"          <sup>",
"           &reg;",
"          </sup>",
"          )",
"         </strong>",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         30 mg capsule",
"        </p>",
"        <p>",
"         45 mg capsule",
"        </p>",
"        <p>",
"         75 mg capsule",
"        </p>",
"        <p>",
"         6 mg/mL suspension",
"         <sup>",
"          &Delta;",
"         </sup>",
"        </p>",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        1 through 12 years",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        &ge;13 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &le;15 kg",
"       </td>",
"       <td>",
"        &gt;15-23 kg",
"       </td>",
"       <td>",
"        &gt;23-40 kg",
"       </td>",
"       <td>",
"        &gt;40 kg",
"       </td>",
"       <td rowspan=\"3\">",
"        150 mg/day divided into 2 doses for 5 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        60 mg/day divided into 2 doses for 5 days",
"       </td>",
"       <td>",
"        90 mg/day divided into 2 doses for 5 days",
"       </td>",
"       <td>",
"        120 mg/day divided into 2 doses for 5 days",
"       </td>",
"       <td>",
"        150 mg/day divided into 2 doses for 5 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        Children &ge;12 months should receive ~4 mg/kg per day divided into 2 doses for a 5-day treatment course",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <p>",
"         <strong>",
"          Zanamivir",
"         </strong>",
"         <sup>",
"          &loz;",
"         </sup>",
"         <strong>",
"          (Relenza",
"          <strong>",
"           <sup>",
"            &reg;",
"           </sup>",
"          </strong>",
"          )",
"         </strong>",
"        </p>",
"        <p>",
"         5 mg per inhalation (Diskhaler)",
"        </p>",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"5\">",
"        Children &ge;7 years and adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"5\">",
"        2 inhalations (10 mg total per dose), twice daily for 5 days",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * The choice of agent for treatment depends upon the age of the patient and the susceptibility patterns of circulating strains (see text for details).",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      Dose adjustment is necessary for patients with renal insufficiency. Oseltamivir doses for infants younger than one year of age are provided in the text.",
"      <br>",
"       &Delta;&nbsp;Oral suspensions in the 12 mg/mL concentration will remain available until supplies run out.",
"       <strong>",
"        Providers should be aware that patients may receive either concentration (12 mg/mL or 6 mg/mL) from their pharmacy during the 2012-2013 season",
"       </strong>",
"       . When dispensing the oral suspension of oseltamivir, providers and pharmacists must take care to provide a dosing device that matches the units of measure on the prescription.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        Zanamivir inhalation powder should not be reconstituted in any liquid formulation and is not recommended for use in nebulizers or mechanical ventilators.",
"        <br>",
"         &sect; Two doses should be administered on day one, provided the doses can be spaced at least two hours apart.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        American Academy of Pediatrics. Antiviral drugs. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL, 2012. p.841.",
"       </li>",
"       <li>",
"        www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183714.htm (Accessed on June 28, 2012).",
"       </li>",
"       <li>",
"        www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm186081.htm (Accessed on June 28, 2012).",
"       </li>",
"       <li>",
"        www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm262432.htm (Accessed on June 28, 2012).",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6877=[""].join("\n");
var outline_f6_45_6877=null;
var title_f6_45_6878="Causes of dyspnea in palliative care and potential treatments";
var content_f6_45_6878=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PALC%2F83934&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PALC%2F83934&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of dyspnea in palliative care and potential treatments",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Disease process",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential interventions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Airway obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Airway obstruction by tumor or by lymphadenopathy",
"       </td>",
"       <td>",
"        <p>",
"         Airway laser/cautery*, stent*, radiation therapy (RT)*, resection*, glucocorticoids",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bronchoconstriction (COPD, asthma)",
"       </td>",
"       <td>",
"        Bronchodilators, glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Retained or excess secretions",
"       </td>",
"       <td>",
"        Anticholinergic agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vocal cord paralysis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Obstructive sleep apnea",
"       </td>",
"       <td>",
"        Continuous positive airway pressure (CPAP) at night",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Pulmonary parenchymal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Widespread tumor metastases",
"       </td>",
"       <td>",
"        RT*, chemotherapy*, glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumonia, aspiration",
"       </td>",
"       <td>",
"        Antibiotics, pulmonary toilet, aspiration precautions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Heart failure",
"       </td>",
"       <td>",
"        Diuretics, ACE inhibitors, etc",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pericardial disease, tamponade",
"       </td>",
"       <td>",
"        Pericardiocentesis*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphangitic tumor",
"       </td>",
"       <td>",
"        Diuretics, glucocorticoids, chemotherapy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lung resection (eg, lobectomy, pneumonectomy)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumonitis caused by antineoplastic therapy",
"       </td>",
"       <td>",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Radiation pneumonitis and fibrosis",
"       </td>",
"       <td>",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Interstitial lung disease",
"       </td>",
"       <td>",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Pulmonary vascular",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Venous thromboembolism",
"       </td>",
"       <td>",
"        Anticoagulation*, thrombolysis*, inferior vena cava filter*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sinusoidal obstruction syndrome (veno-occlusive disease)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tumor thromboembolism",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pulmonary hypertension",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Superior vena cava syndrome",
"       </td>",
"       <td>",
"        Glucocorticoids, RT*, chemotherapy*, stent*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Pleural",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pleural effusion (eg, malignant, drug-induced)",
"       </td>",
"       <td>",
"        Indwelling pleural catheter with intermittent drainage; pleurodesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pleural tumor",
"       </td>",
"       <td>",
"        RT*, chemotherapy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pneumothorax",
"       </td>",
"       <td>",
"        Chest tube",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pleural effusion due to lung entrapment by tumor",
"       </td>",
"       <td>",
"        Indwelling pleural catheter with intermittent drainage as guided by symptoms*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Inspiratory muscle weakness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cachexia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electrolyte imbalance",
"       </td>",
"       <td>",
"        Adjust electrolytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Neuromuscular disease, including paraneoplastic syndromes",
"       </td>",
"       <td>",
"        Noninvasive positive pressure ventilation (NPPV)*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Steroid myopathy",
"       </td>",
"       <td>",
"        Physical therapy, reduce dose of glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Diaphragmatic paralysis, phrenic nerve paralysis",
"       </td>",
"       <td>",
"        NPPV*, diaphragmatic pacing*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Decreased chest wall compliance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Restriction post thoracotomy",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Restriction due to advanced chest wall tumor (eg, inflammatory breast cancer)",
"       </td>",
"       <td>",
"        RT*, chemotherapy*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Massive ascites",
"       </td>",
"       <td>",
"        Drainage*, including indwelling catheter with intermittent drainage",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Massive abdominal organomegaly",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Obesity",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Systemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anemia",
"       </td>",
"       <td>",
"        Red blood cell transfusion*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acidosis",
"       </td>",
"       <td>",
"        Correct metabolic abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Arrhythmias",
"       </td>",
"       <td>",
"        Usual treatments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Neuropsychiatric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pain",
"       </td>",
"       <td>",
"        Opioids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Depression",
"       </td>",
"       <td>",
"        Antidepressants, cognitive behavioral therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anxiety, including hyperventilation",
"       </td>",
"       <td>",
"        Anxiolytic medication, cognitive behavioral therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Respiratory panic",
"       </td>",
"       <td>",
"        Anxiolytics, antidepressants, cognitive behavioral therapy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     RT: radiation therapy; COPD: chronic obstructive pulmonary disease; ACE: angiotensin converting enzyme; NPPV: noninvasive positive pressure ventilation.",
"     <br>",
"      * Decisions regarding all therapies and disease-modifying treatments must be made in light of the expected burdens and benefits and be consistent with the patient's long-term and short-term goals of care.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6878=[""].join("\n");
var outline_f6_45_6878=null;
var title_f6_45_6879="Osteomyelitis bone scan";
var content_f6_45_6879=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F61164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F61164&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 510px\">",
"   <div class=\"ttl\">",
"    Osteomyelitis three-phase bone scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 490px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Three-phase bone scan demonstrating asymmetric increased uptake in the left proximal femur (arrows) of this four-month-old with osteomyelitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rajvee Shah, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f6_45_6879=[""].join("\n");
var outline_f6_45_6879=null;
